Patients enrolled in the first study (Manganotti, 2008).
\\n\\n
More than half of the publishers listed alongside IntechOpen (18 out of 30) are Social Science and Humanities publishers. IntechOpen is an exception to this as a leader in not only Open Access content but Open Access content across all scientific disciplines, including Physical Sciences, Engineering and Technology, Health Sciences, Life Science, and Social Sciences and Humanities.
\\n\\nOur breakdown of titles published demonstrates this with 47% PET, 31% HS, 18% LS, and 4% SSH books published.
\\n\\n“Even though ItechOpen has shown the potential of sci-tech books using an OA approach,” other publishers “have shown little interest in OA books.”
\\n\\nAdditionally, each book published by IntechOpen contains original content and research findings.
\\n\\nWe are honored to be among such prestigious publishers and we hope to continue to spearhead that growth in our quest to promote Open Access as a true pioneer in OA book publishing.
\\n\\n\\n\\n
\\n"}]',published:!0,mainMedia:{caption:"IntechOpen Maintains",originalUrl:"/media/original/113"}},components:[{type:"htmlEditorComponent",content:'
Simba Information has released its Open Access Book Publishing 2020 - 2024 report and has again identified IntechOpen as the world’s largest Open Access book publisher by title count.
\n\nSimba Information is a leading provider for market intelligence and forecasts in the media and publishing industry. The report, published every year, provides an overview and financial outlook for the global professional e-book publishing market.
\n\nIntechOpen, De Gruyter, and Frontiers are the largest OA book publishers by title count, with IntechOpen coming in at first place with 5,101 OA books published, a good 1,782 titles ahead of the nearest competitor.
\n\nSince the first Open Access Book Publishing report published in 2016, IntechOpen has held the top stop each year.
\n\n\n\nMore than half of the publishers listed alongside IntechOpen (18 out of 30) are Social Science and Humanities publishers. IntechOpen is an exception to this as a leader in not only Open Access content but Open Access content across all scientific disciplines, including Physical Sciences, Engineering and Technology, Health Sciences, Life Science, and Social Sciences and Humanities.
\n\nOur breakdown of titles published demonstrates this with 47% PET, 31% HS, 18% LS, and 4% SSH books published.
\n\n“Even though ItechOpen has shown the potential of sci-tech books using an OA approach,” other publishers “have shown little interest in OA books.”
\n\nAdditionally, each book published by IntechOpen contains original content and research findings.
\n\nWe are honored to be among such prestigious publishers and we hope to continue to spearhead that growth in our quest to promote Open Access as a true pioneer in OA book publishing.
\n\n\n\n
\n'}],latestNews:[{slug:"webinar-introduction-to-open-science-wednesday-18-may-1-pm-cest-20220518",title:"Webinar: Introduction to Open Science | Wednesday 18 May, 1 PM CEST"},{slug:"step-in-the-right-direction-intechopen-launches-a-portfolio-of-open-science-journals-20220414",title:"Step in the Right Direction: IntechOpen Launches a Portfolio of Open Science Journals"},{slug:"let-s-meet-at-london-book-fair-5-7-april-2022-olympia-london-20220321",title:"Let’s meet at London Book Fair, 5-7 April 2022, Olympia London"},{slug:"50-books-published-as-part-of-intechopen-and-knowledge-unlatched-ku-collaboration-20220316",title:"50 Books published as part of IntechOpen and Knowledge Unlatched (KU) Collaboration"},{slug:"intechopen-joins-the-united-nations-sustainable-development-goals-publishers-compact-20221702",title:"IntechOpen joins the United Nations Sustainable Development Goals Publishers Compact"},{slug:"intechopen-signs-exclusive-representation-agreement-with-lsr-libros-servicios-y-representaciones-s-a-de-c-v-20211123",title:"IntechOpen Signs Exclusive Representation Agreement with LSR Libros Servicios y Representaciones S.A. de C.V"},{slug:"intechopen-expands-partnership-with-research4life-20211110",title:"IntechOpen Expands Partnership with Research4Life"},{slug:"introducing-intechopen-book-series-a-new-publishing-format-for-oa-books-20210915",title:"Introducing IntechOpen Book Series - A New Publishing Format for OA Books"}]},book:{item:{type:"book",id:"10303",leadTitle:null,fullTitle:"Cardiomyopathy - Disease of the Heart Muscle",title:"Cardiomyopathy",subtitle:"Disease of the Heart Muscle",reviewType:"peer-reviewed",abstract:"Cardiomyopathies are diseases of the heart muscle with diverse etiologies ranging from myocarditis to gene mutations. They are classified according to morphology and function, and then further categorized based on whether they are familial or non-familial and based on specific etiologies. This book examines the various cardiomyopathies, including arrhythmogenic cardiomyopathy, hypertrophic cardiomyopathy, and dilated cardiomyopathy, as well as their genetic basis.",isbn:"978-1-78985-224-0",printIsbn:"978-1-78985-223-3",pdfIsbn:"978-1-78985-923-2",doi:"10.5772/intechopen.91489",price:139,priceEur:155,priceUsd:179,slug:"cardiomyopathy-disease-of-the-heart-muscle",numberOfPages:496,isOpenForSubmission:!1,isInWos:null,isInBkci:!1,hash:"3fa88fd83f8f58fb421674a123bd86ed",bookSignature:"Gustav Mattsson and Peter Magnusson",publishedDate:"October 27th 2021",coverURL:"https://cdn.intechopen.com/books/images_new/10303.jpg",numberOfDownloads:5853,numberOfWosCitations:0,numberOfCrossrefCitations:1,numberOfCrossrefCitationsByBook:0,numberOfDimensionsCitations:4,numberOfDimensionsCitationsByBook:0,hasAltmetrics:1,numberOfTotalCitations:5,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"September 21st 2020",dateEndSecondStepPublish:"October 19th 2020",dateEndThirdStepPublish:"December 18th 2020",dateEndFourthStepPublish:"March 8th 2021",dateEndFifthStepPublish:"May 7th 2021",currentStepOfPublishingProcess:5,indexedIn:"1,2,3,4,5,6",editedByType:"Edited by",kuFlag:!1,featuredMarkup:null,editors:[{id:"238220",title:"Dr.",name:"Gustav",middleName:null,surname:"Mattsson",slug:"gustav-mattsson",fullName:"Gustav Mattsson",profilePictureURL:"https://mts.intechopen.com/storage/users/238220/images/system/238220.jpg",biography:"Gustav Mattsson, MD, graduated from Uppsala University, Sweden, and is currently working in internal medicine at Gävle Hospital, Sweden. He is active in research at the Centre for Research and Development, Gävleborg, Uppsala University, and has a strong interest in research and scientific writing in the field of cardiology. He is an author of thirty peer-reviewed articles, twenty-four articles with an editorial review, six book chapters, and ten scientific posters. His research interests include cardiomyopathies, arrhythmia, and device therapy.",institutionString:"Uppsala University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"5",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Uppsala University",institutionURL:null,country:{name:"Sweden"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,coeditorOne:{id:"188088",title:"Dr.",name:"Peter",middleName:null,surname:"Magnusson",slug:"peter-magnusson",fullName:"Peter Magnusson",profilePictureURL:"https://mts.intechopen.com/storage/users/188088/images/system/188088.png",biography:"Dr. Peter Magnusson earned his MD from Lund University, Sweden, and his Ph.D. from the Karolinska Institute, Sweden. His scientific work mainly involves cardiac arrhythmias, heart failure, cardiomyopathies, and implantable cardiac devices. Dr. Magnusson is a renowned speaker and leader of educational activities for diverse groups of professionals.",institutionString:"Karolinska Institute",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"11",totalChapterViews:"0",totalEditedBooks:"3",institution:{name:"Karolinska Institute",institutionURL:null,country:{name:"Sweden"}}},coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"170",title:"Cardiology and Cardiovascular Medicine",slug:"cardiology-and-cardiovascular-medicine"}],chapters:[{id:"74776",title:"An Overview of the Cardiomyopathies",doi:"10.5772/intechopen.95568",slug:"an-overview-of-the-cardiomyopathies",totalDownloads:287,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Cardiomyopathies constitute a heterogeneous group of heart diseases. In fact, cardiomyopathies is a major cause of death either as end-stage heart failure or sudden cardiac death. Even though prognosis is, in many cases, poor there are several approaches to optimal disease management, which improves outcome and implies better quality of life including reduced risk of hospitalization. Differentiation of underlying etiology in individual cases of cardiomyopathies requires careful clinical evaluation. Echocardiography is the cornerstone in initial evaluation and follow-up but cardiac magnetic resonance provides additional value. ECG, biomarkers, detailed history taking and extracardiac features may provide clues to less common entities. While forty years ago cardiomyopathy was defined as heart muscle disease of unknown origin, the underlying pathophysiology has now been elucidated. Indeed, the last decades the genetic explanations have evolved. Advanced treatment with pacemakers, including cardiac resynchronization, implantable defibrillators, and mechanical devices in the most severe cases are nowadays available for many patients. The evidence-based pharmacological approach to heart failure provides multiple interaction of pathophysiological pathways and has improved outcome. In selected cases specific agents are indicated why differential diagnosis is crucial and the genetic link imply cascade screening. This chapter aims to present a comprehensive overview of the cardiomyopathies, categorized into: dilated-, hypertrophic-, restrictive-, arrhythmogenic and unclassified cardiomyopathy.",signatures:"Ida Kåks, Marianna Leopoulou, Gustav Mattsson and Peter Magnusson",downloadPdfUrl:"/chapter/pdf-download/74776",previewPdfUrl:"/chapter/pdf-preview/74776",authors:[{id:"238220",title:"Dr.",name:"Gustav",surname:"Mattsson",slug:"gustav-mattsson",fullName:"Gustav Mattsson"},{id:"188088",title:"Dr.",name:"Peter",surname:"Magnusson",slug:"peter-magnusson",fullName:"Peter Magnusson"},{id:"315154",title:"Dr.",name:"Marianna",surname:"Leopoulou",slug:"marianna-leopoulou",fullName:"Marianna Leopoulou"},{id:"332715",title:"Dr.",name:"Ida",surname:"Kåks",slug:"ida-kaks",fullName:"Ida Kåks"}],corrections:null},{id:"76628",title:"Cardiomyopathy: Recent Findings",doi:"10.5772/intechopen.97092",slug:"cardiomyopathy-recent-findings",totalDownloads:304,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:1,abstract:"In 1957, Wallace Brigden published an article on the Lancet, such as uncommon myocardial diseases: the non-coronary cardiomyopathy. In this article, he mentioned that “the term cardiomyopathy is used here to indicate isolated noncoronary myocardial disease.” Then “cardiomyopathy” has become a commonly used term in the cardiovascular field, and has been defined and classified by many researchers and academic societies. The basic concept of cardiomyopathy is a group of diseases with mechanical and/or electrophysiological dysfunction of the ventricles, and cardiomyopathy is distinguished with normal ischemic heart disease, valvular disease, and hypertensive heart disease. It can often cause heart failure and cardiac death. In this chapter, we describe the classification, details, and treatment of cardiomyopathy, and iPS cell from pathological myocardium.",signatures:"Yoshihiro Yamada, Keiki Sugi, Hiroyuki Nakajima and Takaaki Senbonmatsu",downloadPdfUrl:"/chapter/pdf-download/76628",previewPdfUrl:"/chapter/pdf-preview/76628",authors:[{id:"145208",title:"Dr.",name:"Takaaki",surname:"Senbonmatsu",slug:"takaaki-senbonmatsu",fullName:"Takaaki Senbonmatsu"},{id:"356637",title:"M.D.",name:"Keiki",surname:"Sugi",slug:"keiki-sugi",fullName:"Keiki Sugi"},{id:"356852",title:"Dr.",name:"Yoshihiro",surname:"Yamada",slug:"yoshihiro-yamada",fullName:"Yoshihiro Yamada"},{id:"356853",title:"M.D.",name:"Hiroyuki",surname:"Nakajima",slug:"hiroyuki-nakajima",fullName:"Hiroyuki Nakajima"}],corrections:null},{id:"74904",title:"Cardiomyopathy Etiologies, Symptoms and Management",doi:"10.5772/intechopen.95566",slug:"cardiomyopathy-etiologies-symptoms-and-management",totalDownloads:261,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Cardiomyopathy can be defined as a structural and functional myocardial disorder that is commonly genetic rather than due to coronary artery, valvular or congenital heart disease. It can be subcategorized into dilated, hypertrophic, restrictive, unclassified, and arrhythmogenic right ventricular cardiomyopathy/dysplasia. They can be further subdivided into primary and secondary cardiomyopathy. Primary includes genetics (HOCM, ARVC/D), mixed (DCM, RCM) or acquired (stress-induced, myocarditis) causes; while secondary cardiomyopathy is derived from the involvement of other organ systems. Cardiomyopathies can be identified by echocardiogram to display the anatomic and functional changes related to each subtype including systolic or diastolic dysfunction. In certain instances, cardiac-MRI or CT are used to further elucidate its specific characteristics such as fatty infiltration and focal hypertrophy. Treatment is very diverse and catered to each individual case. This will all be further elaborated on in the following chapter.",signatures:"Waleed Kian, Melanie Zemel, Emily H. Kestenbaum, Wafeek Alguayn, Boris Shvarts, Adam A. Sharb, Dina Levitas, Yousef Kian, Nir Peled and Alexander Yakobson",downloadPdfUrl:"/chapter/pdf-download/74904",previewPdfUrl:"/chapter/pdf-preview/74904",authors:[{id:"337634",title:"Dr.",name:"Waleed",surname:"Kian",slug:"waleed-kian",fullName:"Waleed Kian"},{id:"344241",title:"BSc.",name:"Melanie",surname:"Zemel",slug:"melanie-zemel",fullName:"Melanie Zemel"},{id:"344242",title:"BSc.",name:"Emily",surname:"H. Kestenbaum",slug:"emily-h.-kestenbaum",fullName:"Emily H. Kestenbaum"},{id:"344243",title:"Dr.",name:"Wafeek",surname:"Alguayn",slug:"wafeek-alguayn",fullName:"Wafeek Alguayn"},{id:"344244",title:"Dr.",name:"Boris",surname:"Shvarts",slug:"boris-shvarts",fullName:"Boris Shvarts"},{id:"344245",title:"Dr.",name:"Adam",surname:"A.Sharb",slug:"adam-a.sharb",fullName:"Adam A.Sharb"},{id:"344246",title:"Dr.",name:"Yousef",surname:"Kian",slug:"yousef-kian",fullName:"Yousef Kian"},{id:"344248",title:"Prof.",name:"Nir",surname:"Peled",slug:"nir-peled",fullName:"Nir Peled"},{id:"344249",title:"Dr.",name:"Alexander",surname:"Yakobson",slug:"alexander-yakobson",fullName:"Alexander Yakobson"},{id:"345587",title:"Dr.",name:"Dina",surname:"Levitas",slug:"dina-levitas",fullName:"Dina Levitas"}],corrections:null},{id:"76672",title:"The Role of Neurohormonal Systems, Inflammatory Mediators and Oxydative Stress in Cardiomyopathy",doi:"10.5772/intechopen.97345",slug:"the-role-of-neurohormonal-systems-inflammatory-mediators-and-oxydative-stress-in-cardiomyopathy",totalDownloads:155,totalCrossrefCites:1,totalDimensionsCites:1,hasAltmetrics:0,abstract:"Cardiomyopathy and more specifically the dilated cardiomyopathy, regardless of severity, is associated with activation of neuro-hormonal, cytokine and oxidative stress signaling pathways that alter the structure and function of cardiac myocytes and non-myocyte cells. These cellular alterations culminate in the morphological changes in cardiac structure termed as cardiac remodeling, a maladaptive process that contributes to further left ventricular dysfunction and heart failure development. This pathological progression is mainly driven by circulating mediators, in particular angiotensin II and norepinephrine. Natriuretic peptides, endothelin-1, vasopressin play also an important role in the progression of the cardiomyopathy. Cardiac inflammation, mediated by cytokines such as tumor necrosis factor-α (TNF-α), interleukins 1 (IL-1) and 6 (IL-6), as well as the oxidative stress were also shown to worsen the cardiac function. Although these pathways have been described separately, they are critically inter-dependent in the response to the development and progression of the dilated cardiomyopathy. This chapter reviews the cellular basis for cardiac remodeling and the mechanisms that contribute to these cellular abnormalities and, more broadly, to the pathophysiology of dilated cardiomyopathy, its progression and its potential treatments.",signatures:"Ronald Zolty",downloadPdfUrl:"/chapter/pdf-download/76672",previewPdfUrl:"/chapter/pdf-preview/76672",authors:[{id:"335960",title:"Prof.",name:"Ronald",surname:"Zolty",slug:"ronald-zolty",fullName:"Ronald Zolty"}],corrections:null},{id:"76301",title:"Genetics of Cardiomyopathy",doi:"10.5772/intechopen.97010",slug:"genetics-of-cardiomyopathy",totalDownloads:367,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Cardiomyopathies (CMs) encompass a heterogeneous group of structural and functional (systolic and diastolic) abnormalities of the myocardium and are either confined to the cardiovascular system or are part of a systemic disorder. CMs represent a leading cause of morbidity and mortality and account for a significant percentage of death and cardiac transplantation. The 2006 American Heart Association (AHA) classification grouped CMs into primary (genetic, mixed, or acquired) or secondary (i.e., infiltrative or autoimmune). In 2008, the European Society of Cardiology classification proposed subgrouping CM into familial or genetic and nonfamilial or nongenetic forms. In 2013, the World Heart Federation recommended the MOGES nosology system, which incorporates a morpho-functional phenotype (M), organ(s) involved (O), the genetic inheritance pattern (G), an etiological annotation (E) including genetic defects or underlying disease/substrates, and the functional status (S) of a particular patient based on heart failure symptoms. Rapid advancements in the biology of cardio-genetics have revealed substantial genetic and phenotypic heterogeneity in myocardial disease. Given the variety of disciplines in the scientific and clinical fields, any desired classification may face challenges to obtaining consensus. Nonetheless, the heritable phenotype-based CM classification offers the possibility of a simple, clinically useful diagnostic scheme. In this chapter, we will describe the genetic basis of dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), arrhythmogenic cardiomyopathy (ACM), LV noncompaction cardiomyopathy (LVNC), and restrictive cardiomyopathy (RCM). Although the descriptive morphologies of these types of CM differ, an overlapping phenotype is frequently encountered within the CM types and arrhythmogenic pathology in clinical practice. CMs appear to originate secondary to disruption of “final common pathways.” These disruptions may have purely genetic causes. For example, single gene mutations result in dysfunctional protein synthesis causing downstream dysfunctional protein interactions at the level of the sarcomere and a CM phenotype. The sarcomere is a complex with multiple protein interactions, including thick myofilament proteins, thin myofilament proteins, and myosin-binding proteins. In addition, other proteins are involved in the surrounding architecture of the sarcomere such as the Z-disk and muscle LIM proteins. One or multiple genes can exhibit tissue-specific function, development, and physiologically regulated patterns of expression for each protein. Alternatively, multiple mutations in the same gene (compound heterozygosity) or in different genes (digenic heterozygosity) may lead to a phenotype that may be classic, more severe, or even overlapping with other disease forms.",signatures:"Evan M. Harvey, Murad Almasri and Hugo R. Martinez",downloadPdfUrl:"/chapter/pdf-download/76301",previewPdfUrl:"/chapter/pdf-preview/76301",authors:[{id:"333238",title:"Dr.",name:"Hugo",surname:"Martinez",slug:"hugo-martinez",fullName:"Hugo Martinez"},{id:"344776",title:"Dr.",name:"Evan M.",surname:"Harvey",slug:"evan-m.-harvey",fullName:"Evan M. Harvey"},{id:"344777",title:"Dr.",name:"Murad",surname:"Almasri",slug:"murad-almasri",fullName:"Murad Almasri"}],corrections:null},{id:"76464",title:"The Role of Genetics in Cardiomyopaties: A Review",doi:"10.5772/intechopen.97242",slug:"the-role-of-genetics-in-cardiomyopaties-a-review",totalDownloads:284,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Cardiomyopathies are defined as disorders of the myocardium which are always associated with cardiac dysfunction and are aggravated by arrhythmias, heart failure and sudden death. There are different ways of classifying them. The American Heart Association has classified them in either primary or secondary cardiomyopathies depending on whether the heart is the only organ involved or whether they are due to a systemic disorder. On the other hand, the European Society of Cardiology has classified them according to the different morphological and functional phenotypes associated with their pathophysiology. In 2013 the MOGE(S) classification started to be published and clinicians have started to adopt it. The purpose of this review is to update it.",signatures:"Luis Vernengo and Haluk Topaloglu",downloadPdfUrl:"/chapter/pdf-download/76464",previewPdfUrl:"/chapter/pdf-preview/76464",authors:[{id:"75404",title:"Dr.",name:"Luis",surname:"Vernengo",slug:"luis-vernengo",fullName:"Luis Vernengo"},{id:"344821",title:"Prof.",name:"Haluk",surname:"Topaloglu",slug:"haluk-topaloglu",fullName:"Haluk Topaloglu"}],corrections:null},{id:"76506",title:"The Z-Disk Final Common Pathway in Cardiomyopathies",doi:"10.5772/intechopen.97532",slug:"the-z-disk-final-common-pathway-in-cardiomyopathies",totalDownloads:292,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"The sarcomeres represent the essential contractile units of the cardiac myocyte and are bordered by two Z-lines (disks) that are made by various proteins. The cardiac Z-disk is recognized as one of the nodal points in cardiomyocyte structural organization, mechano-sensation and signal transduction. Rapid progress in molecular and cellular biology has significantly improved the knowledge about pathogenic mechanisms and signaling pathways involved in the development of inherited cardiomyopathies. Genetic insult resulting in expression of mutated proteins that maintain the structure of the heart can perturb cardiac function. The primary mutation in the cardiac contractile apparatus or other subcellular complexes can lead to cardiac pathology on a tissue level, resulting in organ and organism level pathophysiology. The “final common pathway” hypothesis interpreting the genetic basis and molecular mechanisms involved in the development of cardiomyopathies suggests that mutations in cardiac genes encoding proteins with similar structure, function, or location and operating in the same pathway, are responsible for a particular phenotype of cardiomyopathy with unique morpho-histological remodeling of the heart. This chapter will describe genetic abnormalities of cardiac Z-disk and related “final common pathways” that are triggered by a Z-disk genetic insult leading to heart muscle diseases. In addition, animal models carrying mutations in Z-disk proteins will be described.",signatures:"Enkhsaikhan Purevjav and Jeffrey A. Towbin",downloadPdfUrl:"/chapter/pdf-download/76506",previewPdfUrl:"/chapter/pdf-preview/76506",authors:[{id:"231585",title:"Associate Prof.",name:"Enkhsaikhan",surname:"Purevjav",slug:"enkhsaikhan-purevjav",fullName:"Enkhsaikhan Purevjav"},{id:"345566",title:"Prof.",name:"Jeffrey A.",surname:"Towbin",slug:"jeffrey-a.-towbin",fullName:"Jeffrey A. Towbin"}],corrections:null},{id:"74477",title:"Update on Genes Associated with Arrhythmogenic Cardiomyopathy",doi:"10.5772/intechopen.95332",slug:"update-on-genes-associated-with-arrhythmogenic-cardiomyopathy",totalDownloads:328,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Arrhythmogenic cardiomyopathy is a rare genetic entity characterized by progressive fibro-fatty replacement of myocardium leading to malignant arrhythmias, syncope, and sudden cardiac death. Mostly it affects the right ventricle, but cases have also been described with biventricular and even isolated left ventricular involvement. The disease affects mainly young males and arrhythmias are usually induced by exercise. Arrhythmogenic cardiomyopathy has a genetic origin and is basically caused by deleterious alterations in genes encoding desmosomal proteins, especially plakophilin-2. To date, more than 400 rare genetic alterations have been identified in 18 genes, mainly with autosomal dominant inheritance, but some recessive forms have also been reported (Naxos disease and Carvajal syndrome). A comprehensive genetic analysis identifies a rare variant as potential cause of the disease in around 60% of patients, suggesting the existence of unknown genes as well as other genome alterations not yet discovered. Genetic interpretation classifies some of these rare variants as ambiguous, playing an uncertain role in arrhythmogenic cardiomyopathy. This makes a proper translation of genetic data into clinical practice difficult. Moreover, incomplete penetrance and variable phenotypic expression makes it difficult to arrive at the correct diagnosis. In the present chapter, we focus on recent advances in the knowledge regarding the genetic basis of arrhythmogenic cardiomyopathy.",signatures:"Marta Vallverdú-Prats, Mireia Alcalde, Georgia Sarquella-Brugada, Sergi Cesar, Elena Arbelo, Josep Brugada, Ramon Brugada and Oscar Campuzano",downloadPdfUrl:"/chapter/pdf-download/74477",previewPdfUrl:"/chapter/pdf-preview/74477",authors:[{id:"54165",title:"Prof.",name:"Ramon",surname:"Brugada",slug:"ramon-brugada",fullName:"Ramon Brugada"},{id:"54168",title:"Dr.",name:"Oscar",surname:"Campuzano",slug:"oscar-campuzano",fullName:"Oscar Campuzano"},{id:"218478",title:"Dr.",name:"Georgia",surname:"Sarquella-Brugada",slug:"georgia-sarquella-brugada",fullName:"Georgia Sarquella-Brugada"},{id:"218479",title:"Dr.",name:"Sergi",surname:"Cesar",slug:"sergi-cesar",fullName:"Sergi Cesar"},{id:"341367",title:"MSc.",name:"Marta",surname:"Vallverdú-Prats",slug:"marta-vallverdu-prats",fullName:"Marta Vallverdú-Prats"},{id:"341368",title:"Dr.",name:"Mireia",surname:"Alcalde",slug:"mireia-alcalde",fullName:"Mireia Alcalde"},{id:"341370",title:"Dr.",name:"Elena",surname:"Arbelo",slug:"elena-arbelo",fullName:"Elena Arbelo"},{id:"341372",title:"Prof.",name:"Josep",surname:"Brugada",slug:"josep-brugada",fullName:"Josep Brugada"}],corrections:null},{id:"75133",title:"Naxos Disease: Current Knowledge and Future Advances",doi:"10.5772/intechopen.96020",slug:"naxos-disease-current-knowledge-and-future-advances",totalDownloads:287,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:1,abstract:"Naxos disease is a genetic cardiocutaneous syndrome manifesting with a cardiomyopathy that belongs in the arrhythmogenic right ventricular cardiomyopathy (ARVC) spectrum and follows an autosomal recessive pattern. It manifests with wooly hair, keratosis of the extremities and right ventricular dysfunction. It is accompanied by risk of arrhythmias as well as sudden cardiac death (SCD), even at a young age. Furthermore, the disease often progresses to right ventricular heart failure, but can also affect the left ventricle. Patient management follows current guidelines on ARVC and principles for heart failure management. Bioengineering and research about pluripotent stem cells seem to have potential to improve future management of the disease. This chapter covers current knowledge on Naxos disease regarding clinical features, epidemiology, pathogenesis, guidelines on patient management and provides insights in research frontlines.",signatures:"Marianna Leopoulou, Gustav Mattsson, Ida Kåks and Peter Magnusson",downloadPdfUrl:"/chapter/pdf-download/75133",previewPdfUrl:"/chapter/pdf-preview/75133",authors:[{id:"238220",title:"Dr.",name:"Gustav",surname:"Mattsson",slug:"gustav-mattsson",fullName:"Gustav Mattsson"},{id:"188088",title:"Dr.",name:"Peter",surname:"Magnusson",slug:"peter-magnusson",fullName:"Peter Magnusson"},{id:"315154",title:"Dr.",name:"Marianna",surname:"Leopoulou",slug:"marianna-leopoulou",fullName:"Marianna Leopoulou"},{id:"335178",title:"Dr.",name:"Ida",surname:"Kåks",slug:"ida-kaks",fullName:"Ida Kåks"}],corrections:null},{id:"76233",title:"Arrhythmogenic Right Ventricular Cardiomyopathy",doi:"10.5772/intechopen.96855",slug:"arrhythmogenic-right-ventricular-cardiomyopathy",totalDownloads:280,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Arrythmogenic right ventricular cardiomyopathy (ARVC) is a genetic form of cardiomyopathy causing fibro-fatty replacement of the myocardium. Although usually transmission is autosomal dominant, 12 genes encoding cardiac desmosomes have been found to be closely linked to this disease process shifting the congenital disease theory to a genetic one. The categorisation of ARVC as a myocyte adhesion disorder was first suggested by a molecular genetic study involving patients with Naxos disease. Misnomeric to only affect the right ventricle, ARVC also affects the left ventricle - culminating into biventricular failure as a long term prognosis. Epidemiology is well established with a male to female preponderance. It is currently the second most common cause of sudden cardiac death (SCD) in population < 35 yrs. Pathological basis of the varied clinical presentation is explained at the molecular level with myocardial atrophy, fibro-fatty replacement and chamber dilatation. Diagnosing the condition by ruling out the pitfall differentials is an enormous challenge due to the broad phenotypic spectrum including syncope on one end and SCD on the other. Task Force Criteria combines electrocardiography (ECG), echocardiography (ECHO), cardiac magnetic resonance imaging (CMRI), myocardial biopsy for diagnosis; early detection, family screening and risk stratification being the cornerstones. Therapeutic options although limited due to the progressive nature of the disease is based on preventing life threatening arrhythmias encompassing primary and secondary prevention - Implantable cardioverter -defibrillator (ICD) implantation, radiofrequency ablation and heart transplantation are the main ones.",signatures:"Sukanya Ghosh",downloadPdfUrl:"/chapter/pdf-download/76233",previewPdfUrl:"/chapter/pdf-preview/76233",authors:[{id:"333139",title:"Dr.",name:"Sukanya",surname:"Ghosh",slug:"sukanya-ghosh",fullName:"Sukanya Ghosh"}],corrections:null},{id:"75983",title:"Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Diagnosis, Clinical Course and Therapy",doi:"10.5772/intechopen.97033",slug:"hypertrophic-cardiomyopathy-genetics-pathogenesis-diagnosis-clinical-course-and-therapy",totalDownloads:327,totalCrossrefCites:0,totalDimensionsCites:2,hasAltmetrics:1,abstract:"Hypertrophic cardiomyopathy (HCM) is a genetic disorder of cardiac myocytes that is characterized by cardiac hypertrophy, unexplained by the loading conditions, a non-dilated left ventricle and a normal or increased left ventricular ejection fraction (LV-EF). Prevalence of HCM has been estimated at 0.16% to 0.29% (≈ 1:625–1:344 individuals) in the general adult population. HCM represents the most common genetic heart disease and represent an archetypical single gene disorder with an autosomal dominant pattern of inheritance and historically termed a “disease of the sarcomere”. The precise mechanisms by which sarcomere variants result in the clinical phenotype have not been fully understood. Mutant sarcomere genes trigger several myocardial changes, leading to hypertrophy and fibrosis, which ultimately result in a small, stiff ventricle with impaired systolic and diastolic performance despite a preserved LV-EF. The most common differential diagnosis challenges in the presence of hypertrophic heart disease are represented by: athlete’s heart, hypertensive heart and other cardiomyopathies mimicking HCM. A multimodality approach using ECG, echocardiography, CMR, cardiac computed tomography (CCT) and cardiac nuclear imaging provides unique information about diagnosis, staging and clinical profiles, anatomical and functional assessment, metabolic evaluation, monitoring of treatment, follow-up, prognosis and risk stratification, as well as preclinical screening and differential diagnosis. HCM may be associated with a normal life expectancy and a very stable clinical course. However, about a third of patients develop heart failure (HF); in addition, 5–15% of cases show progression to either the restrictive or the dilated hypokinetic evolution of HCM, both of which may require evaluation for cardiac transplantation. The clinical course of HCM has been classified into four clinical stages: non-hypertrophic, classic, adverse remodeling and overt dysfunction phenotype. No evidence-based treatments are available for non-hypertrophic HCM patients (pre-hypertrophic stage), on the other hand in classic HCM, adverse remodeling and overt dysfunction phenotype, pharmacological or interventional strategies have the target to improve functional capacity, reduce symptoms, prevent disease progression. Therapeutic approach mainly differs on the basis of the presence or absence of significant obstructive HCM. Adult patients with HCM report an annual incidence for cardiovascular death of 1–2%, with sudden cardiac death (SCD), HF and thromboembolism being the main causes of death; the most commonly recorded fatal arrhythmic event is spontaneous ventricular fibrillation. For this reason, SCD risk estimation is an integral part of clinical management of HCM. International guidelines suggest the evaluation of several risk factor for SCD based on personal and family history, non-invasive testing including echocardiography, ambulatory electrocardiographic 24 hours monitoring and CMR imaging in order to identity those patients most likely to benefit implantable cardioverter-defibrillator (ICD) implantation. The present chapter summarize genetics, pathogenesis, diagnosis, clinical course and therapy of HCM as well as novel therapeutic options.",signatures:"Davide Lazzeroni and Claudio Stefano Centorbi",downloadPdfUrl:"/chapter/pdf-download/75983",previewPdfUrl:"/chapter/pdf-preview/75983",authors:[{id:"335128",title:"Dr.",name:"Davide",surname:"Lazzeroni",slug:"davide-lazzeroni",fullName:"Davide Lazzeroni"},{id:"345854",title:"Dr.",name:"Claudio Stefano",surname:"Centorbi",slug:"claudio-stefano-centorbi",fullName:"Claudio Stefano Centorbi"}],corrections:null},{id:"77745",title:"Fabry Disease",doi:"10.5772/intechopen.99142",slug:"fabry-disease",totalDownloads:238,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Fabry disease (FD) is a lysosomal storage disorder where deficient or completely absent activity of the enzyme α-galactosidas A leads to accumulation of globotriaosylceramide (Gb3) and other glycosphingolipids in lysosomes. The condition is rare, approximately 1:50,000, although underdiagnosis seems frequent. The condition can affect multiple organ systems, including the skin, nervous system, kidneys, and heart. Early manifestations include skin lesions (angiokeratoma), neuropathic pain, and gastrointestinal symptoms. Later on, FD can result in cardiomyopathy, kidney failure, and stroke. Both lifespan and health-related quality of life are affected negatively by FD. Patients are divided into a classical or a non-classical phenotype based on presentation, where the diagnosis of classical FD requires that a set of specific criteria are met. Patients with non-classical FD often have a less severe disease course, sometimes limited to one organ. The hereditary pattern is X-linked. Thus, men are in general more severely affected than women, although there is an overlap in symptomatic burden. Two types of specific treatment options are available: enzyme replacement therapy and pharmacological chaperone therapy. In addition to this, management of each organ manifestation with usual treatment is indicated.",signatures:"Ida Kåks and Peter Magnusson",downloadPdfUrl:"/chapter/pdf-download/77745",previewPdfUrl:"/chapter/pdf-preview/77745",authors:[{id:"188088",title:"Dr.",name:"Peter",surname:"Magnusson",slug:"peter-magnusson",fullName:"Peter Magnusson"},{id:"335178",title:"Dr.",name:"Ida",surname:"Kåks",slug:"ida-kaks",fullName:"Ida Kåks"}],corrections:null},{id:"74662",title:"Cardiomyopathy: Getting Bigger All the Time - Lessons Learned about Heart Disease from Tropomyosin",doi:"10.5772/intechopen.95509",slug:"cardiomyopathy-getting-bigger-all-the-time-lessons-learned-about-heart-disease-from-tropomyosin",totalDownloads:277,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"In 1990, John and Christine Seidman uncovered the genetic association between mutations in sarcomeric contractile proteins and hypertrophic cardiomyopathy. Since then, the increase in knowledge and understanding of this disease has increased exponentially. Although pathologies associated with the various cardiomyopathies are vastly different, in some cases, the same proteins are causative, but with different genetic mutations. The focus of this article will be on hypertrophic and dilated cardiomyopathies, which are often caused by mutations in sarcomeric contractile proteins. Tropomyosin, a thin filament protein, serves as a paradigm to illustrate how different mutations within the same protein can generate the hypertrophic or dilated cardiomyopathic condition. As such, the significant advances in information derived from basic science investigations has led to the development of novel therapeutics in the treatment of these pathological diseases. This article will illustrate linkages which occur to bridge scientific advances to clinical treatments in cardiomyopathic patients.",signatures:"David F. Wieczorek",downloadPdfUrl:"/chapter/pdf-download/74662",previewPdfUrl:"/chapter/pdf-preview/74662",authors:[{id:"31675",title:"Prof.",name:"David F.",surname:"Wieczorek",slug:"david-f.-wieczorek",fullName:"David F. Wieczorek"}],corrections:null},{id:"78796",title:"Clinical Management of DMD-Associated Cardiomyopathy",doi:"10.5772/intechopen.98919",slug:"clinical-management-of-dmd-associated-cardiomyopathy",totalDownloads:176,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Over the past decade, cardiomyopathy has become the leading cause of mortality among patients with Duchenne muscular dystrophy (DMD). The majority of DMD patients over the age of 18 experience some degree of cardiac involvement. The primary cardiac manifestations of DMD include progressive left ventricular (LV) wall stress leading to LV dilatation and wall thinning, and the development of cardiac fibrosis, all of which culminate in decreased LV contractility and reduced cardiac output. Mortality in these patients is predominantly related to pump failure and fatal arrhythmias leading to sudden cardiac death. While basic guidelines for the management of cardiomyopathy in DMD patients exist, these recommendations are by no means comprehensive, and this chapter aims to provide further insight into appropriate clinical diagnosis and management of DMD-associated cardiomyopathy. Notably, earlier and more frequent cardiac assessment and care can allow for better outcomes for these patients. Pharmacological treatments typically include an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker, beta-adrenergic receptor blockers, mineralocorticoid receptor antagonists, and corticosteroids. Non-pharmacological therapies include automated implantable cardioverter defibrillators and left ventricular assist devices, as well as in rare cases cardiac transplantation. Additionally, many emerging therapies show great promise for improving standards of care. These novel therapies, based primarily on applied gene therapy and genome editing, have great potential to significantly alter the DMD care landscape in the near future.",signatures:"Theo Lee-Gannon, Hannah Lehrenbaum, Rahul Sheth and Pradeep P.A. Mammen",downloadPdfUrl:"/chapter/pdf-download/78796",previewPdfUrl:"/chapter/pdf-preview/78796",authors:[{id:"336530",title:"Dr.",name:"Pradeep P.A.",surname:"Mammen",slug:"pradeep-p.a.-mammen",fullName:"Pradeep P.A. Mammen"},{id:"336534",title:"Mr.",name:"Theo",surname:"Lee-Gannon",slug:"theo-lee-gannon",fullName:"Theo Lee-Gannon"},{id:"336535",title:"Dr.",name:"Rahul",surname:"Sheth",slug:"rahul-sheth",fullName:"Rahul Sheth"},{id:"336537",title:"Dr.",name:"Hannah",surname:"Lehrenbaum",slug:"hannah-lehrenbaum",fullName:"Hannah Lehrenbaum"}],corrections:null},{id:"76015",title:"Cardiomyopathy in Duchenne Muscular Distrophy: Clinical Insights and Therapeutic Implications",doi:"10.5772/intechopen.97022",slug:"cardiomyopathy-in-duchenne-muscular-distrophy-clinical-insights-and-therapeutic-implications",totalDownloads:214,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Duchenne muscular dystrophy cardiomyopathy (DMD-DCM) is characterized by progressive ventricular dilation and dysfunction that can begin at any age and worsens over time. Thanks to the lengthening of life expectancy due to better management of respiratory involvement, end-stage heart failure (HF) is becoming the main cause of death for DMD patients. Therefore, from the time of DMD diagnosis, every effort should be focused to early detect the onset and the worsening of the DMD-DCM, with the aim of starting and modulating the therapy to slow the progression of cardiac dysfunction. In cardiac evaluation, biomarkers, electrocardiograms, and echocardiograms must be considered, but cardiac magnetic resonance (CMR) is now acquiring a leading role due to its sensitivity in the earlier identification of cardiac involvement. The management of DMD-DCM at end stage is a difficult challenge that requires a multidisciplinary team composed of clinical cardiologists, electrophysiologists, cardiac surgeons, neuromuscular specialists, and psychologists. Because of the lack of specific drugs for DMD, we will review the actual cardiovascular armamentarium including drugs used for HF.",signatures:"Rachele Adorisio, Erica Mencarelli, Nicoletta Cantarutti and Maria Grandinetti",downloadPdfUrl:"/chapter/pdf-download/76015",previewPdfUrl:"/chapter/pdf-preview/76015",authors:[{id:"338239",title:"Dr.",name:"Rachele",surname:"Adorisio",slug:"rachele-adorisio",fullName:"Rachele Adorisio"},{id:"345855",title:"Dr.",name:"Erica",surname:"Mencarelli",slug:"erica-mencarelli",fullName:"Erica Mencarelli"},{id:"345856",title:"Dr.",name:"Nicoletta",surname:"Cantarutti",slug:"nicoletta-cantarutti",fullName:"Nicoletta Cantarutti"},{id:"345857",title:"Dr.",name:"Maria",surname:"Grandinetti",slug:"maria-grandinetti",fullName:"Maria Grandinetti"}],corrections:null},{id:"76755",title:"Peripartum Cardiomyopathy: The Hidden Enemy",doi:"10.5772/intechopen.97610",slug:"peripartum-cardiomyopathy-the-hidden-enemy",totalDownloads:250,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Peripartum cardiomyopathy (PPCM) is the most common cardiomyopathy in pregnancy. It is potentially life-threatening. It is, diagnosed in women without a history of heart disease 1 month before delivery or within 5 months. It is marked by heart failure and left ventricular dyshfunction. The evolution is favorable. LV function improves within 6 months in the majority of patients, but long-lasting mortality and morbidity are not infrequent. Recent work suggests the critical toxic role for late-gestational hormones on the maternal vasculature and the genetic underpinnings of PPCM. Complications include different types of supraventricular and ventricular arrhythmias, heart failure and ischemic stroke. The brain natriuretic peptide (BNP) can be used to risk stratify women for adverse events. Management of peripartum cardiomyopathy is based on treatment of heart failure. The addition of bromocriptine seemed to improve LVEF. Close monitoring of pregnant women with cardiomyopathy by multidisciplinary team is recommended.",signatures:"Fatima Zahra Merzouk, Sara Oualim and Mohammed Sabry",downloadPdfUrl:"/chapter/pdf-download/76755",previewPdfUrl:"/chapter/pdf-preview/76755",authors:[{id:"339805",title:null,name:"Sara",surname:"Oualim",slug:"sara-oualim",fullName:"Sara Oualim"},{id:"356403",title:"Dr.",name:"Fatima Zahra",surname:"Merzouk",slug:"fatima-zahra-merzouk",fullName:"Fatima Zahra Merzouk"},{id:"357221",title:"Prof.",name:"Mohammed",surname:"Sabry",slug:"mohammed-sabry",fullName:"Mohammed Sabry"}],corrections:null},{id:"78096",title:"Myocarditis and Inflammatory Cardiomyopathy",doi:"10.5772/intechopen.98998",slug:"myocarditis-and-inflammatory-cardiomyopathy",totalDownloads:187,totalCrossrefCites:0,totalDimensionsCites:1,hasAltmetrics:0,abstract:"Activation of the inflammatory system occurs in most patients with advanced heart failure, regardless of etiology, and contributes to the pathophysiological milieu and the progression of the disease. The term inflammatory cardiomyopathy (ICM) refers to a group of disorders for which an acute or chronic myocardial inflammation is the central cause of abnormal cardiac structure or impaired cardiac function. The most common cause of inflammatory cardiomyopathy is lymphocytic myocarditis, which is most usually triggered by a viral infection, and occasionally by other infectious agents. Rare causes of specific inflammatory cardiomyopathies include cardiac sarcoidosis, giant cell myocarditis and eosinophilic myocarditis. Inflammatory cardiomyopathy can also occur in connection with autoimmune inflammatory diseases. Typical manifestations of inflammatory cardiomyopathy include chest pain, heart failure, and arrhythmias, but these symptoms and signs are unspecific. Although non-invasive diagnostic methods are emerging, the gold standard of diagnosis is the histological examination of an endomyocardial biopsy. Owing to the invasive nature of this technique and a modest diagnostic sensitivity, its use is limited. Therefore, the identification of inflammatory cardiomyopathy is elusive and the true incidence of the condition remains unknown. In most cases of lymphocytic myocarditis, recovery occurs within a few weeks following supportive treatment. In patients with cardiac sarcoidosis, giant cell myocarditis or eosinophilic myocarditis the use of immunosuppressive treatment is recommended, as is the case in myocarditis associated with autoimmune disorders. Such interventions may also have beneficial effects in chronic viral myocarditis once the virus has been cleared. In severe cases, treatment with mechanical circulatory support and/or heart transplantation may be required. Randomized intervention trials including antiviral, immunomodulating, or immunosuppressive agents are lacking. Similarly, new molecular-based methods and therapies tailored to specific pathogeneses have a potential to improve diagnosis and outcomes in patients with inflammatory cardiomyopathy. Still, such techniques and interventions are to be evaluated in adequate randomized controlled studies.",signatures:"Emanuele Bobbio and Kristjan Karason",downloadPdfUrl:"/chapter/pdf-download/78096",previewPdfUrl:"/chapter/pdf-preview/78096",authors:[{id:"334279",title:"Assistant Prof.",name:"Kristjan",surname:"Karason",slug:"kristjan-karason",fullName:"Kristjan Karason"},{id:"334282",title:"Dr.",name:"Emanuele",surname:"Bobbio",slug:"emanuele-bobbio",fullName:"Emanuele Bobbio"}],corrections:null},{id:"75993",title:"Cardiac Amyloidosis",doi:"10.5772/intechopen.97129",slug:"cardiac-amyloidosis",totalDownloads:261,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Amyloidosis represents a heterogeneous group of disorders caused by amyloid fibril deposition in the extracellular space in different organs. Among the many types of amyloidosis cardiac involvement occurs almost exclusively with immunoglobulin light chain amyloidosis (AL amyloidosis) or transthyretin amyloidosis (ATTR amyloidosis). When present cardiac amyloidosis (CA) has a significant impact on disease prognosis. The typical clinical presentation in CA is that of a restrictive cardiomyopathy. Clinical suspicion of CA is based on clinical, laboratory and electrocardiographic findings. The diagnosis is confirmed using echocardiography, cardiac magnetic resonance imaging, biopsy, and/or bone scintigraphy. A precise definition of amyloidosis type is essential for choosing the specific treatment for this condition. Treatment of CA has two components: general treatment of congestive HF, and specific treatment of the underlying protein misfolding disorder.",signatures:"Csilla Andrea Eötvös, Giorgia Pastiu, Iulia Zehan, Cerasela Goidescu, Roxana Chiorescu, Roxana Lazar, Florina Frîngu, Raluca Tomoaia, Monica Pop, Adrian Molnar, Sorin Pop and Dan Blendea",downloadPdfUrl:"/chapter/pdf-download/75993",previewPdfUrl:"/chapter/pdf-preview/75993",authors:[null],corrections:null},{id:"76401",title:"Reversible Cardiomyopathies",doi:"10.5772/intechopen.97309",slug:"reversible-cardiomyopathies",totalDownloads:290,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Cardiomyopathy includes a diverse and heterogeneous group of disorders affecting the myocardium and eventually leading to cardiac dysfunction. Cardiomyopathy is the leading cause of hospitalization in patients older than 65 years of age and it is an important cause for enormous healthcare expenditure. All reversible cardiomyopathies can be associated with cardiomegaly, systolic heart failure, structural changes, and an increase in mortality, but when the offensive agent is identified and stopped, these conditions tend to stop their progression and reverse. The prognosis of reversible nonischemic cardiomyopathies is better than ischemic or other nonreversible cardiomyopathies. Additionally, it is important to diagnose etiology of HF early and precisely to determine prognosis and effective treatment. Most patients with reversible cardiomyopathy present with clinical picture similar to that of systolic heart failure. Here in this book chapter, we discuss about different types of reversible cardiomyopathy including pathogenesis, clinical picture, diagnosis and treatment.",signatures:"Niel Shah, Miguel Rodriguez-Guerra, Muhammad Saad, Anthony Kang and Timothy J. Vittorio",downloadPdfUrl:"/chapter/pdf-download/76401",previewPdfUrl:"/chapter/pdf-preview/76401",authors:[{id:"333788",title:"Dr.",name:"Timothy",surname:"Vittorio",slug:"timothy-vittorio",fullName:"Timothy Vittorio"},{id:"357522",title:"M.D.",name:"Niel",surname:"Shah",slug:"niel-shah",fullName:"Niel Shah"},{id:"357523",title:"M.D.",name:"Miguel",surname:"Rodriguez-Guerra",slug:"miguel-rodriguez-guerra",fullName:"Miguel Rodriguez-Guerra"},{id:"357524",title:"M.D.",name:"Muhammad",surname:"Saad",slug:"muhammad-saad",fullName:"Muhammad Saad"},{id:"357525",title:"Dr.",name:"Anthony",surname:"Kang",slug:"anthony-kang",fullName:"Anthony Kang"}],corrections:null},{id:"77100",title:"Ischemic Heart Disease",doi:"10.5772/intechopen.97515",slug:"ischemic-heart-disease",totalDownloads:192,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"All over the world ischemic heart disease remains as the leading cause of death, followed by stroke. Ischemic heart disease, also called coronary artery disease has a broad spectrum of clinical manifestations from the acute coronary syndromes which include, unstable angina pectoris and acute myocardial infarction with and without elevation of the ST segment and chronic coronary disease. In patients with diabetes mellitus the cardiovascular complications mainly ischemic heart disease, are the main cause of morbidity and mortality. However, in population-based studies, the risk of heart failure in patients with diabetes mellitus is significantly increased following adjustment for well-established heart failure risk factors such as hypertension or ischemic heart disease. Ischemic heart failure angiographically diagnosed is associated with a shorter survival than non-ischemic heart failure. Coronary artery disease is independently associated with higher mortality.",signatures:"Saraí López De Lucio and Marco Antonio López Hernández",downloadPdfUrl:"/chapter/pdf-download/77100",previewPdfUrl:"/chapter/pdf-preview/77100",authors:[{id:"138831",title:"Dr.",name:"Marco Antonio",surname:"López Hernández",slug:"marco-antonio-lopez-hernandez",fullName:"Marco Antonio López Hernández"},{id:"335144",title:"Mrs.",name:"Saraí López",surname:"De Lucio",slug:"sarai-lopez-de-lucio",fullName:"Saraí López De Lucio"}],corrections:null},{id:"76092",title:"Gene Therapy for Heart Disease: Modified mRNA Perspectives",doi:"10.5772/intechopen.97184",slug:"gene-therapy-for-heart-disease-modified-mrna-perspectives",totalDownloads:267,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:1,abstract:"Ischemic heart disease (IHD) presents a gigantic clinical challenge that demands effective therapeutic approaches. With increasing knowledge of the basic molecular mechanisms guiding the progress of this disease, it is now possible to target the key pathological players through gene therapy. Modified mRNA-based gene delivery presents a promising alternative to traditional gene therapy, because modRNA approaches have high potency, non-immunogenicity, greater efficiency and controlled nucleic acid transfer to the body. However, until recently the therapeutic applications of mRNA have been limited, as naturally occurring mRNA is rapidly degraded and cleared from the circulation. In this chapter, we outline the compositional changes made to mRNA to enhance its translational capacity and discuss the available carrier molecules currently being employed to deliver modRNA to the heart. We provide a detailed overview of modRNA applicability for cardiac repair and regeneration and consider future directions for novel delivery methods that can facilitate its cardiac therapeutic use.",signatures:"Lior Zangi, Ravinder K. Kaundal and Keerat Kaur",downloadPdfUrl:"/chapter/pdf-download/76092",previewPdfUrl:"/chapter/pdf-preview/76092",authors:[{id:"337615",title:"Dr.",name:"Keerat",surname:"Kaur",slug:"keerat-kaur",fullName:"Keerat Kaur"},{id:"348954",title:"Dr.",name:"Lior",surname:"Zangi",slug:"lior-zangi",fullName:"Lior Zangi"},{id:"348957",title:"Dr.",name:"Ravinder K.",surname:"Kaundal",slug:"ravinder-k.-kaundal",fullName:"Ravinder K. Kaundal"}],corrections:null},{id:"74681",title:"Possibility of the Subcutaneous Implantable Cardioverter-Defibrillator for Prevention of Sudden Cardiac Death in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy",doi:"10.5772/intechopen.95546",slug:"possibility-of-the-subcutaneous-implantable-cardioverter-defibrillator-for-prevention-of-sudden-card",totalDownloads:330,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"The EMBLEM™ entirely subcutaneous implantable cardioverter-defibrillator (S-ICD) system (Boston Scientific, Marlborough, Massachusetts, USA) was introduced as a new alternative to the conventional transvenous implantable cardioverter-defibrillator and has been expected to reduce device-related complications, especially in young patients who require long-term lead placement. Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a well-known hereditary disease recognized as a cause of sudden cardiac death (SCD) in young adults. However, the precise clinical role of S-ICD in patients with ARVC remains to be defined because of the low QRS amplitude of subcutaneous electrocardiogram (S-ECG) followed by the high incidence of inappropriate shock (IAS) delivery due to oversensing. It is well known that the sensing of S-ICD is largely dependent on the QRS/T ratio of S-ECG. The decrease in the QRS amplitude is more likely to lead to oversensing such as T wave or myopotential oversensing. In patients with ARVC, the decrease in the QRS amplitude due to degeneration of the right ventricular myocardium progresses overtime. In this chapter, we would like to discuss the usefulness of S-ICD lead repositioning for young adult patients with ARVC based on our experience of patients with IAS.",signatures:"Shingo Sasaki",downloadPdfUrl:"/chapter/pdf-download/74681",previewPdfUrl:"/chapter/pdf-preview/74681",authors:[{id:"335123",title:"Associate Prof.",name:"Shingo",surname:"Sasaki",slug:"shingo-sasaki",fullName:"Shingo Sasaki"}],corrections:null}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},subseries:null,tags:null},relatedBooks:[{type:"book",id:"6209",title:"Endothelial Dysfunction",subtitle:"Old Concepts and New Challenges",isOpenForSubmission:!1,hash:"f6e76bbf7858977527679a6e6ad6a173",slug:"endothelial-dysfunction-old-concepts-and-new-challenges",bookSignature:"Helena Lenasi",coverURL:"https://cdn.intechopen.com/books/images_new/6209.jpg",editedByType:"Edited by",editors:[{id:"68746",title:"Dr.",name:"Helena",surname:"Lenasi",slug:"helena-lenasi",fullName:"Helena Lenasi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7220",title:"Congenital Heart Disease",subtitle:null,isOpenForSubmission:!1,hash:"f59bacfffcccc636ec3082869d10a82e",slug:"congenital-heart-disease",bookSignature:"David C. Gaze",coverURL:"https://cdn.intechopen.com/books/images_new/7220.jpg",editedByType:"Edited by",editors:[{id:"71983",title:"Dr.",name:"David C.",surname:"Gaze",slug:"david-c.-gaze",fullName:"David C. Gaze"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6752",title:"Cholesterol",subtitle:"Good, Bad and the Heart",isOpenForSubmission:!1,hash:"599b1f8bc760449a4ee6ecd816a1df93",slug:"cholesterol-good-bad-and-the-heart",bookSignature:"Madan L. Nagpal",coverURL:"https://cdn.intechopen.com/books/images_new/6752.jpg",editedByType:"Edited by",editors:[{id:"182681",title:"Dr.",name:"Madan L.",surname:"Nagpal",slug:"madan-l.-nagpal",fullName:"Madan L. Nagpal"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6777",title:"Advances in Extra-corporeal Perfusion Therapies",subtitle:null,isOpenForSubmission:!1,hash:"1e52fb6e834ada962495c512111f684e",slug:"advances-in-extra-corporeal-perfusion-therapies",bookSignature:"Michael S. Firstenberg",coverURL:"https://cdn.intechopen.com/books/images_new/6777.jpg",editedByType:"Edited by",editors:[{id:"64343",title:"Dr.",name:"Michael S.",surname:"Firstenberg",slug:"michael-s.-firstenberg",fullName:"Michael S. Firstenberg"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6373",title:"Myocardial Infarction",subtitle:null,isOpenForSubmission:!1,hash:"10bca0bf18d68ec3c1641dbc3a1ae899",slug:"myocardial-infarction",bookSignature:"Burak Pamukçu",coverURL:"https://cdn.intechopen.com/books/images_new/6373.jpg",editedByType:"Edited by",editors:[{id:"70686",title:"Dr.",name:"Burak",surname:"Pamukçu",slug:"burak-pamukcu",fullName:"Burak Pamukçu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8629",title:"Visions of Cardiomyocyte",subtitle:"Fundamental Concepts of Heart Life and Disease",isOpenForSubmission:!1,hash:"1cae2b319d6f3c230849834f10715701",slug:"visions-of-cardiomyocyte-fundamental-concepts-of-heart-life-and-disease",bookSignature:"Angelos Tsipis",coverURL:"https://cdn.intechopen.com/books/images_new/8629.jpg",editedByType:"Edited by",editors:[{id:"77462",title:"Dr.",name:"Angelos",surname:"Tsipis",slug:"angelos-tsipis",fullName:"Angelos Tsipis"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7556",title:"Dyslipidemia",subtitle:null,isOpenForSubmission:!1,hash:"dfd1faefe925f0f8335c42cdb36256c1",slug:"dyslipidemia",bookSignature:"Samy I. McFarlane",coverURL:"https://cdn.intechopen.com/books/images_new/7556.jpg",editedByType:"Edited by",editors:[{id:"53477",title:"Prof.",name:"Samy I.",surname:"McFarlane",slug:"samy-i.-mcfarlane",fullName:"Samy I. McFarlane"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7055",title:"Angiography",subtitle:null,isOpenForSubmission:!1,hash:"20638a6ce5e042484cc33b5b510cdca6",slug:"angiography",bookSignature:"Burak Pamukçu",coverURL:"https://cdn.intechopen.com/books/images_new/7055.jpg",editedByType:"Edited by",editors:[{id:"70686",title:"Dr.",name:"Burak",surname:"Pamukçu",slug:"burak-pamukcu",fullName:"Burak Pamukçu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6311",title:"Blood Pressure",subtitle:"From Bench to Bed",isOpenForSubmission:!1,hash:"2e393b1d66ff57ba49a6e00a6f50714d",slug:"blood-pressure-from-bench-to-bed",bookSignature:"Aise Seda Artis",coverURL:"https://cdn.intechopen.com/books/images_new/6311.jpg",editedByType:"Edited by",editors:[{id:"99453",title:"Dr.",name:"Aise Seda",surname:"Artis",slug:"aise-seda-artis",fullName:"Aise Seda Artis"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7842",title:"Basic and Clinical Understanding of Microcirculation",subtitle:null,isOpenForSubmission:!1,hash:"a57d5a701b51d9c8e17b1c80bc0d52e5",slug:"basic-and-clinical-understanding-of-microcirculation",bookSignature:"Kaneez Fatima Shad, Seyed Soheil Saeedi Saravi and Nazar Luqman Bilgrami",coverURL:"https://cdn.intechopen.com/books/images_new/7842.jpg",editedByType:"Edited by",editors:[{id:"31988",title:"Prof.",name:"Kaneez",surname:"Fatima Shad",slug:"kaneez-fatima-shad",fullName:"Kaneez Fatima Shad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],ofsBooks:[]},correction:{item:{id:"80207",slug:"corrigendum-to-aspects-regarding-thermal-mechanical-fatigue-of-shape-memory-alloys",title:"Corrigendum To: Aspects Regarding Thermal-Mechanical Fatigue of Shape Memory Alloys",doi:null,correctionPDFUrl:"https://cdn.intechopen.com/pdfs/80207.pdf",downloadPdfUrl:"/chapter/pdf-download/80207",previewPdfUrl:"/chapter/pdf-preview/80207",totalDownloads:null,totalCrossrefCites:null,bibtexUrl:"/chapter/bibtex/80207",risUrl:"/chapter/ris/80207",chapter:{id:"62954",slug:"aspects-regarding-thermal-mechanical-fatigue-of-shape-memory-alloys",signatures:"Petrică Vizureanu and Dragoș-Cristian Achiței",dateSubmitted:"April 12th 2018",dateReviewed:"April 25th 2018",datePrePublished:null,datePublished:"September 26th 2018",book:{id:"7213",title:"Shape-Memory Materials",subtitle:null,fullTitle:"Shape-Memory Materials",slug:"shape-memory-materials",publishedDate:"September 26th 2018",bookSignature:"Alicia Esther Ares",coverURL:"https://cdn.intechopen.com/books/images_new/7213.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"91095",title:"Dr.",name:"Alicia Esther",middleName:null,surname:"Ares",slug:"alicia-esther-ares",fullName:"Alicia Esther Ares"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"12354",title:"Prof.",name:"Petrică",middleName:null,surname:"Vizureanu",fullName:"Petrică Vizureanu",slug:"petrica-vizureanu",email:"peviz2002@yahoo.com",position:null,institution:{name:"Gheorghe Asachi Technical University of Iași",institutionURL:null,country:{name:"Romania"}}},{id:"209329",title:"Dr.",name:"Mirabela Georgiana",middleName:null,surname:"Minciuna",fullName:"Mirabela Georgiana Minciuna",slug:"mirabela-georgiana-minciuna",email:"mirabela.minciuna@yahoo.ro",position:null,institution:{name:"Gheorghe Asachi Technical University of Iași",institutionURL:null,country:{name:"Romania"}}},{id:"245668",title:"Dr.",name:"Dragos Cristian",middleName:null,surname:"Achitei",fullName:"Dragos Cristian Achitei",slug:"dragos-cristian-achitei",email:"dragos_adc@tuiasi.ro",position:null,institution:null},{id:"245669",title:"Dr.",name:"Manuela Cristina",middleName:null,surname:"Perju",fullName:"Manuela Cristina Perju",slug:"manuela-cristina-perju",email:"cryss_ela@yahoo.com",position:null,institution:null}]}},chapter:{id:"62954",slug:"aspects-regarding-thermal-mechanical-fatigue-of-shape-memory-alloys",signatures:"Petrică Vizureanu and Dragoș-Cristian Achiței",dateSubmitted:"April 12th 2018",dateReviewed:"April 25th 2018",datePrePublished:null,datePublished:"September 26th 2018",book:{id:"7213",title:"Shape-Memory Materials",subtitle:null,fullTitle:"Shape-Memory Materials",slug:"shape-memory-materials",publishedDate:"September 26th 2018",bookSignature:"Alicia Esther Ares",coverURL:"https://cdn.intechopen.com/books/images_new/7213.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"91095",title:"Dr.",name:"Alicia Esther",middleName:null,surname:"Ares",slug:"alicia-esther-ares",fullName:"Alicia Esther Ares"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"12354",title:"Prof.",name:"Petrică",middleName:null,surname:"Vizureanu",fullName:"Petrică Vizureanu",slug:"petrica-vizureanu",email:"peviz2002@yahoo.com",position:null,institution:{name:"Gheorghe Asachi Technical University of Iași",institutionURL:null,country:{name:"Romania"}}},{id:"209329",title:"Dr.",name:"Mirabela Georgiana",middleName:null,surname:"Minciuna",fullName:"Mirabela Georgiana Minciuna",slug:"mirabela-georgiana-minciuna",email:"mirabela.minciuna@yahoo.ro",position:null,institution:{name:"Gheorghe Asachi Technical University of Iași",institutionURL:null,country:{name:"Romania"}}},{id:"245668",title:"Dr.",name:"Dragos Cristian",middleName:null,surname:"Achitei",fullName:"Dragos Cristian Achitei",slug:"dragos-cristian-achitei",email:"dragos_adc@tuiasi.ro",position:null,institution:null},{id:"245669",title:"Dr.",name:"Manuela Cristina",middleName:null,surname:"Perju",fullName:"Manuela Cristina Perju",slug:"manuela-cristina-perju",email:"cryss_ela@yahoo.com",position:null,institution:null}]},book:{id:"7213",title:"Shape-Memory Materials",subtitle:null,fullTitle:"Shape-Memory Materials",slug:"shape-memory-materials",publishedDate:"September 26th 2018",bookSignature:"Alicia Esther Ares",coverURL:"https://cdn.intechopen.com/books/images_new/7213.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"91095",title:"Dr.",name:"Alicia Esther",middleName:null,surname:"Ares",slug:"alicia-esther-ares",fullName:"Alicia Esther Ares"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}}},ofsBook:{item:{type:"book",id:"9558",leadTitle:null,title:"Active Learning",subtitle:"Theory and Practice",reviewType:"peer-reviewed",abstract:"In the context of globalization changes in educational systems, it is important to modify approaches to the educational process and introduce learning technologies that allow for maximum involvement in learning. One such technology is the technology of active learning, which engages learners through participation in the cognitive process and certain tasks as well as through the collective activities of the subjects of the educational process. This book discusses the theoretical analysis of active learning and contains practical recommendations for its implementation.",isbn:"978-1-83968-477-7",printIsbn:"978-1-83968-473-9",pdfIsbn:"978-1-83968-478-4",doi:"10.5772/intechopen.87353",price:119,priceEur:129,priceUsd:155,slug:"active-learning-theory-and-practice",numberOfPages:174,isOpenForSubmission:!1,isSalesforceBook:!1,isNomenclature:!1,hash:"c55b272766d51c3d563abc25c026b939",bookSignature:"Olena Lutsenko and Gregory Lutsenko",publishedDate:"February 9th 2022",coverURL:"https://cdn.intechopen.com/books/images_new/9558.jpg",keywords:null,numberOfDownloads:3971,numberOfWosCitations:0,numberOfCrossrefCitations:3,numberOfDimensionsCitations:4,numberOfTotalCitations:7,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"August 24th 2020",dateEndSecondStepPublish:"September 21st 2020",dateEndThirdStepPublish:"November 20th 2020",dateEndFourthStepPublish:"February 8th 2021",dateEndFifthStepPublish:"April 9th 2021",dateConfirmationOfParticipation:null,remainingDaysToSecondStep:"2 years",secondStepPassed:!0,areRegistrationsClosed:!0,currentStepOfPublishingProcess:5,editedByType:"Edited by",kuFlag:!1,biosketch:"Dr. Olena Ivanivna Lutsenko now works on research topics at the Hlukhiv National Pedagogical University of Alexander Dovzhenko and teaches medical and biological disciplines. She has published over 74 scientific works including five textbooks and two monographs.",coeditorOneBiosketch:"Dr. Gregory Lucenko is a Head of the Department of Pedagogy and Management of Education at Glukhiv National Pedagogical University. He was the head of the state budget project 'Creation of the Internet portal' Diffusion and solid-phase reactions. DIFTRANS ',He worked as a contractor in the state budget project 'Fundamentalisation of Vocational Education and Methods of its Implementation in the Content of Physical Education.",coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"225667",title:"Mrs.",name:"Olena",middleName:null,surname:"Lutsenko",slug:"olena-lutsenko",fullName:"Olena Lutsenko",profilePictureURL:"https://mts.intechopen.com/storage/users/225667/images/system/225667.jpg",biography:"Olena Lutsenko obtained her Ph.D. in 2021. Since 2015, she has had the opportunity to work on a departmental research topic on the fundamentalization of natural education for sustainable development. She is currently working on scientific topics at Oleksandr Dovzhenko Hlukhiv National Pedagogical University, Ukraine, and teaches medical and biological disciplines and features of teaching methods of these disciplines. She has published more than seventy-nine scientific papers, including five textbooks and five monographs. Her recent research focuses on the peculiarities of preparing future teachers for their professional activities, as well as on the introduction of modern educational technologies in educational activities.",institutionString:"Oleksandr Dovzhenko Hlukhiv National Pedagogical University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"2",institution:{name:"Oleksandr Dovzhenko Hlukhiv National Pedagogical University",institutionURL:null,country:{name:"Ukraine"}}}],coeditorOne:{id:"316545",title:"Dr.",name:"Gregory",middleName:null,surname:"Lutsenko",slug:"gregory-lutsenko",fullName:"Gregory Lutsenko",profilePictureURL:"https://mts.intechopen.com/storage/users/316545/images/system/316545.jpg",biography:'Gregory Lutsenko obtained a Ph.D. in 2014 with his dissertation, \\"Theoretical and methodological principles of fundamentalization of physical education in higher education: didactic and managerial aspects.” He has served as head of the Department of Pedagogy and Education Management, Oleksandr Dovzhenko Hlukhiv National Pedagogical University, Ukraine, since September 2015. His research interests include automated management systems for educational and scientific activities of higher education. Dr. Lutsenko is the author of more than eighty published works.',institutionString:"Oleksandr Dovzhenko Hlukhiv National Pedagogical University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"0",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Oleksandr Dovzhenko Hlukhiv National Pedagogical University",institutionURL:null,country:{name:"Ukraine"}}},coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"265",title:"Education",slug:"social-sciences-education"}],chapters:[{id:"79315",title:"Features of Management of Research Activity in Higher Educational Institutions",slug:"features-of-management-of-research-activity-in-higher-educational-institutions",totalDownloads:155,totalCrossrefCites:0,authors:[{id:"225667",title:"Mrs.",name:"Olena",surname:"Lutsenko",slug:"olena-lutsenko",fullName:"Olena Lutsenko"}]},{id:"75350",title:"Active Learning: The Panacea to Miseducative Practices in Teacher Education",slug:"active-learning-the-panacea-to-miseducative-practices-in-teacher-education",totalDownloads:362,totalCrossrefCites:0,authors:[{id:"332250",title:"Dr.",name:"Davison",surname:"Zireva",slug:"davison-zireva",fullName:"Davison Zireva"}]},{id:"69557",title:"Usage-Based and Universal Grammar-Based Approaches to Second Language Acquisition",slug:"usage-based-and-universal-grammar-based-approaches-to-second-language-acquisition",totalDownloads:1156,totalCrossrefCites:0,authors:[{id:"284466",title:"Associate Prof.",name:"Kim Hua",surname:"Tan",slug:"kim-hua-tan",fullName:"Kim Hua Tan"},{id:"309067",title:"Dr.",name:"Vafa",surname:"Shojamanesh",slug:"vafa-shojamanesh",fullName:"Vafa Shojamanesh"}]},{id:"75088",title:"Non-Formal Education as a Foundation for Active Learning",slug:"non-formal-education-as-a-foundation-for-active-learning",totalDownloads:296,totalCrossrefCites:0,authors:[{id:"297298",title:"Dr.",name:"Roy",surname:"Alonso Terrazas Marín",slug:"roy-alonso-terrazas-marin",fullName:"Roy Alonso Terrazas Marín"},{id:"340946",title:"Dr.",name:"Brenda",surname:"Linda Alvarado Espinoza",slug:"brenda-linda-alvarado-espinoza",fullName:"Brenda Linda Alvarado Espinoza"}]},{id:"75959",title:"Activity-Based Online Learning: A Response to Dyslexia and COVID",slug:"activity-based-online-learning-a-response-to-dyslexia-and-covid",totalDownloads:215,totalCrossrefCites:1,authors:[{id:"93190",title:"Dr.",name:"Charles",surname:"Potter",slug:"charles-potter",fullName:"Charles Potter"}]},{id:"75444",title:"Artificial Intelligence in Education",slug:"artificial-intelligence-in-education",totalDownloads:1386,totalCrossrefCites:2,authors:[{id:"332017",title:"Dr.",name:"Andrej",surname:"Flogie",slug:"andrej-flogie",fullName:"Andrej Flogie"},{id:"332021",title:"Prof.",name:"Boris",surname:"Aberšek",slug:"boris-abersek",fullName:"Boris Aberšek"}]},{id:"75643",title:"Technology Enabled Active Learning in Electrical Engineering",slug:"technology-enabled-active-learning-in-electrical-engineering",totalDownloads:71,totalCrossrefCites:0,authors:[{id:"329692",title:"M.Sc.",name:"Syed Abdur Rauf",surname:"Magrabi",slug:"syed-abdur-rauf-magrabi",fullName:"Syed Abdur Rauf Magrabi"}]},{id:"76643",title:"University Mathematics-Laden Education, Competencies and the Fighting of Syllabusitis",slug:"university-mathematics-laden-education-competencies-and-the-fighting-of-syllabusitis",totalDownloads:205,totalCrossrefCites:0,authors:[{id:"341219",title:"Dr.",name:"Tomas",surname:"Højgaard",slug:"tomas-hojgaard",fullName:"Tomas Højgaard"}]},{id:"78086",title:"The Development Biology Authentic Learning of Mahasarakham University Demonstration School (Secondary), Thailand",slug:"the-development-biology-authentic-learning-of-mahasarakham-university-demonstration-school-secondary",totalDownloads:125,totalCrossrefCites:0,authors:[{id:"342787",title:"Dr.",name:"Wutthisak",surname:"Bunnaen",slug:"wutthisak-bunnaen",fullName:"Wutthisak Bunnaen"}]}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"252211",firstName:"Sara",lastName:"Debeuc",middleName:null,title:"Ms.",imageUrl:"https://mts.intechopen.com/storage/users/252211/images/7239_n.png",email:"sara.d@intechopen.com",biography:"As an Author Service Manager my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review, to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact."}},relatedBooks:[{type:"book",id:"7494",title:"Menstrual Cycle",subtitle:null,isOpenForSubmission:!1,hash:"f3e1135f2d45bbaafe6e61b252108d05",slug:"menstrual-cycle",bookSignature:"Olena Ivanivna Lutsenko",coverURL:"https://cdn.intechopen.com/books/images_new/7494.jpg",editedByType:"Edited by",editors:[{id:"225667",title:"Mrs.",name:"Olena",surname:"Lutsenko",slug:"olena-lutsenko",fullName:"Olena Lutsenko"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6674",title:"Contemporary Pedagogies in Teacher Education and Development",subtitle:null,isOpenForSubmission:!1,hash:"33d1ab42e6304ea91a1ee326da9b4101",slug:"contemporary-pedagogies-in-teacher-education-and-development",bookSignature:"Yehudith Weinberger and Zipora Libman",coverURL:"https://cdn.intechopen.com/books/images_new/6674.jpg",editedByType:"Edited by",editors:[{id:"201297",title:"Dr.",name:"Yehudith",surname:"Weinberger",slug:"yehudith-weinberger",fullName:"Yehudith Weinberger"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5980",title:"New Pedagogical Challenges in the 21st Century",subtitle:"Contributions of Research in Education",isOpenForSubmission:!1,hash:"3023022a959e4709cccf3d89270f33f8",slug:"new-pedagogical-challenges-in-the-21st-century-contributions-of-research-in-education",bookSignature:"Olga Bernad Cavero and Núria Llevot-Calvet",coverURL:"https://cdn.intechopen.com/books/images_new/5980.jpg",editedByType:"Edited by",editors:[{id:"193391",title:"Ph.D.",name:"Olga",surname:"Bernad-Cavero",slug:"olga-bernad-cavero",fullName:"Olga Bernad-Cavero"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6936",title:"Early Childhood Education",subtitle:null,isOpenForSubmission:!1,hash:"f4092f476f58833b460010a63f5397dc",slug:"early-childhood-education",bookSignature:"Donna Farland-Smith",coverURL:"https://cdn.intechopen.com/books/images_new/6936.jpg",editedByType:"Edited by",editors:[{id:"197003",title:"Dr.",name:"Donna",surname:"Farland-Smith",slug:"donna-farland-smith",fullName:"Donna Farland-Smith"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6161",title:"Advanced Learning and Teaching Environments",subtitle:"Innovation, Contents and Methods",isOpenForSubmission:!1,hash:"20c18affe0d4b2b99d72800247328d9e",slug:"advanced-learning-and-teaching-environments-innovation-contents-and-methods",bookSignature:"Núria Llevot-Calvet and Olga Bernad Cavero",coverURL:"https://cdn.intechopen.com/books/images_new/6161.jpg",editedByType:"Edited by",editors:[{id:"193390",title:"Ph.D.",name:"Núria",surname:"Llevot-Calvet",slug:"nuria-llevot-calvet",fullName:"Núria Llevot-Calvet"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6929",title:"Active Learning",subtitle:"Beyond the Future",isOpenForSubmission:!1,hash:"fe54807c3ff7c1b500127e814988f5e2",slug:"active-learning-beyond-the-future",bookSignature:"Sílvio Manuel Brito",coverURL:"https://cdn.intechopen.com/books/images_new/6929.jpg",editedByType:"Edited by",editors:[{id:"170935",title:"Ph.D.",name:"Sílvio Manuel",surname:"Brito",slug:"silvio-manuel-brito",fullName:"Sílvio Manuel Brito"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6586",title:"Sport Pedagogy",subtitle:"Recent Approach to Technical-Tactical Alphabetization",isOpenForSubmission:!1,hash:"ecdd15ab29df9d59f4b4a46928b11ffe",slug:"sport-pedagogy-recent-approach-to-technical-tactical-alphabetization",bookSignature:"Jaime Serra-Olivares",coverURL:"https://cdn.intechopen.com/books/images_new/6586.jpg",editedByType:"Edited by",editors:[{id:"221512",title:"Dr.",name:"Jaime",surname:"Serra-Olivares",slug:"jaime-serra-olivares",fullName:"Jaime Serra-Olivares"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9535",title:"Education in Childhood",subtitle:null,isOpenForSubmission:!1,hash:"edc0b902fe67ee1b6fab1df4992cb55d",slug:"education-in-childhood",bookSignature:"Olga María Alegre de la Rosa, Luis Miguel Villar Angulo and Carla Giambrone",coverURL:"https://cdn.intechopen.com/books/images_new/9535.jpg",editedByType:"Edited by",editors:[{id:"338767",title:"Prof.",name:"Olga María",surname:"Alegre de la Rosa",slug:"olga-maria-alegre-de-la-rosa",fullName:"Olga María Alegre de la Rosa"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10807",title:"Teacher Education",subtitle:"New Perspectives",isOpenForSubmission:!1,hash:"3baeedd4e6dfcdbccca461891bd66a8d",slug:"teacher-education-new-perspectives",bookSignature:"Ulas Kayapinar",coverURL:"https://cdn.intechopen.com/books/images_new/10807.jpg",editedByType:"Edited by",editors:[{id:"232425",title:"Dr.",name:"Ulas",surname:"Kayapinar",slug:"ulas-kayapinar",fullName:"Ulas Kayapinar"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10229",title:"Teacher Education in the 21st Century",subtitle:"Emerging Skills for a Changing World",isOpenForSubmission:!1,hash:"b01f9136149277b7e4cbc1e52bce78ec",slug:"teacher-education-in-the-21st-century-emerging-skills-for-a-changing-world",bookSignature:"Maria Jose Hernández-Serrano",coverURL:"https://cdn.intechopen.com/books/images_new/10229.jpg",editedByType:"Edited by",editors:[{id:"187893",title:"Dr.",name:"Maria Jose",surname:"Hernández-Serrano",slug:"maria-jose-hernandez-serrano",fullName:"Maria Jose Hernández-Serrano"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"45187",title:"Neuroimaging of Epilepsy: EEG-fMRI in the Presurgical Evaluation of Focal Epilepsy",doi:"10.5772/55197",slug:"neuroimaging-of-epilepsy-eeg-fmri-in-the-presurgical-evaluation-of-focal-epilepsy",body:'
Epilepsies of surgical interest are focal and drug-resistant forms associated with various different conditions (malformations, stroke, tumors, infectious and/or inflammatory processes, brain injuries). There is mounting evidence that early resective surgery can achieve seizure-free status or reduce seizure frequency. The main challenge in the presurgical assessment of patients with epilepsy is to localize the area of seizure onset (the epileptogenic zone) and to distinguish it from lesional and interictal foci (the irritative zone) because it is only by treating the epileptogenic zone that seizure freedom or a reduction in events may be attained (Thorton, 2010).
This is explained by the fact that since the interictal focus is larger than the epileptogenic zone, the epileptogenic zone does not always overlap the lesional area and the epileptogenic focus is often larger than lesional area (Avesani, 2008/a; Manganotti, 2008; Thorton, 2010). In general, interictal epileptic discharges may affect brain areas well beyond the presumed region in which they are generated (Gotman, 2008). While resection of the lesional area alone is not sufficient, neither can the entire interictal focus be removed due to the high risk of cognitive, motor, sensitive or language deficits.
Presurgical evaluation involves invasive investigation by stereoelectroencephalography (SEEG) performed after other routine exams (standard EEG, video-EEG, functional neuroimaging) to identify the interictal focus within the epileptogenic zone. The lesional area, instead, is nowadays studied with advanced MRI techniques developed to better identify the interictal focus.
Functional imaging refers to noninvasive methods to identify the interictal focus and the epileptogenic zone which, in a subsequent step, is studied with an invasive technique (SEEG, electrocortical mapping). The most widely used are:
positron-emission tomography (PET)
single-photon-emission computed tomography (SPECT)
magnetic resonance spectroscopy (MRS)
functional magnetic imaging (fMRI)
These techniques allow the study of a specific area of the brain, obviating the need for invasive studies of the entire brain. PET and SPECT were initially utilized for this purpose. While both provide a better knowledge of the brain’s functional anatomy, they rarely allow for a precise localization of an epileptogenic focus, making them less useful for surgical planning (Marks, 1992; Henry, 1993; Newton, 1995).
The rationale for SPECT is based on its ability to reveal, in vivo, the volume distribution of a radiotracer after intravenous injection, and to evaluate, quantitatively and qualitatively, regional brain perfusion (Devous, 2005). The application of SPECT in epilepsy derives from a known association between an electrical event and brain perfusion: brain perfusion increases during the ictal phase and decreases during the interictal phase. Studies using dynamic and static SPECT have demonstrated interictal temporal hypoperfusion in 50% patients with temporal-lobe epilepsy (TLE). Nevertheless, the limitation of this technique is that 5-10% of patients demonstrate contralateral hypoperfusion, which raises the risk of false localization (Krausz, 1991). The localization power of SPECT during the interictal phase is, therefore, variable, with a sensitivity of 36% and a specificity of 95% (Engel, 1982). For this reason, SPECT is useful as a comparative study of ictal and interictal perfusion in selected patients. When applied during a seizure, it demonstrates the dynamic aspect of the seizure during its development. Unlike interictal studies, ictal SPECT, in both temporal and extratemporal epilepsy, is accurate in localizing an epileptogenic focus. During the ictal phase it can reveal, with a sensitivity of 70-95%, hyperperfusion in an area activated by seizures (Engel, 1983; Lee, 1994).
PET is a powerful imaging technique to quantify, in vivo and noninvasively, cerebral blood flow, metabolism and receptorial links. Its main application derives from the need to identify epileptogenic foci in patients with drug-resistant epilepsy, potential candidates for surgical treatment to control or abolish drug-resistant focal seizures. In up to 20-30% of such patients, who are candidates for surgical treatment, the MRI exam is negative (Duncan, 1997) because microscopic structural malformations, identifiable only by histological study, are not detectable with conventional MRI (Kuzniecky, 1991). Using [11C]flumazenil positron-emission tomography ([11C]FMZ-PET), Hammers studied 18 patients with TLE and normal MRI: 16 demonstrated abnormalities in the binding of 11 C-FMZ in the temporal lobe; 7 of these were concordant with clinical and standard EEG data; 3 patients underwent surgical treatment of the anterior temporal lobe, with marked clinical improvement. The neuropathological data revealed microdysgenesis not detected by MRI (Hammers, 2002).
In patients with focal seizures, glucose metabolism and cerebral blood flow in a particular focal region are increased during an ictal event (Engel, 1983). In the postictal phase, hyperperfusion gradually returns to the basal level, but glucose metabolism remains elevated for 24-48 hours after seizure termination (Leiderman, 1994). In the interictal phase, PET demonstrates a decrease in glucose metabolism and cerebral blood flow in the epileptogenic focus. Studies using
MR spectroscopy can be utilized in the noninvasive assessment of specific cerebral metabolites. In epilepsy the aim is to determine a focal change in the main metabolites deriving from focal brain dysfunction. The initial aim of the method was to delimit the epileptogenic focus and to analyze the distant repercussions of the lesion and the focus. For example, spectroscopy can reveal bilateral hippocampal abnormalities in unilateral mesial temporal sclerosis (MTS). The technique has demonstrated its utility in identifying metabolic dysfunction in patients with TLE. Nevertheless, owing to its high sensitivity, metabolic abnormalities may be revealed in regions without an epileptogenic focus, making it difficult to distinguish the causal abnormalities from their consequences (Ruben, 2005).
In patients with drug-resistant TLE, spectroscopy demonstrated a lower N-acetyl aspartate/creatine (NAA/Cr) ratio, a reliable marker of neuronal integrity, in the ipsi- and contralateral lobes, and this finding correlated negatively with seizure duration (Bernasconi, 2002). Patients with frequent generalized seizures were noted to have a lower NAA/Cr ratio than those with rare or no seizures. Another interesting finding was the demonstration of reversible dysfunction in the cortical area after surgical treatment (Hugg, 1996). What all this suggests is that seizures may induce additional neuronal damage that will progress with the duration of epilepsy. From this point of view, spectroscopy may be useful as a metabolic marker of disease progression. In the future, it may be possible to decide whether evidence of disease progression on spectroscopy may be sufficient to suggest a change of therapy (Petroff, 2002).
Functional MRI (fMRI) provides high-resolution images using the classical principles of MRI, with the difference that signal recording exploits the paramagnetic properties of hemoglobin when its iron atom changes from Fe3+ (oxygenated hemoglobin) to Fe2+ (deoxygenated hemoglobin). Only Fe 2+ has the ability to locally modify the magnetic state of cerebral tissues (Berns, 1999). Activation of a cerebral area causes both oxidative metabolism and local cerebral blood flow to increase, leading to greater oxygen extraction by the tissues. This results in a local increase of deoxyhemoglobin. Functional MRI reveals the activation of a cerebral area from the higher level of deoxyhemoglobin compared to the basal condition. And it does this indirectly by measuring the vascular response to activation of the cerebral area under study. The response has a variable latency (from 3-5 to 10 seconds), which is why this kind of information is defined as “functional”, and the recorded signal, related to hemoglobin oxygenation, is defined as BOLD (Blood Oxygen Level Dependent) (Ogawa, 1990; Prichard, 1994).
fMRI works by comparing the images obtained in rest condition with those acquired during a task. Whether and to what extent physiological correlates match different BOLD phases (Menon, 2001) continues to fuel debate, though studies suggest that the fMRI signal is closely related to neuronal activation (Logothetis, 2001). The method was first applied to localize areas associated with motor, sensory and cognitive functions in epileptic patients and to obtain a precise localization of these functions in the presurgical evaluation of epilepsy (Puce, 1995; Binder, 1996; Dupon, 2002).
This noninvasive technique provides reliable information to localize cerebral regions generating interictal epileptic activity. It involves the simultaneous recording of EEG and fMRI. With ongoing refinement of the technology (first of all removal of magnetic field artifact on EEG), initial technical limitations have been overcome (Ives, 1993). EEG-fMRI permits the study cerebral activation and deactivation related to infra-clinical spikes by comparing EEG with spiked activity against EEG without abnormalities (Krakow, 1999 and 2001; Lazeyras 2000; Archer, 2003).
Research to date has investigated lesional epilepsy in the temporal region in particular, the most frequent cause of epilepsy of surgical interest. Up until several years ago, triggered EEG-fMRI was used. EEG was recorded during a scanning session, and fMRI acquisition was performed when a neurologist identified, on line, interictal (spikes, polyspikes, spike waves) activity on EEG. Acquisition was performed after a fixed latency (3-5 seconds) from detected interictal activity, which was decided before starting acquisition. The technique had several limitations: it was based on the concept of standardized cerebral hemodynamic activity, even if we know that such activity varies widely (from 3 up to 10 seconds); analysis had to be performed offline using, as a task, spikes with different morphology; and the temporal dynamics of hemodynamic responses could not be identified. Owing to these limitations, early studies with triggered EEG-fMRI (Krakow, 1999 and 2001) showed low sensitivity (60%) in detecting hemodynamic activation related to interictal activity.
Later studies (Lazeyras, 2001; Lemieux, 2001;\n\t\t\t\tAl-Asmi, 2003) demonstrated the superiority of continuous EEG-fMRI based on offline analysis after simultaneous EEG recording during a fMRI scanning session and following artifact removal. This development brought about clear advantages: since it was no longer necessary to decide beforehand which abnormal events were to be studied (and recorded) during a single acquisition, the temporal evolution of activations (after 1 to 10 seconds) could be identified and pathophysiological hypotheses about their propagation postulated. Continuous EEG-fMRI detects activation with a sensitivity of 80%.
Numerous studies have applied continuous EEG-fMRI to investigate various different epileptic syndromes (Boor, 2003; Salek-Haddadi, 2003 and 2006; Bagshaw, 2004 and 2006; Aghakhani, 2004 and 2005; Gotman, 2004 and 2005; Kobayashi, 2005 and 2006; Laufs, 2006; Di Bonaventura, 2006; Vaudano, 2009). Some studied focal epilepsies, while others examined idiopathic generalized forms underlying absence seizures.
The application of EEG-fMRI in idiopathic generalized epilepsy (IGE), for evident technical problems, is limited to absence seizures or nonconvulsive status, to analyze the network underlying impaired consciousness related to generalized spike wave (GSW) discharges. Clinically, absences are characterized by a blank stare and impaired consciousness. Activities requiring vigilant attention have been coupled with a lesser likelihood of absences, whereas an increased frequency of seizures during relaxation is well established (Andermann, 2000; Guey, 1969). These findings suggest a causal link between changes in the level of awareness and the occurrence of GSW discharges.
Recent functional imaging studies have revealed the existence of a set of brain regions which show increased functional and metabolic activity during rest, compared to attention-demanding tasks (Raichle, 2000; Mazoyer, 2001). Involved brain areas (the posterior cingulated cortex, the precuneus, the medial prefrontal cortex, the mid-dorsolateral prefrontal and the anterior temporal cortices) have been hypothesized to constitute the so-called default mode network (DMN) (Raichle, 2000). Decreased DMN activity during cognitive tasks indicates that the network sustains spontaneous thought processes or self-oriented mental activity that characterizes the brain’s resting state.
Additionally, the precuneus/posterior cingulate node has been recently demonstrated to have the highest degree of interactions (as shown by a partial correlation approach to fMRI data) with the rest of the DMN (Frasson, 2008), suggesting a pivotal role of this area within the network. This interpretation is in line with evidence from previous PET studies that this brain region, and the precuneus in particular, has the highest metabolic rate, consuming 35% more glucose than any other area of the cerebral cortex at rest (Gusnard, 2001).
The DMN shows decreased activity during both attention-demanding tasks and states of reduced vigilance and, especially in the posteromedial cortical regions, during altered states of consciousness (Laureys, 2004; Faymonville, 2006). From these observations, several authors (Cavanna, 2006 and 2007; Boly, 2008) suggested a pivotal role of the posteromedial cortical region in self-consciousness inside the DMN.
EEG-correlated functional magnetic resonance imaging (EEG-fMRI) studies have shown a common pattern of BOLD signal decrease in the precuneus and other DMN areas, together with an increase in the thalamic BOLD signal, during ictal and interictal GSW discharges (Aghakhani, 2004; Archer, 2003; Gotman, 2005; Hamandi, 2006; Laufs, 2006; Salek-Haddadi, 2003; De Tiège, 2007; Labate, 2005). Decreased cerebral blood flow consistent with a decrease in neuronal activity was demonstrated in DMN regions during GSW discharges (Hamandi, 2008). Therefore, these relative BOLD signal decreases can be interpreted as a transitory suspension of the brain’s “default state” which occurs in association with an altered level of awareness observed during GSW discharges and absences, respectively (Gotman, 2005; Hamandi, 2006; Laufs, 2006; Salek-Haddadi, 2003).
The pathophysiological substrate of GSW remains enigmatic. Studies in animals and humans have tried to answer persistent questions about the putative role of the thalamus and cortex as generators. Data from invasive recordings and manipulations in well-validated genetic models of absence epilepsy have lent support to the hypothesis that absence seizures are of cortical origin (Steriade, 1998; Meeren, 2002 and 2005; Polack, 2007; Holmes, 2004; Tucker, 2007).
Following on the suggestion of the involvement of dorsal cortical regions (particularly the posterior-medial cortical regions) in GSW discharges from neuroimaging studies (Gotman, 2005; Hamandi, 2006; Laufs, 2006; Salek-Haddadi, 2003) and their role in conscious awareness (Faymonville, 2006; Boly, 2008), a recent work (Vaudano, 2009) attempted to elucidate the interaction between these areas and the (frontal)cortical-thalamic loop by means of dynamic causal modeling (DCM) to study effective connectivity based on simultaneously recorded EEG-fMRI data in 7 patients with GSW discharges.
The results of this study are consistent with the concept of the precuneus as a key region that changes its activity with altered states of vigilance, thus influencing the occurrence of generalized seizures: changes in the precuneus state (an increase or decrease in its neuronal activity), which reflects spontaneous fluctuations in awareness, act on the thalamic-(frontal) cortical network, facilitating the development of GSW. This contrasts with previous observations (Gotman, 2005; Hamandi, 2006; Laufs, 2006) that decreases in precuneal activity reflect the semiology of impaired consciousness and are a consequence of GSW.
A similar hypothesis was advanced by Archer et al. (Archer, 2003) who observed a significant posterior cingulate negative BOLD response in 5 IGE patients with interictal GSW discharges but no BOLD signal changes in the thalamus or prefrontal cortex. The authors suggested that decreases in posterior cingulate activity and associated regions may be involved in the initiation of GSW activity.
Additionally, a fMRI study showed a BOLD signal decrease in the posterior cingulate in IGE subjects following photic stimulation whether or not GSW activity occurred, while the control subjects showed no change in this region (Hill, 1999). Such changes would be consistent with a decrease in posterior cingulate activity being a precursor (or facilitator) of GSW activity rather than a secondary phenomenon. The posterior cingulate cortex is adjacent to the precuneus and some authors would define it as part of the precuneal cortical area (Frackowiak, 1997; Frasson, 2008).
Current thinking about the pathophysiology of GSW has it that the neuronal state of the precuneus, and the level of awareness, may reflect a “physiological initiator” of generalized synchronous discharges. In this connection, EEG-fMRI adds electrophysiological data to GSW generation and precuneal involvement where, besides the scant evidence for a strict consequentiality between a particular state of vigilance and the occurrence of GSW discharges, there is a notable lack of studies on the possible role of cortical structures (particularly the precuneus) other than the thalamus and frontal cortex in GSW.
Unlike surface electrophysiological recordings, fMRI studies with concurrent EEG in patients with GSW discharges have shown common hemodynamic changes not only in the thalamus and frontal cortex, but also in the precuneus and other brain regions (including the fronto-parietal association cortices) of the DMN (Aghakhani, 2004; Archer, 2003; Gotman, 2005; Laufs, 2007). Moreover, fMRI\'s relatively homogeneous sensitivity across the brain compared to that of scalp EEG may explain why recent EEG-fMRI studies have been able to reveal precuneal involvement in epilepsies characterized by impaired consciousness and associated with GSW (Gotman, 2005; Hamandi, 2006; Laufs, 2006).
In brief, there is an active role in generalized epilepsy for the precuneus, a region previously neglected in electrophysiological studies of GSW. DCM based on EEG-fMRI data has shown that the precuneus is not only strongly connected with the frontal cortex and the thalamus but also that the neuronal activity in this area may facilitate epileptic activity within a thalamo-cortical loop, the existence of which is well established. These findings suggest that GSW may arise through the direct influence of the neuronal state of the precuneus associated with spontaneous changes in the level of awareness.
EEG-fMRI provides insight into the pathophysiology of changes in the level of awareness during GSW discharges in absence seizures; however, the practical usefulness of technique resides in the study of focal epilepsy, especially if drug resistant and associated with a condition which, if amenable to removal, could achieve seizure freedom or a reduction of frequency. Numerous studies have applied EEG-fMRI to focal seizures to identify the interictal focus and the ictal onset zone (Krakow 1999 and 2001; Boor, 2003; Salek Haddadi, 2006; Bagshaw, 2004 and 2006; Aghakani, 2005;\n\t\t\t\t\tKobayashi, 2005 and 2006). Some also applied SEEG and electrocortical mapping to study areas previously identified with EEG-fMRI and confirmed co-localization between interictal events (IEDs) and hemodynamic activation detected on fMRI (Krakow, 1999; Kobayashi, 2006; Benar, 2006).
All these studies analyzed patients with spiked activity on focal EEG (spikes, spikes and waves, polyspikes) that differed in frequency. It was then suggested that a limiting factor to obtain sufficient BOLD activation is IED frequency. Two studies (Krakow, 1999 and 2001) proposed 1 IED/minute as the minimum value to obtain sufficient activation. But because a lower frequency does not have sufficient power to stimulate an IED-correlated BOLD signal change, the sensitivity of the technique is very low. More recent studies applied EEG-fMRI to compare the location of IED-correlated BOLD signal change with the resected area and postoperative outcome (Thorton, 2010). Seven out of 10 surgically treated patients were seizure-free following surgery and the area of maximal BOLD signal change was concordant with resection in 6 out of 7 patients. In the remaining 3 patients with reduced seizure frequency post-surgically, the areas of significant IED-correlated BOLD signal change lay outside the resection, thus confirming that the epileptogenic zone (to be removed) is different from the lesional area.
Although some studies analyzed focal epilepsies (Liu, 2008), focal slow-wave activity as a marker of activation of cerebral blood flow was initially studied in only two single case reports (Laufs, 2006/a; Avesani 2008/a-b). The one additionally used SEEG to demonstrate co-localization between IEDs and fMRI activation. The second, our case report (Avesani 2008/a), involved a patient with temporal lobe epilepsy (TLE) due to a cavernoma, who had undergone surgical treatment without attaining freedom of seizures. This woman had no medical history of note until the age of 24 years (1975), when symptoms characterized by painful sensations including a lightening stabbing pain developed in the left parietal region of the head, preceded by absence attacks lasting 30 seconds. After seizures she always experienced profound weakness. Her seizures recurred at a variable rate, ranging from more than one a day to one every 10-15 days. During the seizure-free periods she remained healthy. The EEG at that time was negative for an interictal focus. In 1986, when the patient was 35 years old, the EEG disclosed an interictal focus in left temporal regions, characterized by very frequent, and polymorphous, theta-delta activity in association with sharp waves, blocked by eye opening and without contralateral diffusion. Subsequent EEG confirmed the irritative focus in the left fronto-temporal region. When the patient was 37-year-old she began therapy with phenobarbitone (PB) and carbamazepine (CBZ), benefiting from a decrease in seizure intensity (but not frequency). A computed tomographic (CT) brain scan disclosed a mild, non-homogeneous, subcortical hyperdensity on the mesial side of the left temporal lobe, containing rough calcifications with no contrast enhancement. An MRI scan revealed two small lesions in the left temporal lobe, similar to cavernomas (one anterior, in the Sylvian fissure and another posterior, in the paratrigonal region). The patient underwent surgery but the partial seizures remained unchanged. Treatment with PB and CBZ was therefore continued. Twelve years later (2002), another MRI scan revealed three small independent cavernomas in the left temporal lobe (left temporo-basal, left temporo-mesial, and in the left post-central gyrus). A year later (2003), bleeding of the large lesion (localized in the left temporo-basal region) caused the patient to be re-admitted to the neurosurgical ward to undergo a second operation. Despite repeat surgery the seizures continued so she needed further therapy. A following MRI scan (2005), confirmed the presence of the previous cavernomas without bleeding.
Using interictal focus of slow waves recorded in the left temporal region as a trigger of activation (Fig. 1), we obtained activation in the left posterior cortical region around the poro-encephalic cavity (residual of previous surgical treatment) (Fig. 2). Our findings confirmed observations by Thorton of 3 patients in whom surgical treatment failed to achieve seizure freedom: in these situations areas of significant IED correlated BOLD signal change lay outside the resection (Thorton, 2010).
Interictal EEG of patient affected by cavernosa. Focal IEDs in left temporal region
Interitcal focal slow wave activity correlated BOLD activation in patient affected by cavernoma: results of data analysis both in 2D and in 3D recontruction
In a previous study involving 8 patients with focal slow-wave interictal discharges on EEG (Manganotti, 2008), we suggested that an IED-correlated BOLD change triggered by interictal slow-wave activity could be obtained if the focal activity is frequent (about 2 IEDs/min). The study was primarily designed to verify whether the interictal slow waves originating from an EEG interictal focus were sufficient to increase cerebral blood flow in a spatially related brain area. To do so, using EEG-fMRI, we investigated BOLD responses to IEDs characterized by focal interictal slow-wave activity in patients with partial epilepsy.
We also wanted to understand whether, in patients with lesional epilepsy, fMRI-BOLD activation areas were correlated with lesions previously identified with standard MRI. We then investigated whether EEG-fMRI could document the spatial relationship between the interictal zone and the ictal onset zone in patients with interictal focal slow-wave discharges arising from a known epileptogenic lesion (i.e., the lesional area).
To obtain a homogeneous study sample, 8 patients with focal epilepsy were selected from among patients hospitalized in our epilepsy ward whose routine EEG recordings showed frequent focal IEDs manifesting as 5-6 Hz focal EEG activity (slow waves, slow spike waves, high-amplitude slow waves), over a few lateralized electrodes. Three of the 8 patients selected for study had a structural lesion on MRI: 2 patients with hippocampal atrophy secondary to mesial temporal sclerosis (MTS) and 1 patient with a cavernous angioma. Among the remaining 5 patients, 1 patient had cryptogenic epilepsy and 4 patients had nonlesional (idiopathic) epilepsy. Routine EEG showed slow-wave activity in 1 patient with MTS (P4), the patient with cryptogenic epilepsy (P2) and the one with idiopathic epilepsy (P7); slow spike waves were observed in the patient with a cavernoma (P3) and the 2 patients with idiopathic epilepsy (P5 and P8); high-amplitude slow-waves (> 130 μV) were noted in 1 patient with idiopathic epilepsy (P6) and the second patient with MTS (P1) (Table 1).
\n\t\t\t\t | \n\t\t\t\n\t\t\t\t | \n\t\t\t\n\t\t\t\t | \n\t\t\t\n\t\t\t\t | \n\t\t\t\n\t\t\t\t | \n\t\t
1 | \n\t\t\tLesional | \n\t\t\tMTS | \n\t\t\tHASW | \n\t\t\tT3-T5 | \n\t\t
2 | \n\t\t\tCryptogenic | \n\t\t\tNegative | \n\t\t\tSW | \n\t\t\tT3-T5 | \n\t\t
3 | \n\t\t\tLesional | \n\t\t\tCavernoma | \n\t\t\tSPSW | \n\t\t\tT5 | \n\t\t
4 | \n\t\t\tLesional | \n\t\t\tMTS | \n\t\t\tSW | \n\t\t\tT4-T6 | \n\t\t
5 | \n\t\t\tIdiopathic | \n\t\t\tNegative | \n\t\t\tSPSW | \n\t\t\tO1 | \n\t\t
6 | \n\t\t\tIdiopathic | \n\t\t\tNegative | \n\t\t\tHASW | \n\t\t\tT4-T6 | \n\t\t
7 | \n\t\t\tIdiopathic | \n\t\t\tNegative | \n\t\t\tSW | \n\t\t\tF7 | \n\t\t
8 | \n\t\t\tIdiopathic | \n\t\t\tNegative | \n\t\t\tHASPSW | \n\t\t\tT4-T6 | \n\t\t
Patients enrolled in the first study (Manganotti, 2008).
MTS denotes mesial temporal sclerosis; SW slow waves; HASW high-amplitude slow waves; SPSW spiked slow waves; HASPSW high- amplitude spiked slow waves.
The good results we obtained (BOLD activations correlated to IEDs in 8/8 patients) allowed us to extend the study to 8 other patients (for a total of 16 patients), all with the same characteristics: focal epilepsy in which routine EEG recordings showed frequent focal IEDs manifesting as 5-6 Hz focal EEG activity (slow waves, slow spike waves, high-amplitude slow waves) over a few lateralized electrodes. The results did not change. MRI revealed a structural lesion in 4 patients: MTS in 2, tuberose sclerosis (TS) in 1; and hypothalamic hamartoma (HH) in 1. Three patients had cryptogenic and one nonlesional (idiopathic) epilepsy.
Standard EEG showed: focal sharp-wave activity in 1 patient (P15) with idiopathic epilepsy; high-amplitude slow-wave activity (or high-amplitude sharp waves) in 1 with TS (P12) and in 1 with HH (P14); spiked sharp waves in 1 with MTS (P10) and in 2 patients with cryptogenic epilepsy (P13 and P16); and high-amplitude spiked waves in 1 with MTS (P9) and in 1 with cryptogenic epilepsy (P11) (Table 2).
\n\t\t\t\t | \n\t\t\t\n\t\t\t\t | \n\t\t\t\n\t\t\t\t | \n\t\t\t\n\t\t\t\t | \n\t\t\t\n\t\t\t\t | \n\t\t
9 | \n\t\t\tLesional | \n\t\t\tMTS | \n\t\t\tHASPSW | \n\t\t\tT8 | \n\t\t
10 | \n\t\t\tLesional | \n\t\t\tMTS | \n\t\t\tSPSW | \n\t\t\tF7-T3 | \n\t\t
11 | \n\t\t\tCryptogenic | \n\t\t\tNegative | \n\t\t\tHASPSW | \n\t\t\tF7-T3 | \n\t\t
12 | \n\t\t\tLesional | \n\t\t\tTS | \n\t\t\tHASW | \n\t\t\tP4 | \n\t\t
13 | \n\t\t\tCryptogenic | \n\t\t\tNegative | \n\t\t\tSPSW | \n\t\t\tT6 | \n\t\t
14 | \n\t\t\tLesional | \n\t\t\tHH | \n\t\t\tHASW | \n\t\t\tT4-T6 | \n\t\t
15 | \n\t\t\tIdiopathic | \n\t\t\tNegative | \n\t\t\tSW | \n\t\t\tT3-T5 | \n\t\t
16 | \n\t\t\tCryptogenic | \n\t\t\tNegative | \n\t\t\tSPSW | \n\t\t\tF8-T4 | \n\t\t
Characteristics of the 8 additional patients. MTS denotes mesial temporal sclerosis; TS tuberose sclerosis; HH: hypothalamic hamartoma.
The EEG was acquired using a MR compatible EEG amplifier (SD MRI 32, Micromed, Treviso, Italy) and a cap providing 32 Ag/AgCl electrodes positioned according to a 10/20 system (impedance was kept below 10 kΩ). To remove pulse and movement artifacts during scanning two of these electrodes were used to record the electrocardiogram (ECG) and electromyogram (EMG). The EMG electrode was placed on the right abductor pollicis brevis (APB) muscle and the other (ECG) on the precordial area.
The reference was placed anterior to Fz, and the ground posterior to Fz as in other studies (Gonçalves et al. 2006; Avesani et al. 2008/a; Formaggio et al., 2008; Manganotti et al. 2008) using the same system. To ensure subjects’ safety, the wires were carefully arranged to avoid loops and physical contact with the subject. To minimize the variability in the EEG artifacts due to the MR sequence and avoid wire movement caused by mechanical vibration the wires rested on foam pads.
EEG data were acquired at the rate of 1024 Hz using the software package SystemPlus (Micromed, Treviso, Italy). To avoid saturation, the EEG amplifier had a resolution of 22 bits with a range of ±25.6 mV. An anti-aliasing hardware band-pass filter was applied with a bandwidth between 0.15 and 269.5 Hz. Details of the EEG recording method are given in Bènar (Bènar et al, 2003). The EEG artifact induced by the gradient magnetic field was digitally removed off-line by an adaptive filter (Micromed). EEG artifacts associated with pulsatile blood flow were digitally removed off-line using a simple averaging procedure (Allen, 1998-2000). Subsequently a single electroencephalographer visually reviewed the filtered EEGs, and marked the time of onset and duration of each IED.
Images were acquired on a 1.5 T MR scanner (Symphony, Siemens, Erlangen, Germany) equipped with EPI capability and a standard transient/receive (TR) head coil. At the start of each study, a T1-weighted anatomical MRI was acquired (192 slices; FOV = 256X256; scanning matrix 512X512; slice thickness 1 mm; sagittal slice orientation; echo time (TE) = 3ms; repetition time (TR) = 1990 ms).
All patients then underwent a 24-min fMRI recording session, after giving informed consent. BOLD fMRI data were acquired, using a standard gradient-echo (EPI) sequence, on the axial orientation, in 1 run of 8 minutes with the patient in the resting state, as described by the Kobayashi team (Kobayashi,2006) (voxel dimension 3x3x3 mm; 36 slices; matrix 64x64; TE = 50 ms, TR = 3.7 s; and slice thickness = 3 mm). At the onset of each fMRI acquisition, the scanner provided a trigger signal that was recorded by the EEG system and used as a volume marker.
For image processing and statistical analysis of the fMRI time series data we used BrainVoyager QX 1.9 software (
In each subject, activated voxels were identified with a single-subject general linear model (GLM) approach for time series data (Friston, 1995). To account for the hemodynamic delay, the boxcar waveform representing the rest and task conditions was convolved with an empirical hemodynamic response function (Friston, 1998).
A t statistic was used to determine significance on a voxel-by-voxel basis and correlation values were transformed into a normal distribution (Z statistic). The results were displayed on parametric statistical maps in which the pixel Z value is expressed on a colorimetric scale. We identified the single region of condition-associated BOLD signal changes with a statistical threshold based on the amplitude (p<0.05) and extent of the regions of activation. The location of voxels with maximal signal increase was expressed in terms of x, y, and z in the Talairach space, and activation volumes were expressed in terms of number of activated voxels. Positive BOLD-fMRI responses were defined as activations. Significant responses were defined as almost five contiguous voxels with p<0.05 over at least two contiguous slices (Krakow 1999 and 2001;\n\t\t\t\t\t\tSalek-Haddadi 2006) in 2D-reconstruction. The anatomic localization of BOLD responses was determined by co-registration of the anatomic data and statistical t maps.
We analyzed the extent and maximum fMRI response for each study, considering all areas with significative activations. We also determined the locations of maximum activation based on the maximum peak response (maximum t value).
In all patients, EEG showed unilateral focal activity during the EEG-fMRI session. IEDs recorded inside the scanner had a localization, amplitude and morphology similar to those seen in the previous routine EEG recordings. EEG recordings showed focal high-amplitude slow waves in 4 patients (P1, P6, P12 and P14), and slow-wave discharges over the temporal electrodes in the other 3 patients (P2, P4 and P15). In 1 patient (P7) slow-wave activity was detected in the extratemporal (F7) region. In the patient with a cavernoma (P3), in 1 with MTS (P10), and in 2 patients with cryptogenic epilepsy (P13 and P16), focal EEG activity was characterized by focal slow-spiked wave activity, reaching maximal amplitude over the left temporal electrodes (T5). In 1 patient (P5) slow-spiked waves were detected in the extratemporal region (left occipital region). The EEG tracings also showed high-amplitude spiked slow-wave activity in 3 patients (P8, P9 and P11): in the right temporal region in 2 (P8 and P9) and in the left fronto-temporal region in 1 patient (P11).
The mean frequency was 2.4 IEDs per minute (SD 0.17) for the first 8 patients and 2.495 for the second 8 patients, thus confirming sample homogeneity.
In all 8 patients from the first study and in 7/8 from the second study, fMRI analysis showed, in 2-D reconstruction, significant focal BOLD activation in a single activated area related to the EEG irritative focus (Tables 3 and 4). This activation was considered significant (Krakow, 1999) because it was identified in two contiguous MRI slices.
\n\t\t\t\t | \n\t\t\t\n\t\t\t\t | \n\t\t\t\n\t\t\t\t | \n\t\t\t\n\t\t\t\t | \n\t\t\t\n\t\t\t\t | \n\t\t
1 | \n\t\t\t\n\t\t\t\t | \n\t\t\t\n\t\t\t\t | \n\t\t\tLeft mesial temporal lobe | \n\t\t\t2 | \n\t\t
2 | \n\t\t\t\n\t\t\t\t | \n\t\t\t\n\t\t\t\t | \n\t\t\tLeft mesial temporal lobe | \n\t\t\t2 | \n\t\t
3 | \n\t\t\t\n\t\t\t\t | \n\t\t\t\n\t\t\t\t | \n\t\t\tLeft superior temporal lobe – neocortical region | \n\t\t\t3 | \n\t\t
4 | \n\t\t\t\n\t\t\t\t | \n\t\t\t\n\t\t\t\t | \n\t\t\tRight mesial temporal lobe | \n\t\t\t2 | \n\t\t
5 | \n\t\t\t\n\t\t\t\t | \n\t\t\t\n\t\t\t\t | \n\t\t\tLeft occipital lobe-calcarin cortex | \n\t\t\t2 | \n\t\t
6 | \n\t\t\t\n\t\t\t\t | \n\t\t\t\n\t\t\t\t | \n\t\t\tRight superior temporal lobe | \n\t\t\t2 | \n\t\t
7 | \n\t\t\t\n\t\t\t\t | \n\t\t\t\n\t\t\t\t | \n\t\t\tLeft frontal lobe | \n\t\t\t2 | \n\t\t
8 | \n\t\t\t\n\t\t\t\t | \n\t\t\t\n\t\t\t\t | \n\t\t\tRight superior temporal lobe | \n\t\t\t2 | \n\t\t
Number of IEDs revealed on EEG during recording and BOLD activation in 2D reconstruction of fMRI, with number of contiguous activated slices.
\n\t\t\t\t | \n\t\t\t\n\t\t\t\t | \n\t\t\t\n\t\t\t\t | \n\t\t\t\n\t\t\t\t | \n\t\t\t\n\t\t\t\t | \n\t\t
9 | \n\t\t\tLeft mesial temporal lobe | \n\t\t\t3 | \n\t\t||
10 | \n\t\t\tLeft mesial temporal lobe | \n\t\t\t3 | \n\t\t||
11 | \n\t\t\tLeft supplementary motor cortex | \n\t\t\t5 | \n\t\t||
12 | \n\t\t\tRight parietal lobe | \n\t\t\t3 | \n\t\t||
13 | \n\t\t\tRight mesial temporal lobe | \n\t\t\t2 | \n\t\t||
14 | \n\t\t\tRight mesial temporal lobe | \n\t\t\t2 | \n\t\t||
15 | \n\t\t\t==== | \n\t\t\t0 | \n\t\t||
16 | \n\t\t\tLeft mesial temporal lobe | \n\t\t\t2 | \n\t\t
Number of IEDs revealed on EEG during recording and BOLD activation in 2D reconstruction of fMRI, with number of contiguous activated slices, in the second study of 8 patients.
This result was confirmed with analysis of 3D reconstruction of fMRI: in all 8 patients from the first study (Manganotti, 2008) and in 7/8 from the second study, fMRI BOLD activation corresponded to the irritative focus on standard EEG recordings (Tables 5 and 6).
\n\t\t\t\t | \n\t\t\t\n\t\t\t\t | \n\t\t\t\n\t\t\t\t | \n\t\t
1 | \n\t\t\t177 | \n\t\t\tLeft cerebrum, limbic lobe, parahippocampal gyrus, \n\t\t\t\t | \n\t\t
2 | \n\t\t\t522 | \n\t\t\tLeft cerebrum, limbic lobe, parahippocampal gyrus, \n\t\t\t\t | \n\t\t
3 | \n\t\t\t540 | \n\t\t\tLeft cerebrum, temporal lobe, inferior temporal gyrus, \n\t\t\t\t | \n\t\t
4 | \n\t\t\t175 | \n\t\t\tRight cerebrum, limbic lobe, parahippocampal gyrus, \n\t\t\t\t | \n\t\t
5 | \n\t\t\t1227 | \n\t\t\tLeft cerebrum occipital lobe, lingual gyrus, \n\t\t\t\t | \n\t\t
6 | \n\t\t\t364 | \n\t\t\tRight cerebrum, temporal lobe, transverse temporal gyrus, \n\t\t\t\t | \n\t\t
7 | \n\t\t\t442 | \n\t\t\tLeft cerebrum, frontal lobe, precentral gyrus, \n\t\t\t\t | \n\t\t
8 | \n\t\t\t422 | \n\t\t\tRight cerebrum, temporal lobe, middle temporal gyrus, \n\t\t\t\t | \n\t\t
Number of activated voxels, and localization, according to the Talairach system, of activated regions in 3D reconstruction, of the 8 patients from the first study (Manganotti, 2008).
\n\t\t\t\t | \n\t\t\t\n\t\t\t\t | \n\t\t\t\n\t\t\t\t | \n\t\t
9 | \n\t\t\t368 | \n\t\t\t1) Right cerebrum, temporal lobe, superior temporal gyrus 2) Right cerebrum, frontal lobe, mesial frontal region | \n\t\t
10 | \n\t\t\t350 | \n\t\t\tLeft cerebrum, temporal lobe, fusiform gyrus \n\t\t\t\t | \n\t\t
11 | \n\t\t\t322 | \n\t\t\tLeft cerebrum, frontal lobe, supplementary motor cortex \n\t\t\t\t | \n\t\t
12 | \n\t\t\t52 | \n\t\t\tRight cerebrum, parietal lobe, precuneus \n\t\t\t\t | \n\t\t
13 | \n\t\t\t256 | \n\t\t\tRight cerebrum, temporal lobe, superior temporal gyrus \n\t\t\t\t | \n\t\t
14 | \n\t\t\t200 | \n\t\t\tRight cerebrum, anterior cingulate, limbic lobe | \n\t\t
15 | \n\t\t\t0 | \n\t\t\t===== | \n\t\t
16 | \n\t\t\t150 | \n\t\t\tRight cerebrum, parahippocampal gyrus, limbic lobe \n\t\t\t\t | \n\t\t
Number of activated voxels, and localization, according to the Talairach system, of activated regions in 3D reconstruction, of the 8 patients from the second study.
Focal BOLD signal changes in 11 patients reached statistical significance in the temporal regions. In 10 patients (4 of which with MTS [P1, P4, P9, and P10]; 1 with HH [P14]; 3 with cryptogenic epilepsy [P2, P13, and P16]; in 2 of the 4 with idiopathic epilepsy [P6 and P8]), the significant BOLD changes were located in the mesial temporal lobe and in the neocortical regions (laterally and posteriorly to the resection margins) in the 1 patient with a cavernoma (P3).
An interesting case of surgically treated mesial temporal sclerosis involved P9. Of Moroccan origin, he has suffered from focal seizures since the age of 6 years, with loss of consciousness and oral and motor automatisms of the legs (pedaling) and arms, preceded by an epigastric aura, lasting 1 minute and resistant to therapy. On MRI, right mesial temporal sclerosis (MTS) was detected (fig.3). Standard EEG demonstrated an interictal focus in the right temporal region. The seizures first occurred rarely but then increased in frequency with time, eventually manifesting in “clusters” of 10-15 seizures every 1 to 2 months. Auras occurred every 2 weeks. Video-EEG demonstrated the same abnormal activity in the right temporal region, with an ictal event manifesting with the same characteristics. The hypothesis was that the seizures arose in an epileptogenic area related to the known MTS and then spread anteriorly to the right mesial frontal region (cause of motor manifestation). EEG-fMRI recording session identified an interictal slow wave activity in right temporal region (T4-T6), with a following diffusion both to contralateral region and to right frontal region (fig. 4). Two significant activations were detected (figg. 5-6): one in the right mesial temporal region (Brodmann area 38) and one in the right mesial frontal region (Brodmann area 10). Also in this case, BOLD activations were concordant with focal IEDs and with clinical syndrome. On subsequent analysis with invasive techniques (SEEG), the origin of seizure in an epileptogenic zone correlated with MTS was confirmed, with spread to the right mesial frontal region. The study also confirmed the co-localization between EEG and fMRI data. He was surgically treated and is now seizure free.
Right mesial temporal sclerosis (MTS) in Patient n. 9
Patient n. 9. Focal IEDs in right temporal region, with following diffusion both to contralateral region and to right frontal region
Patient n. 9. Focal IEDs correlated BOLD activations in mesial right temporal region, with following diffusion to contralateral region
Patient n. 9. Focal IEDs correlated BOLD activation in right mesial frontal region
Another case involved a young man (P14) affected with gelastic seizures due to a hypothalamic hamartoma and manifesting since he was 2 years old. They were well defined: dissociated deviation of the eyes (the left eye toward the right and the right eye upwards) or associated deviation of both eyes upwards, followed by right head deviation, absent facial expression, and asymmetric smile. Often, an aura (tingling in the left temporal region) would precede the seizures, with concurrent rubor. The patient attempted to speak but was impeded by fixed smiling. The episode frequency was very high (up to 5 seizures/day). Over time, the syndrome worsened, with falls and subsequent injuries. SEEG confirmed an epileptogenic zone inside the hamartoma, with spread to the right mesial temporal region during the seizures. EEG-fMRI detected a significant BOLD activation in the limbic lobe (anterior cingulate), substantiating the anatomic-clinical correlation suggested by seizures and EEG.
This case parallels recently published findings on the networks involved in seizure generation in hypothalamic hamartoma (Kokkinos, 2012). EEG-fMRI was performed in 2 adult patients with hypothalamic hamartoma, the one with predominantly gelastic seizures and the other with complex partial but no typical gelastic seizures. Ictal and interictal analysis of the patient with gelastic seizures revealed involvement of the hypothalamic hamartoma, the cingulate gyrus, the precuneus and prefrontal cortex. The interictal analysis of the patient with complex partial seizures showed BOLD signal changes over the temporal lobes, the base of the frontal lobe, the precuneus and prefrontal cortex but not the hypothalamic hamartoma. It was presumed that the differences in the neural networks implicated may have accounted for the differences in the clinical manifestation of seizures owing to the tumor.
Other interesting cases are cryptogenic (P2, P13) and idiophatic forms (P6, P8, P15), all characterized by atypical absences and vagal symptomatology. In patient n. 2, focal IEDs (fig. 7) were recorded in left temporal region and focal IEDs correlated BOLD activation (fig. 8) was detected in mesial left temporal region, in limbic lobe. In patient n. 6 focal IEDs were recorded in right temporal region, with a characteristic phase reversal in T4 (fig. 9), and focal IEDs correlated BOLD activation was detected in Brodam area 42 (fig. 10). In patient n. 8, focal IEDs were recorded in right temporal region (fig. 11) and focal IEDs correlated BOLD activation was detected in Brodman area 21 (fig. 12).
Patient n. 2 (cryptogenic epilepsy). Focal IEDs in left temporal region during scanning session
Patient n. 2. Focal IEDs correlated BOLD activations in left mesial temporal lobe
Patient n. 6. Focal IEDs in right temporal lobe with phase reversal in T4
Patient n. 6. Focal IEDs correlated activation in transverse temporal gyrus, Brodmann area 42
Patient n. 8. Focal IEDs in right temporal region
Patient n.8. Focal IEDs correlated BOLD activation in middle temporal gyrus, Brodmann area 21
In our series, fMRI showed extratemporal activation in 4 patients: the left occipital lobe (P5); the left frontal lobe (P7); the left supplementary motor cortex (P11); and the right parietal lobe (P12). In all four cases there was a correlation between BOLD activation and IEDs and with clinical syndromes as well. This correlation is relevant to the discussion about the technique’s sensitivity in revealing activation in extratemporal regions.
A rare case (P5) involved non ketotic hyperglycemia (NKH)-induced seizures occurring in the left occipital lobe studied by EEG-fMRI (Del Felice, 2009). These seizures usually occur in the frontal regions and cause motor ictal syndromes, whereas occipital seizures have been described in very rare situations. Cases of NKH presenting as hemichorea or hemianopia have also been reported. Seven such patients (Seo, 2003; Raghavendra, 2007) were studied by standard MRI transient T2-weighted and fluid-attenuated inversion recovery (FLAIR). Subcortical hypointensity with or without abnormalities in the occipital overlying cortex or striatal nuclei was documented in occipital seizures associated with NKH. A single case investigated by Tc-99m HMPAO SPECT (Wang, 2005) showed occipital hyperperfusion during seizure recurrence and hypoperfusion during the interictal state.
Our patient (P5) was a 50-year-old woman admitted to hospital after repeated emergency room visits because of visual disturbances and left-sided headache. On clinical examination, she was obese and had a right-sided homonymous hemianopia. Her medical history was unremarkable, except for hypertension and a 15-kg weight gain during the past 12 months. She had no history of migraine, epilepsy or neurological disorders. Two days before admission she reported a short-lasting episode of visual disturbance (distortion). A few hours later, she noted diplopia when looking to the right, with image distortion in the right visual field and intermittent right-sided hemianopia, lasting several minutes, elicited by looking to the right or by fixation. The episodes were accompanied by a left-sided throbbing headache but no other autonomic symptoms (i.e., nausea or vomiting). No language disturbance was reported. She was presented to the emergency room.
On neurological examination, a right-sided homonymous hemianopia was noted. A standard computed tomography (CT) scan of the brain and an ophthalmologic exam were negative. She was discharged with a diagnosis of migraine with aura and started on antiplatelet therapy, with the recommendation to undergo out-patient visual field analysis.
Two days later, she was admitted to our ward owing to the persistence of symptoms, including a transient conjugated deviation of the eyes and the head to the right. On that occasion, which lasted less than 1 minute, the patient did not lose consciousness and referred seeing red flashing lights in her right visual field. Standard EEG performed immediately thereafter showed multiple clinical-EEG seizures during a prolonged recording, with spiked slow waves originating from the left posterior region, and with bilateral diffusion (fig. 13). Laboratory data on admission revealed hyperglycemia (14.5 mm/L to 261 mg/dL) with a serum osmolarity of 333 mmol/kg, and glycosilated hemoglobin of 10.5%. Urine analysis was negative for ketone bodies but was strongly positive for glycosuria (>1 g/dL) and microalbuminuria (up to 6 mg/24 h). A brain MRI scan with and without gadolinium, an MR angiography, and a 3T brain MRI were normal. Tc-99m hexamethylpropylene amine oxime (HMPAO) single-photon-emission computed tomography (SPECT), during which no clinical seizures were reported, showed non-significant hypocaptation over the posterior regions bilaterally.
Patient n. 5. Standard EEG tracing during clinical seizures. Spiked slow waves on posterior regions (O1 and O2).
On continuous EEG-fMRI a few days later, no clinical or EEG manifestations of ictal events occurred, but interictal spiked slow wave discharges (IEDs) with localization, amplitude and morphology similar to those previously recorded on routine EEG (fig. 13) were noted. A slow-spiked wave on the left occipital (O1) channel was detected. The mean frequency was 2.4 IEDs per minute. Functional MRI analysis showed significant focal BOLD activation in a single area related to the EEG paroxysmal activity. In a 3D reconstruction using the Talairach system (fig. 14), focal significant BOLD activation based on the EEG-related protocol was identified in Brodmann area 18 (grey matter of the left cerebrum occipital lobe and lingual gyrus). During her hospital stay, she was started on carbamazepine (200 mg/daily, up to 800 mg t. d.), with only partial benefit in frequency and intensity of symptoms. Since her glycemia was still uncontrolled (250 mg/dL), she was started on insulin therapy. Over the following 2 weeks, seizures and hyperglycemia both progressively decreased. On the basis of a possible diagnosis of NKH-induced seizures, carbamazepine was tapered, without the reappearance of symptoms. Serial EEG showed a decrease in epileptic activity (sharp waves) with persistent bilateral slowing. A few weeks later, insulin therapy was replaced with oral antidiabetics. One year later, the patient was seizure free, with a normal EEG. Following the loss of 18 kg, the oral antidiabetics were tapered, with good control of serum glucose and HbA1 values.
Patient n. 5. 3D fMRI-BOLD activation in Brodmann area 18.
A BOLD occipital activation in patients referring visual symptoms has been reported, confirming the involvement of visual functional areas in the occipital lobes: Brodmann areas 19 and 37 in reported cases of fixation sensitivity occipital spiking (Iannetti et al., 2002; Avesani, 2008/b) or the left occipital lobe in cases of cryptogenic and symptomatic (cortical malformation) occipital epilepsy (Salek-Haddadi et al., 2006). In our patient, an analogous BOLD activation was elicited by the NKH. Hyperglycemia may induce paroxysmal activity in brain areas more susceptible to metabolic changes – the occipital lobe in this case - with an analogous pattern of activation of self-sustained focal discharges. Neuroimaging, in this case fMRI-EEG co-registration, pointed to a change in blood volume in the involved posterior areas.
In the patient (P7) in whom fMRI revealed BOLD activation in the left frontal region (Brodmann area 6), standard EEG showed a left fronto-temporal irritative focus characterized by frequent slow-spiked waves. A recent polygraphic study (recorded during stage I and II non-rapid-eye-movement [NREM] sleep) showed polymorphic slow waves (theta-delta) in the left frontal regions, with phase inversion at F7 and without spread. These findings suggested that the patient was a good candidate for an EEG-fMRI study. During the EEG-fMRI sessions, we confirmed the fMRI activation area within the precentral gyrus.
Patient no. 11, a young woman, illustrates an interesting case of frontal lobe epilepsy characterized by focal seizures, with speech arrest and right arm clonus followed by generalization (Borelli, 2010), where, as reported elsewhere (So, 1998; Westmoreland, 1998), scalp EEG is often ambiguous because it is poorly sensitive to deep generators on the mesial surface of the frontal lobe. Also in this instance, EEG-fMRI effectively identified the interictal focus.
According to a detailed account by relatives, the events took the form of sudden episodes of speech arrest lasting from a few seconds up to several minutes, without any warning sensation. The patient reported she was able to move, understand and write properly during the ictal phase (sometimes writing a note to her husband that she was unable to speak). No clonic movements or orofacial automatisms were experienced at this early stage. Usually, an event did not progress any further and the patient was able to fully recollect the episode. Sometimes an episode was followed by clonic jerking over the right side of the face and arms with occasional, generalized tonic-clonic seizures. The seizure frequency was weekly despite polytherapy. The 3T MRI was normal. She reported no febrile seizures nor having sustained significant head injuries. Pregnancy, delivery and developmental milestones were unremarkable, as was the remainder of her medical history. Trials with various antiepileptic drugs (first with dintoine, then carbamazepine, and then fenobarbital) were unsuccessful. She was admitted to an intensive care unit for a status epilepticus and begun on valproate and lamotrigine.
Interictal scalp EEG showed frequent generalized high-amplitude (2 to 3 Hz) spiked slow-wave discharges. There was an inconstant, mild amplitude prevalence over the left hemisphere electrodes (F7-T3).
During a conventional scalp EEG recording, she complained of a brief episode of speech arrest associated with an EEG pattern characterized by diffuse spike and wave discharges (fig. 15). This event was witnessed by a neurologist from our ward who was aware of the patient’s clinical history. He noted that the patient had a brief inability to speak (a few seconds) during which she waved her hands to attract his attention. There were no clonic movements, and after regaining speech, she accurately described the event. Three-hour video-EEG monitoring during a day of seizure clustering recorded no usual events. On the basis of these elements, a diagnosis of generalized epilepsy was also made in another hospital.
Patient n. 11. Ictal EEG during a brief speech arrest episode (‘‘Afasia’’ marks the beginning of the speech impairment).
The clinical syndrome suggested involvement of the left supplementary motor area (SMA) with spread to the primary motor area. EEG -fMRI recording session confirmed the same pattern EEG identified by standard EEG (fig. 16) and following analysis showed prominent BOLD activation over the left SMA during the high-amplitude spiked slow-wave discharges compared to the rest state (Fig. 17). According to the Duncan criteria, such an activation pattern is reproducible since it was present in two contiguous slices (Duncan, 1999). The statistical significance of the activation was p < 0.0028 even after FDR correction. More activations were found in the contralateral SMA and homolateral motor strip as well. No significant deactivation areas or thalamic involvement (activation or deactivation) were found. The patient was referred to a level II epilepsy surgery center for presurgical work-up, including long-term video-EEG monitoring, but she refused further testing.
Patient n.11. EEG recorded during the fMRI acquisition showing generalized high amplitude spiked slow wave discharges, prevalent on left fronto-temporal regions.
Patient n. 11. The EEG-fMRI shows a clear-cut activation of the left (radiological convention) Supplementary Motor Area (SMA) and on the contralateral SMA on a lesser degree. Spread over the left motor strip is also evident.
The speech arrest noted in this patient is an epileptic feature usually related to involvement of the supplementary motor cortex over either the dominant or the non-dominant hemisphere. A bilateral spike and wave discharge pattern (secondary bilateral synchrony) is often detected in frontal-lobe epilepsy, particularly if the generator is deep, for instance, over the mesial surface of the frontal lobe (So, 1998; Westmoreland, 1998). In the presurgical work-up for epilepsy surgery, such a scalp EEG pattern certainly raises questions about the origin of the focal epilepsy especially when conventional MRI is negative. In the latter case, more investigations are usually obtained to guide depth electrode placement for invasive EEG. Ictal SPECT and interictal PET are commonly used for this purpose, but they are expensive, difficult to interpret, and usually provide regional rather than local data. In addition, if the ictal event is brief, SPECT may yield false negatives due to incorrect timing of the tracer injection (Salmenpera, 2005; Devous, 1998). The use of radioactive substances also raises safety issues.
A relatively new tool to obtain localizing data on the basis of EEG changes, EEG-fMRI is safe for the patient and relatively inexpensive (Al Asmi, 2003; Di Bonaventura, 2006). As our knowledge about the technique increases, it is gaining acceptance in the study of focal nonlesional epilepsy and presurgical work-up, as reported by Moeller et al. and Zijlmans et al. (Devous, 1998; Moeller, 2009). Nonetheless, few studies to date have applied EEG-fMRI in patients with secondary bilateral synchrony, except for one by Aghakhani (Aghakhani, 2006) involving 11 patients with such an EEG pattern, with a variable activation-deactivation pattern including thalamic involvement in 6 out of 11 (55%). The clinical seizure pattern and the MRI findings were variable.
In our patient, EEG-fMRI revealed the origin of the epileptiform discharges, including the spread over the homolateral motor strip, which was highly consistent with the patient’s clinical features (speech arrest followed by clonic jerks over right half of the face and right arm), whereas 3T MRI and conventional interictal scalp EEG were useless in this regard. Some involvement of the contralateral SMA was also detected but its significance is less clear: it may have been the result of a transcallosal spread from the left SMA or simply an imperfect spatial resolution of the technique. In contrast with Aghakhani (Aghakhani, 2006) in our case no thalamic changes were seen.
Unfortunately, our localizing hypothesis could not be proved by invasive EEG and postsurgical outcome since the patient refused surgical treatment. Nonetheless, this patient suggests that, in the presurgical work up for epilepsy, EEG-fMRI may be considered a useful tool to generate a localizing hypothesis to be tested with invasive recording also in patients with focal epilepsy and bilateral slow spiked-wave discharges on EEG (secondary bilateral synchrony) and negative MRI. The recording of ictal EEG demonstrates that the slow waves we triggered in our study were irritative and not lesional.
The main finding in our EEG-fMRI study of patients with partial epilepsy is that the focal interictal slow-wave activity was invariably associated with increased focal fMRI-BOLD activation responses in a spatially related brain area. Our study extends current knowledge on epileptic foci localization and confirms previous reports suggesting that EEG-fMRI BOLD activation associated with modeled slow activity might have a role in localizing the epileptogenic region, even in the absence of clear interictal spikes (Laufs, 2006; Avesani, 2008/a).
All the patients with partial epilepsy we enrolled in this study had frequent interictal focal slow-wave activity on standard EEG. In all continuous EEG-fMRI recording sessions, after fMRI artifact removal, we obtained good quality EEG that allowed us to detect spontaneous IEDs and analyze the related fMRI BOLD activation. The EEG recording left the quality of the fMRI data almost undistorted, and the focal activity seen in the concurrent EEG was associated, in 15 of 16 patients enrolled, with a focal increase in the MRI signal in all patients. In their focal distribution, these BOLD activations resembled the focal IEDs seen on routine scalp EEG and EEG recorded during EEG-fMRI sessions.
An interesting finding came from the patients with lesional epilepsy. These patients, whose standard MRI documented a lesion and whose standard EEG identified an irritative focus, are ideal candidates for verifying a possible spatial relationship between the epileptogenic and the irritative focus (Ebersole, 1991; Benbadis, 1996).
In the patient who had undergone surgery to remove a cavernoma (P3), the EEG-fMRI study, by localizing the irritative focus and linking it to fMRI as an “active state”, showed a significant BOLD activation signal closely related to the poro-encephalic cavity (a residual of previous treatment). Although this focal BOLD activation presumably arose from a blood vessel (residual cavernoma), it was undoubtedly obtained by a protocol study linking an active fMRI state to IEDs on EEG. To clarify the relationship, we decided to progressively test the specificity to a very high level (p < 0.0001), as demonstrated in the iconography. Even with these high specificity values, the BOLD activation in that site persisted.
Another new finding is the BOLD activation we detected on fMRI in the patients with MTS. In contrast to others who studied a series of patients with MTS (5 studied with continuous co-registration) (Al Asmi, 2003) and found no significant activation, we detected significant BOLD activation in 4 patients (P1, P4, P9 and P10). These results suggest a possible role of simultaneous EEG-fMRI in disclosing focal activation in the mesial temporal cortex. This cortical area is notoriously difficult to study with standard methods because the deep localization of the irritative area often makes spikes smoother and therefore harder to recognize on recordings from standard EEG scalp electrodes than in SEEG. Hence, IEDs presenting as slow-wave discharges could be useful in determining significant BOLD activation in a corresponding area, as previously suggested by Laufs et al. (Laufs, 2006).
Useful information that may help us to understand BOLD responses in various forms of epilepsy came also from studying activation in extratemporal IEDs. In the patients with extratemporal discharges (P5, P7, P11, and P12), we noted a good correlation between the clinical polygraphic data and BOLD activation during fMRI. No significant difference was found between activation in the frontal or the occipital lobe. In both regions, BOLD activation increased after focal IEDs. One patient (P11) demonstrated the usefulness of EEG-fMRI, especially when scalp EEG is ambiguous because it is poorly sensitive to detect deep generators on the mesial surface of the frontal lobe, and confirmed that the slow waves were irritative and not lesional.
The reason for such good results (15/16 activations -- significant concordance between EEG and fMRI data) is open to question. The most plausible reason is that during enrolment, to obtain the largest possible percentage of activations, patients were explicitly selected whose standard EEGs showed a high IED firing rate confirmed on EEG during the scanning session. The mean frequency of IEDs in the 15 patients was about 2/min, considerably higher than the 1 IED per minute Duncan considered as the minimum to obtain a focal BOLD activation (Krakow, 1999). Collectively, these findings confirm the importance of IED firing rates in EEG-fMRI.
Perhaps the most interesting finding in this study was that morphology seemed less important than IED firing rates in triggering EEG-fMRI-BOLD activation: 8 of the 16 patients had pure slow waves on standard EEG (4 with high amplitude and 4 with a normal voltage) and 7 had slow spike-wave discharges (4 with high amplitude and 3 with normal voltage); 1 patient (P10) had a focus of normal amplitude, sometimes pure, sometimes with spiked morphology. There were no differences in BOLD activation between the two groups.
Although these slow spike-wave discharges might have originated from a spike focus smoothed by filtering (unlikely because EEG detected the same IEDs before the patients entered the magnet room), there was no difference in the statistical significance of BOLD activation between the two groups. Specifically, slow spike-wave IEDs were no more efficient than slow-wave IEDs in eliciting significant BOLD activation. Hence, it was agreed as previously suggested (Laufs, 2006/a; Avesani, 2008/a) that slow-wave IEDs, like spikes, could elicit a significant increase in cerebral blood flow in a spatially related brain area.
The study also suggests that voltage might have a minor role in determining BOLD activation: in this small study sample there were no differences in BOLD activations between IEDs with high-amplitude (9 patients) and those with normal amplitude slow waves (7 patients).
The significant concordance between EEG and fMRI data, and the absence of multiple activation areas in particular, depended on the high specificity threshold the study design envisaged. In designing this study, only the single activation with the strongest specificity was maintained so that we could verify whether this activation, and this activation alone, coincided with the epileptic focus previously documented by standard EEG and used as a paradigm for the activation-state during the fMRI analysis.
Given the criticism raised against the use of EEG-fMRI instead of other techniques such as EEG-source analysis in the presurgical work-up (Elshoff, 2012), a possible objection to the conclusions we draw could derive from our decision to include only a well-defined sample of patients, all characterized by a focus with a high firing rate, without evidence of the same result in other patients with low firing rate foci (being the most frequent among patients affected by focal drug-resistant epilepsy of surgical interest. We reply that this study was the first approach to investigating interictal slow-wave foci. This will be addressed in a future study in order to validate the technique in patients with slow-wave interictal activity with a low firing rate focus.
At the moment, the complete EEG-fMRI concordance achieved in this study suggests that slow-wave IEDs, even without spikes, may be useful in activating fMRI BOLD responses during the presurgical, noninvasive evaluation of patients with partial drug-resistant seizures.
The authors wish to thank:
Prof. Bernardo Dalla Bernardina, Dp of Life and Reproduction Sciences, University of Verona
Dr. Giuseppe Moretto and Dr. Tiziano Zanoni, Dp of Neurological Sciences, Civil Hospital of Verona, Dp of Neurological Sciences, Civil Hospital of Verona
Prof. Nicolò Rizzuto, Dp of Neurological, Neuropsychological, Morphological and Movement Sciences, University of Verona
Dr. Paolo Manganotti, Dr. Luigi Giuseppe Bongiovanni, Dr. Paolo Borelli, Dr. Alessandra Del Felice, dott. Emanuela Formaggio, dott. Silvia Francesca Storti, Dp of Neurological, Neuropsychological, Morphological and Movement Sciences, University of Verona, Dp of Neurological, Neuropsychological, Morphological and Movement Sciences, University of Verona for their collaboration
Prof. Roberto Pozzi Mucelli, Dr.ssa Anna Gasparini and Dr. Roberto Cerini , Dp of Radiology University of Verona
Every human psychic aspect cannot be considered separately from the financial and cultural context in which it is embedded. Adopting this perspective, it appears evident that the realization of individual freedom must be closely related to wider economic and social changes, which influence the individual about the realization of his own self, and probably also about his awareness development. Our reflection starts from Fromm’s point of view: man is the center of his life, the growth and realization of human individuality is a target which can never be subordinated to other purposes, which are supposed to have greater dignity. As a matter of fact, according to Fromm, the average man is often not really aware about his life and his reality, since most of what he thinks is real is only a sort of illusion: often he is aware of reality only to the necessary level to carry out his activity in his own social context and cultural context to which he belongs, as his survival targets makes such awareness actually necessary [1].
Throughout the humanity history we have witnessed a revolution about the reference values, with respect to the man role in culture and in social development. While Western culture fathers (the Greeks and Jews), believed that the supreme life target was man perfection, modern human beings often look more and more to things perfection, and to the knowledge of methods to produce these perfect objects. The long and complex transition from a “humanistic” society to a “technological” society have repercussions on the personality development (and therefore on the human self development [2]), since it embodies the process through which society transmits its cultural system from one generation to another, creating values, style of life ideals, social roles, habits and customs, language and expressive behaviors. In this regard, during the twentieth century second half, both in the anthropological field and in the psychological area, particular attention was given to the culture study, realizing how it has a strong influence on people’s life, making available different belief systems and values. The questions that man think are therefore affected by his own context: it influences individual experiences, how he perceives reality, how to satisfy fundamental needs, etc. The culture, which in the past was considered an outside objective frame, today is conceived as a sort of individual “internal” dimension, like a part of human self, and as a constitutive basis of individual behaviors: this makes us think on how the limits between “interior spaces” and “exterior spaces” are blurred and mixed. Thus, we can ask ourselves how profound is the culture influence on human being? We know, for example, that the probability that certain emotional experiences became conscious depends from the specific culture context in which they are experienced. According to this point of view, we can therefore affirm that an experience for which a specific language does not have a corresponding word to represent it rarely comes to man’s awareness: language embodies a certain disposition towards life, and can therefore be defined as an expression of a certain way of experiencing life [1]. According to this perspective, the psycholinguistic analysis that can be made with respect to verbs and nouns use in various languages is really interesting. The cultural paradigm shift from the self development to the technology development is represented by the growing number of people that today prefer to think in terms of having something, rather than in terms of being and acting: there is actually a preference for the use of nouns, instead a preference for verbs. Language, grammar, and words are indicative of the way and perspective of our life experience, and establish which kind of experiences can have access to our awareness (if there is not a term to indicate an experience in our language is difficult to became aware of this specific aspect). It is often believed a language differs from another only because it uses different words to mean the same thing, erroneously assuming some thought pattern and rules are universal, but this fact is not true because thought is influenced by a cultural system, which can show some conflicting logics with other cultural systems logics; thus, the individual often cannot afford to be aware of thoughts and feelings that are incompatible with his cultural models (according to which he grew up), and he is therefore unconsciously forced to remove them. About this topic, Fromm states that the conscience represents the social man and the contingent limitations imposed by his historical situation and context. In summary, we can note that the psychological functioning is therefore “intrinsically cultural”, since persons reason about the world using language and communication systems that acquire in their own culture, which are the product of human generations’ cultural experience; furthermore, we must focus that the themes to which individuals think about have a personal meaning within systems of meaning, based precisely on cultural and social practices, which are different according to context. We must point out, moreover, that the cultures are built by the same people who acquire the sense of being individuals from this same culture: the personality (the self) and culture structure each other; as a matter of fact, the proper significant culture customs and psychological processes of each of its members are mutually interacting [2]. In this regard, for example, we can also assert that there are collectivist cultures and individualist cultures, present more frequently respectively in East and West countries: how are they related to the constitution of the Self, and vice versa? The collectivist cultures place emphasis on membership, and on the shared rules that govern the community relationships: the person often define himself as part of the social community, since there is an intense emotional attachment to the largest social group to which he belong (not only to the family, but also to wider society); in this context, the self is often very focused on cooperation and social control. Therefore, people who refer to a collectivistic perspective more frequently pay attention to others and attribute greater relevance to contextual and external factors to explain a certain individual action; instead, individualistic cultures, often give emphasis on the “ego”, emphasizing the importance of personal autonomy, success and self-sufficiency: the self is often defined as an distinct entity from the social group in which it is contextualized; this perspective encourages to reach personal objectives. In this cultural framework, the personality is more oriented towards autonomy and competition values. People who refer to an individualistic perspective frequently give importance to individual responsibility in the explanation of the behavior causes [2]. Finally we have to state that the idea that Oriental culture and Westerners culture have created a sense of a more interdependent human self (in the former case), and a a sense of more independent self (in the second case), is blurred by the globalization phenomenon. This dynamic has been made possible by technological achievements (especially telematic ones), and has involved the entire planet in many areas: international exchanges have increased at an economic level and, consequently, also political, social and cultural one. This fact has led to a new worldwide phenomena emergence, both in the East and in the West countries: individual and context are not independent, but are interacting with each other in a dynamic way, and they really create each other [2]. The individual considered isolated is therefore a pure abstraction: he is a part of an articulated relationship system not only with the physical environment, but also with the socio-cultural and relational environment that surrounds him: we can therefore also ask, today, how hyper-modern era influences the ideal self and the real self, in various contexts, and vice versa.
The communications speed, the reduction of the space–time distance between the various countries has paradoxically caused increasing social disparities, the exploitation of wage labor and the reduction of the local economies autonomy. From an individual level, globalization has also promoted a sort of needs homogeneity, often standardizing the individual tastes to an imposed standard influenced by advertising. Another globalization consequence is the fact that it favors the ideological visions conformity and the lifestyles conformity, determining individual identification with the consumers mass. Paradoxically today in parallel there is also a generalized individualism. Assuming that the specific economic aspect is important for human development, however, it is necessary to explain why, despite the globalization pressures, different populations live in socio-economic conditions which are often very different from each other; even in the same context of the industrialized world, and in the “rich nations”, there are profound social inequalities regarding earnings, and consequently regarding the opportunities that individuals can have: today in many nations, the differences in economic conditions between poor and rich people have widened. At this point we can ask ourselves: which influence do these socio- economic circumstances have on the development of the individual self? In this regard there are some scientific evidences [2], for example, considering a particularly important and complex issue: it have been observed that individuals living in environments characterized by low and medium socio-economic conditions, often experience higher levels of psychological distress, such as depression and anxiety; this result may appear very ambiguous: it is not clear whether the individual personality characteristics indicate that they reside in more disadvantaged neighborhoods, or if it is on, the contrary, the fact that they live in these neighborhoods which can cause psychological malaise: thanks to scientific research it has emerged that between these aspects there are complex and significant interactions. Some studies have been carried out on this topic [3, 4, 5, 6] and of a very important result emphasize that the relations of cause and effect vary precisely according to the personality characteristics. We can ask ourselves is it the personality that exerts an influence on the social class or if it is the social class that influences the personality? It has been observed that social circumstances and self are deeply connected to each other: the children who grow up in disadvantaged families often become more anxious adolescents, and adolescents who have access to a lower education level often become more anxiety-prone adults; the relationship, however, does not seem to be one-to-one: the available data show how anxiety can develop from predisposing social contexts but that the reverse phenomenon is not so evident. In contrast, the data regarding antisocial disorders revealed a different result: the antisocial behavior has a social class effect; as a matter of fact, individuals who exhibit antisocial conduct show more difficulty at school, which in turn create a negative economic condition when they are adults. In general, scientists are able to explain the mutual influences of personality and economic status/social class but only by specifying the exact personality characteristics and studying the people development over time (through longitudinal studies) [2]. From what has been explained up to now, it is evident that the social, economic and cultural context can influence the self development, as well as the personality structuring can in turn determine important consequences in the various socioeconomic contexts.
The individual grows up and evolves influenced by his genetic characteristics and by the events that he has experienced during his life, in various contexts in which he lives; perceptions that the individual harvested from his experiences form his own inner world. When reality reaches awareness (and is psychologically represented), it substantiates the perceptions set that represent individual experiences; we must therefore focus that the human being does not react to reality as it is, but he reacts to his own perception of reality itself: therefore, each person can develop a different perception of a specific situation, and in general of the surrounding world, this process is also based on the concept that a person has of himself. At the development beginning, the child recognizes a part of his own experience as “me”, “I”, “myself”: this is the first part of “self “; therefore emerges the awareness of existing: the set of perceptions relating to oneself, which influence the perception of the surrounding reality. The set of meanings that the child attributes to what he calls “me” or “I” constitutes “ the self core”, which continues to develop during human growth. The self is a conceptual, organized and coherent perception configuration of personal characteristics: it is a fundamental personality structure, and it is very complex [7]. In summary, term self refers to the whole person as a reality, including his body and his psychic organization [7]. It may also be observed that one of the first and most important experiences that a child has of the self is the experience of being loved by his parents; as a matter fact, an important variable in the pattern towards self-realization is precisely the need to receive positive consideration by others: this is a particularly strong desire of the infant, who expects that the people who take care of him are ready to love it and accept him. Parents positive consideration can be, however, “unconditioned” or “ conditioned “, but what do we mean with these terms? In the first case the child is fully accepted as a person, regardless his behaviors, in the second case, child is welcomed and accepted only if he adapts to the parents expectations: “value conditions” are therefore set. Basically, the child feels to be considered and loved only if he welcomes certain parents’ needs; we also must specify that, according Alfred Adler, the feeling to be inferior is an experience that has its origins in infancy: the children feel inferior, because they are always surrounded by more powerful individuals (adults). The child then is very influenced by adults, and usually try to emulate them because he is motivated by the social environment that drives him to achieve some results [8]. How can we contextualize this situation today? The subjectivity affirmation, a last century conquest which appears to be historically consolidated, is perhaps not really guaranteed today as regards the possibilities of individual development. Today attitudes towards offspring appear to be diverse and complex. According to some authors, children today are often objects of emotional consumption [9, 10], because they can satisfy the parents needs (who can therefore set more often than in the past “value conditions” for the child acceptance: “you have to behave in this way to be loved”); as a matter of fact, it is not infrequent parents pour their unprocessed emotional needs both in the couple relationship and on the offspring, and they express also their existential problems in the relationship with their sons: when you feel you have not been able to give meaning to your life, then you try to reach one by dedicating yourself voraciously to your children [9, 10]. According to other authors, however, today children are also often valued as owner of rights and needs and as the family affectivity fulcrum [10]. We can ask ourselves if perhaps children today are often the protagonists of a family affectivity based not infrequently on emotional consumerism (and therefore, implicitly, on “value conditions”)? Consumer goods meet the desires, and even a child can satisfy many specific aspirations: he metaphorically opens the door to the “joys of parenting, “ which nothing else can provide, and many parents expect an emotional satisfaction that justifies this expensive investment [10, 11]. As a matter of fact, often parents have high expectations towards the children: the offspring is therefore invested with vital expectations for parents ‘self-esteem, and the child is therefore often aware of always being judged, and can internalize the continuous judgment his own [12]. Parents can manifest narcissistic needs towards children, and they can create the conditions for the institution of the children inability to distinguish between their real feelings and the efforts to please or d impress others. The ambiguous message of being appreciated, but only in the particular role that they play, can let the children believe that if their real feelings are discovered, they will be rejected and humiliated. Thus, the creation of the “false self” of which Winnicott wrote can therefore be stimulated [13]: only those aspects which are considered acceptable are shown to others, according to what has been learned in the primary infant experiences [14]. When the child experiences a “conditioned” positive consideration in the relationship with his parents, he will therefore tend to behave in a way that neglects his true nature, in order not to lose respect and love. When his experiences are in contrast with the “value conditions” set by the parents, the child will perceive a discrepancy between the real self and external the experience. He will then use his own defense mechanisms, but he will no longer feel really himself, he will find difficult to recognize himself, maybe he will experience a state of inauthenticity, and this leads to an alienation state [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 15].
The personality is a representations organization that that everyone own [13], and in this regard we can state there are various self form among which we can mention:
Real self: the one who reflects the individual true qualities, his aptitudes, inclinations and characteristics.
Ideal self: that is constituted by the characteristics to which the individual aspires. It is a guide of the self.
Imperative self: what the individual feels he must be [13, 16], it a guide of the self too.
Evaluate yourself means also to compare with your inner canons (also called the self guides), these comparisons can arouse negative or positive feelings about yourselves; it is also appropriate to specify that while most of the time our thoughts are turned outward, some events can create a state of intensified self-awareness, which confronts you with your inner canons (this may be the case of the comparison with with some social idols, like the perfect rich top model). Focusing the attention on the self makes also obvious discrepancies with respect to the self guides: this happens because the knowledge of the self includes beliefs about you, and also about the comparison with the royalties to which you try to conform to. Self-esteem is therefore influenced not only by what happens outside, but also by what happens “inside us”, that is the comparisons with the ideal self, which includes the traits that help to achieve some aspirations, and the imperative self which instead includes the traits that spur to fulfill one’s obligations. The self guide are useful for the auto-adjustment function: the discrepancy theory says that there is a the difference between the self guide and what people think to be, and this discrepancy can influence the individual emotional state and the well-being, it also influence our self-esteem. Focusing on these topics, we can assert that the ideal self represents the positive outcomes that people try to achieve, therefore their goals for advancement: discrepancies with respect to the ideal self can produce disappointment feelings, sadness and depression. On the contrary, when you actually achieve progress targets the emotion that derives is joy. The imperative self is focused on the negative outcomes that people try to avoid, that are the prevention goals. The deviations from the self imperative stimulate anxiety and restlessness feelings. Achieving the objectives of the imperative self produces instead relief and relaxation feelings [17]. Thinking about our inner canons can make us aware of our self discrepancies, activating an emotional response among those mentioned above, and one’s own canons can also focused by thinking to specific people who represent them, that is, who can embody idols (i.e. a perfect top model). The construction of ideal self and imperative self often refers to idols supported by the propagation dynamics of globalization both in the Western and Oriental Countries. The propagation of certain myths and idols can therefore constitute a real problem when the real self and the ideal and imperative self come into conflict: the person experiences incongruity: an unpleasant experience, which causes a sense of inadequacy, anxiety, malaise and maladjustment [16]. Incongruent experiences with respect to the self, on the other hand, are perceived as threatening and anxious, and often activate some defense mechanisms, such as the distortion of the meaning of the experience, i.e. the manipulation of the experience itself (because this dynamic can make it compatible with the self), or even denial of experience. On the contrary, a smaller the discrepancy between the real self and the ideal self and imperative self can create wellness: the subject is in harmony with himself. The so-called “white psychosis” can have a diffusion in these conditions of discrepancy. They are characterized by confusion, loss of the sense of reality, denial of reality itself, disorganization. These states are also called “private psychoses”, perhaps also to underline the dimension of individual closure that generates them, the inability to open up in a sane way to the world and to the other, maintaining their own authentic individual identity: they therefore reveal themselves conditions that prevent a process of healthy individualization [18]. A cause of psychological malaise can therefore also be living constantly trying to correspond to the environment expectations, precisely to fill the incongruity between the real self, the ideal self and imperative self. As a matter of fact, the self, in its formation and evolution follows the law of congruence: it constantly aims to seek coherence between its own self-perceptions and between these and external reality [16, 18, 19]: when the self is congruent with experience, the individual is fully functional and healthy. On the contrary, when the incongruity between the self and personal experience is so strong that it does not allow the successful application of the defense mechanisms, the person can develop a psychological state of disorganization, as anticipated.
As anticipated, in the independent cultures (Western, especially “Protestant” ones) the positive characteristics of the individual are the ones which are the most important for self-esteem, while for interdependent cultures (Oriental ones) is more considered the affiliation to others [2]. Beyond these differences, in all cultures self esteem performs the function to indicate how the person is behaving in life (in a right way or not). According to Alfred Adler, children and adults with a balanced and healthy personality, universally acquire confidence and self-esteem every time they are aware of being able to reach a goal: in synthesis, the sense of inferiority is resolved when a new challenge is overcome [19]. The self-esteem levels therefore play a crucial role in this process, precisely because they are signals how effectively the individual is acting. An accurate knowledge of own capabilities and preferences is also important because can guide a person through his existence, and d helps him to live in a manner more appropriate regarding his own needs and abilities. Self knowledge also represents as a reference for perceiving other people, and it influences what types of social aspects are more considered. It must also be noted that sometimes we act in such a way as to express our authentic self, other times, as anticipated, we can act because we want to shape others opinions about themselves, in order to gain power, influence or approval [2, 13]: in this consists the difference between self-expression and of self-presentation. When you dedicate yourself to self- expression, you try to convey the concept you have of yourself through your actions. The self-expression and communicates it to other people, and it that can even work as a powerful reaction strategy when we are under stress, and can also beneficially affect out auto-immune system [16]. The self-presentation is however only our attempt to create a good impression, to please other people and to obtain confirmations by others, to increase self-esteem and strengthen out ego. Well-being, on the other hand, goes in another direction. According to Fromm [1] the well-being is different to narcissism. Well-being means becoming what one is really, it means being fully open to joy and sadness. Wellness means being fully awake, it also means being creative and authentic, being able to express our real self [1].
The self-expression helps people to meet their real emotions and their real self: also simple forms of self-expression, for example, talking about feelings caused by threatening events, may help overcome some of the physical and emotional costs of those events [16]. Self-realization and self-expression are indeed among the highest needs on the scale of human needs, and certainly affect human health [20]. The need of self-expression, specifically, is the need to use our talents, abilities and potentials. Self-realization and self-expression can therefore be briefly defined as the courage to be yourself; in this regard according Kierkegaard we can achieve harmony and inner peace only through the courage to be ourselves, instead of trying to be like someone else (or want to please someone else); he was convinced that despair vanishes the moment we stop denying who we really are and try to accept and discover our real nature. According to this author, the opposite of despair consists in really wanting to be who one is [14]. Fromm believed in this regard that we can make life better, even if it is painful at times, by giving it meaning by seeking and developing an authentic self. He believes that man’s innate existential condition is a state of anxiety, which however can be overcome by finding one’s purpose in life: by struggling to become free and unique individuals. As we have seen, however, at the same time we always feel the need to be in relationship with others, and to confront ourselves with a social group; however, it is very important in parallel to discover one’s own independent self, one’s opinions and one’s values, rather than always adhering to pre-established norms, imposed by one’s neighbor, or by the reference culture; according to Fromm we become precisely alienated if we try to delegate to others the responsibility of our choices, we could add, if we modulate all our conduct on the basis of self-presentation and the others’ satisfaction. The purpose of life, according to this author, is to define ourselves, accepting our personal uniqueness, and discovering our abilities: it is very important to focus on what differentiates us from others. In this way it is possible to free oneself from alienation, confusion and loneliness; we must discover our individuality, understanding our true passions, inclinations and ideas, setting ourselves a creative purpose in life [1, 21]. However, there are several types of personality that can hamper personal and true self-realization, among these are: personality receptive orientation (ie those who live passively and accept the fate in a fatalistic way, those which behave as gregarious complacent); people which have an demanding orientation, that usually use other people like and object; the accumulators also show a pathological orientation: they are constantly looking for a social climb and consider the people they frequent as property. These kind of personalities are far from the development of an authentic self; finally there are those who have a mercantile orientation: those who are obsessed by their own narcissistic image and by their status (and this is the type that most represents modern society). A healthy personality type is the productive one: it is that who show flexibility, creativity, sociability, rationality and mental openness; this kind of people develop a high level of consciousness, willing to change their beliefs in the face of new evidence, and to evolve. Thus, the human health is conceived as a dynamic process of evolution, rather than as an end state, and certainly in this process are the fundamental expression of one’s self, a healthy self-esteem and personal development; the value that a person thinks he has, is therefore not only in the result of his individual actions, but in representations that are built over time and evolve in the life process. The Well-being human involves in fact the expression of a v auction range of potential: intellectual, social, emotional and physical one. In the field of scientific research, therefore, an attempt has been made to identify indices that can be measured in this regard; when examining the characteristics of the Welfare reported in these various theoretical formulations, it is noted that the various authors have spoken of similar features. A certain number of indicators of good psychic development were therefore obtained, subsequently putting them to the scrutiny of empirical experimentation. Thus, the following six dimensions were identified:
A true purpose and a sense of direction in life;
Personnel development;
Good relationships with others;
Persona control and effectiveness;
Self-acceptance, self-respect, self-esteem;
This is non-definitive list and will certainly be reviewed or expanded [17, 22, 23, 24], but in any case we can say that regardless of the reference culture there are some dimensions which focus on a healthy individualization: the overcoming of the limits of a selfish ego, the conquest of love, objectivity and humility and respect for life, until the end of life is there life itself and man becomes what he is in potential [25]. The malaise can instead be represented by the alienation from ourselves, a malaise creeps into the awareness that life slips from our hands like sand, that we will die without having lived. Today there is also a more and more frequent paradox: while narcissistic individualism as an unlimited self-affirmation increases on a world scale, the idea of a subject who feels he is part of a human and natural totality often disappears. As a matter of fact, being an individual often coincides with the claim of the right to the immediate and mandatory satisfaction of one’s desires, where the one who has more economic power, can impose himself on the weaker people. We must also consider in this regard, as Byung-chul Han reminds us, that we live in a society that is becoming increasingly narcissistic, and narcissism is definitely not a form of self-realization or self-love; following this narcissistic attitude today almost nothing has a long shelf life, and everything is disposable, also relationships, and this has harmful consequences [26, 27]. We can therefore ask: what can psychoanalysis can offer to those suffering from sickness of the century (ie. narcissism and alienation)? This is an aid that must be different from the only treatment aimed at the removal of symptom, which can preserve the normal performance of social functions. Because for those who are alienated (ie for those who are far from living fully their real self), the goal cannot be only in the absence of disease, but in the presence of wellness. A first definition of Wellbeing can therefore be the following: wellbeing is being in harmony with the nature of man. However, if we go beyond this formal statement, a question arises: what does it mean to be in harmony with the conditions of human existence? And what are these conditions? The human existence arises a problem. Man is thrown into this world not by his will and so he is torn from it. According to Fromm [1, 25], unlike the animal, man does not have an immediate innate mechanism in his instincts, which allows him to adapt immediately and completely to nature. The questions that life poses are many: how can we overcome the pain, slavery, shame caused by the experience of isolation? How we can find the harmony with ourselves, with our fellow humans, with nature? Man is required to give some answers; he even responds in case of madness, rejecting external reality and living completely enclosed in his selves, to overcome the fear of loneliness. Therefore, the solutions that can be worked out, in response to the existential questions, are basically reducible to two. One is to overcome isolation, to find unity through regression to the state of primordial harmony, existing before the awareness development (ie before birth). The other solution consists in being metaphorically completely born, in strengthening one’s awareness, one’s reason, one’s ability to love to the point of overcoming one’s self-centeredness and narcissism and thus reaching a new harmony, a new communion with the world. However, most proceed along the life pattern are far from wellness: attached to their family (in a symbiotic way), or attached to the state, the social rank, to idols, myths, and etc. To be able also to understand the individual patient, and d in general any individual, it is important therefore to understand what his response than human existence to these question, ie what is the object of all his passions and all his efforts. According to Fromm what are considered psychological problems are often consequences of this fundamental answer: it is very important to know the fundamental answer that the subject has given to the existence problem, in a certain sense his secret and private religion. As a matter of fact, man often tries to compensate for his depression with idolatry, with destructive tendencies, or with the fame desire and the desire for possession. And when any of these solution fails, his fragile sanity crumbles. The cure for potential madness therefore lies in the passage from alienation to the creative perception of the world and harmony with it: a man cannot be truly free if he is a slave to his passions. He can be free only if he has an ideal and a philosophical attitude which makes it possible for him to have a consistent activity in life [1, 25]. By ideal we obviously do not mean an idol. As Zoj a stated [28] modern culture is characterized by the conviction that in each of us there exists a personal psychological dimension, which everyone has the right to explore and to consider a source of knowledge, aiming to broaden it. However, it often happens that this disposition arouses a sense of solitude and incompleteness. The current situation of frequent alienation can therefore be considered as a symptom, not to be healed in order to return to a previous situation, considered healthy, but as a signal and message: the subject produces a symptom, as a sign of a discomfort that has now exploded, so that he himself can change the its situation. The first step, therefore, is to become aware of the current limit condition: the split between self-perception, emotion and thought, which has become the norm and narcissistic closure in one’s own needs. The further step is the acceptance of the limit of our human being not as a condemnation, but as a push to increase knowledge and creativity in the essential relationship with others with whom we are linked in a common destiny.
"Open access contributes to scientific excellence and integrity. It opens up research results to wider analysis. It allows research results to be reused for new discoveries. And it enables the multi-disciplinary research that is needed to solve global 21st century problems. Open access connects science with society. It allows the public to engage with research. To go behind the headlines. And look at the scientific evidence. And it enables policy makers to draw on innovative solutions to societal challenges".
\n\nCarlos Moedas, the European Commissioner for Research Science and Innovation at the STM Annual Frankfurt Conference, October 2016.
",metaTitle:"About Open Access",metaDescription:"Open access contributes to scientific excellence and integrity. It opens up research results to wider analysis. It allows research results to be reused for new discoveries. And it enables the multi-disciplinary research that is needed to solve global 21st century problems. Open access connects science with society. It allows the public to engage with research. To go behind the headlines. And look at the scientific evidence. And it enables policy makers to draw on innovative solutions to societal challenges.\n\nCarlos Moedas, the European Commissioner for Research Science and Innovation at the STM Annual Frankfurt Conference, October 2016.",metaKeywords:null,canonicalURL:"about-open-access",contentRaw:'[{"type":"htmlEditorComponent","content":"The Open Access publishing movement started in the early 2000s when academic leaders from around the world participated in the formation of the Budapest Initiative. They developed recommendations for an Open Access publishing process, “which has worked for the past decade to provide the public with unrestricted, free access to scholarly research—much of which is publicly funded. Making the research publicly available to everyone—free of charge and without most copyright and licensing restrictions—will accelerate scientific research efforts and allow authors to reach a larger number of readers” (reference: http://www.budapestopenaccessinitiative.org)
\\n\\nIntechOpen’s co-founders, both scientists themselves, created the company while undertaking research in robotics at Vienna University. Their goal was to spread research freely “for scientists, by scientists’ to the rest of the world via the Open Access publishing model. The company soon became a signatory of the Budapest Initiative, which currently has more than 1000 supporting organizations worldwide, ranging from universities to funders.
\\n\\nAt IntechOpen today, we are still as committed to working with organizations and people who care about scientific discovery, to putting the academic needs of the scientific community first, and to providing an Open Access environment where scientists can maximize their contribution to scientific advancement. By opening up access to the world’s scientific research articles and book chapters, we aim to facilitate greater opportunity for collaboration, scientific discovery and progress. We subscribe wholeheartedly to the Open Access definition:
\\n\\n“By “open access” to [peer-reviewed research literature], we mean its free availability on the public internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from gaining access to the internet itself. The only constraint on reproduction and distribution, and the only role for copyright in this domain, should be to give authors control over the integrity of their work and the right to be properly acknowledged and cited” (reference: http://www.budapestopenaccessinitiative.org)
\\n\\nOAI-PMH
\\n\\nAs a firm believer in the wider dissemination of knowledge, IntechOpen supports the Open Access Initiative Protocol for Metadata Harvesting (OAI-PMH Version 2.0). Read more
\\n\\nLicense
\\n\\nBook chapters published in edited volumes are distributed under the Creative Commons Attribution 3.0 Unported License (CC BY 3.0). IntechOpen upholds a very flexible Copyright Policy. There is no copyright transfer to the publisher and Authors retain exclusive copyright to their work. All Monographs/Compacts are distributed under the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). Read more
\\n\\nPeer Review Policies
\\n\\nAll scientific works are Peer Reviewed prior to publishing. Read more
\\n\\nOA Publishing Fees
\\n\\nThe Open Access publishing model employed by IntechOpen eliminates subscription charges and pay-per-view fees, enabling readers to access research at no cost. In order to sustain operations and keep our publications freely accessible we levy an Open Access Publishing Fee for manuscripts, which helps us cover the costs of editorial work and the production of books. Read more
\\n\\nDigital Archiving Policy
\\n\\nIntechOpen is committed to ensuring the long-term preservation and the availability of all scholarly research we publish. We employ a variety of means to enable us to deliver on our commitments to the scientific community. Apart from preservation by the Croatian National Library (for publications prior to April 18, 2018) and the British Library (for publications after April 18, 2018), our entire catalogue is preserved in the CLOCKSS archive.
\\n\\nOpen Science is transparent and accessible knowledge that is shared and developed through collaborative networks.
\\n\\nOpen Science is about increased rigour, accountability, and reproducibility for research. It is based on the principles of inclusion, fairness, equity, and sharing, and ultimately seeks to change the way research is done, who is involved and how it is valued. It aims to make research more open to participation, review/refutation, improvement and (re)use for the world to benefit.
\\n\\nOpen Science refers to doing traditional science with more transparency involved at various stages, for example by openly sharing code and data. It implies a growing set of practices - within different disciplines - aiming at:
\\n\\nWe aim at improving the quality and availability of scholarly communication by promoting and practicing:
\\n\\n\\n"}]'},components:[{type:"htmlEditorComponent",content:'
The Open Access publishing movement started in the early 2000s when academic leaders from around the world participated in the formation of the Budapest Initiative. They developed recommendations for an Open Access publishing process, “which has worked for the past decade to provide the public with unrestricted, free access to scholarly research—much of which is publicly funded. Making the research publicly available to everyone—free of charge and without most copyright and licensing restrictions—will accelerate scientific research efforts and allow authors to reach a larger number of readers” (reference: http://www.budapestopenaccessinitiative.org)
\n\nIntechOpen’s co-founders, both scientists themselves, created the company while undertaking research in robotics at Vienna University. Their goal was to spread research freely “for scientists, by scientists’ to the rest of the world via the Open Access publishing model. The company soon became a signatory of the Budapest Initiative, which currently has more than 1000 supporting organizations worldwide, ranging from universities to funders.
\n\nAt IntechOpen today, we are still as committed to working with organizations and people who care about scientific discovery, to putting the academic needs of the scientific community first, and to providing an Open Access environment where scientists can maximize their contribution to scientific advancement. By opening up access to the world’s scientific research articles and book chapters, we aim to facilitate greater opportunity for collaboration, scientific discovery and progress. We subscribe wholeheartedly to the Open Access definition:
\n\n“By “open access” to [peer-reviewed research literature], we mean its free availability on the public internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from gaining access to the internet itself. The only constraint on reproduction and distribution, and the only role for copyright in this domain, should be to give authors control over the integrity of their work and the right to be properly acknowledged and cited” (reference: http://www.budapestopenaccessinitiative.org)
\n\nOAI-PMH
\n\nAs a firm believer in the wider dissemination of knowledge, IntechOpen supports the Open Access Initiative Protocol for Metadata Harvesting (OAI-PMH Version 2.0). Read more
\n\nLicense
\n\nBook chapters published in edited volumes are distributed under the Creative Commons Attribution 3.0 Unported License (CC BY 3.0). IntechOpen upholds a very flexible Copyright Policy. There is no copyright transfer to the publisher and Authors retain exclusive copyright to their work. All Monographs/Compacts are distributed under the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). Read more
\n\nPeer Review Policies
\n\nAll scientific works are Peer Reviewed prior to publishing. Read more
\n\nOA Publishing Fees
\n\nThe Open Access publishing model employed by IntechOpen eliminates subscription charges and pay-per-view fees, enabling readers to access research at no cost. In order to sustain operations and keep our publications freely accessible we levy an Open Access Publishing Fee for manuscripts, which helps us cover the costs of editorial work and the production of books. Read more
\n\nDigital Archiving Policy
\n\nIntechOpen is committed to ensuring the long-term preservation and the availability of all scholarly research we publish. We employ a variety of means to enable us to deliver on our commitments to the scientific community. Apart from preservation by the Croatian National Library (for publications prior to April 18, 2018) and the British Library (for publications after April 18, 2018), our entire catalogue is preserved in the CLOCKSS archive.
\n\nOpen Science is transparent and accessible knowledge that is shared and developed through collaborative networks.
\n\nOpen Science is about increased rigour, accountability, and reproducibility for research. It is based on the principles of inclusion, fairness, equity, and sharing, and ultimately seeks to change the way research is done, who is involved and how it is valued. It aims to make research more open to participation, review/refutation, improvement and (re)use for the world to benefit.
\n\nOpen Science refers to doing traditional science with more transparency involved at various stages, for example by openly sharing code and data. It implies a growing set of practices - within different disciplines - aiming at:
\n\nWe aim at improving the quality and availability of scholarly communication by promoting and practicing:
\n\n\n'}]},successStories:{items:[]},authorsAndEditors:{filterParams:{},profiles:[{id:"396",title:"Dr.",name:"Vedran",middleName:null,surname:"Kordic",slug:"vedran-kordic",fullName:"Vedran Kordic",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/396/images/7281_n.png",biography:"After obtaining his Master's degree in Mechanical Engineering he continued his education at the Vienna University of Technology where he obtained his PhD degree in 2004. He worked as a researcher at the Automation and Control Institute, Faculty of Electrical Engineering, Vienna University of Technology until 2008. His studies in robotics lead him not only to a PhD degree but also inspired him to co-found and build the International Journal of Advanced Robotic Systems - world's first Open Access journal in the field of robotics.",institutionString:null,institution:{name:"TU Wien",country:{name:"Austria"}}},{id:"441",title:"Ph.D.",name:"Jaekyu",middleName:null,surname:"Park",slug:"jaekyu-park",fullName:"Jaekyu Park",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/441/images/1881_n.jpg",biography:null,institutionString:null,institution:{name:"LG Corporation (South Korea)",country:{name:"Korea, South"}}},{id:"465",title:"Dr",name:"Christian",middleName:null,surname:"Martens",slug:"christian-martens",fullName:"Christian Martens",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"479",title:"Dr.",name:"Valentina",middleName:null,surname:"Colla",slug:"valentina-colla",fullName:"Valentina Colla",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/479/images/358_n.jpg",biography:null,institutionString:null,institution:{name:"Sant'Anna School of Advanced Studies",country:{name:"Italy"}}},{id:"494",title:"PhD",name:"Loris",middleName:null,surname:"Nanni",slug:"loris-nanni",fullName:"Loris Nanni",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/494/images/system/494.jpg",biography:"Loris Nanni received his Master Degree cum laude on June-2002 from the University of Bologna, and the April 26th 2006 he received his Ph.D. in Computer Engineering at DEIS, University of Bologna. On September, 29th 2006 he has won a post PhD fellowship from the university of Bologna (from October 2006 to October 2008), at the competitive examination he was ranked first in the industrial engineering area. He extensively served as referee for several international journals. He is author/coauthor of more than 100 research papers. He has been involved in some projects supported by MURST and European Community. His research interests include pattern recognition, bioinformatics, and biometric systems (fingerprint classification and recognition, signature verification, face recognition).",institutionString:null,institution:null},{id:"496",title:"Dr.",name:"Carlos",middleName:null,surname:"Leon",slug:"carlos-leon",fullName:"Carlos Leon",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Seville",country:{name:"Spain"}}},{id:"512",title:"Dr.",name:"Dayang",middleName:null,surname:"Jawawi",slug:"dayang-jawawi",fullName:"Dayang Jawawi",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Technology Malaysia",country:{name:"Malaysia"}}},{id:"528",title:"Dr.",name:"Kresimir",middleName:null,surname:"Delac",slug:"kresimir-delac",fullName:"Kresimir Delac",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/528/images/system/528.jpg",biography:"K. Delac received his B.Sc.E.E. degree in 2003 and is currentlypursuing a Ph.D. degree at the University of Zagreb, Faculty of Electrical Engineering andComputing. His current research interests are digital image analysis, pattern recognition andbiometrics.",institutionString:null,institution:{name:"University of Zagreb",country:{name:"Croatia"}}},{id:"557",title:"Dr.",name:"Andon",middleName:"Venelinov",surname:"Topalov",slug:"andon-topalov",fullName:"Andon Topalov",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/557/images/1927_n.jpg",biography:"Dr. Andon V. Topalov received the MSc degree in Control Engineering from the Faculty of Information Systems, Technologies, and Automation at Moscow State University of Civil Engineering (MGGU) in 1979. He then received his PhD degree in Control Engineering from the Department of Automation and Remote Control at Moscow State Mining University (MGSU), Moscow, in 1984. From 1985 to 1986, he was a Research Fellow in the Research Institute for Electronic Equipment, ZZU AD, Plovdiv, Bulgaria. In 1986, he joined the Department of Control Systems, Technical University of Sofia at the Plovdiv campus, where he is presently a Full Professor. He has held long-term visiting Professor/Scholar positions at various institutions in South Korea, Turkey, Mexico, Greece, Belgium, UK, and Germany. And he has coauthored one book and authored or coauthored more than 80 research papers in conference proceedings and journals. His current research interests are in the fields of intelligent control and robotics.",institutionString:null,institution:{name:"Technical University of Sofia",country:{name:"Bulgaria"}}},{id:"585",title:"Prof.",name:"Munir",middleName:null,surname:"Merdan",slug:"munir-merdan",fullName:"Munir Merdan",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/585/images/system/585.jpg",biography:"Munir Merdan received the M.Sc. degree in mechanical engineering from the Technical University of Sarajevo, Bosnia and Herzegovina, in 2001, and the Ph.D. degree in electrical engineering from the Vienna University of Technology, Vienna, Austria, in 2009.Since 2005, he has been at the Automation and Control Institute, Vienna University of Technology, where he is currently a Senior Researcher. His research interests include the application of agent technology for achieving agile control in the manufacturing environment.",institutionString:null,institution:null},{id:"605",title:"Prof",name:"Dil",middleName:null,surname:"Hussain",slug:"dil-hussain",fullName:"Dil Hussain",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/605/images/system/605.jpg",biography:"Dr. Dil Muhammad Akbar Hussain is a professor of Electronics Engineering & Computer Science at the Department of Energy Technology, Aalborg University Denmark. Professor Akbar has a Master degree in Digital Electronics from Govt. College University, Lahore Pakistan and a P-hD degree in Control Engineering from the School of Engineering and Applied Sciences, University of Sussex United Kingdom. Aalborg University has Two Satellite Campuses, one in Copenhagen (Aalborg University Copenhagen) and the other in Esbjerg (Aalborg University Esbjerg).\n· He is a member of prestigious IEEE (Institute of Electrical and Electronics Engineers), and IAENG (International Association of Engineers) organizations. \n· He is the chief Editor of the Journal of Software Engineering.\n· He is the member of the Editorial Board of International Journal of Computer Science and Software Technology (IJCSST) and International Journal of Computer Engineering and Information Technology. \n· He is also the Editor of Communication in Computer and Information Science CCIS-20 by Springer.\n· Reviewer For Many Conferences\nHe is the lead person in making collaboration agreements between Aalborg University and many universities of Pakistan, for which the MOU’s (Memorandum of Understanding) have been signed.\nProfessor Akbar is working in Academia since 1990, he started his career as a Lab demonstrator/TA at the University of Sussex. After finishing his P. hD degree in 1992, he served in the Industry as a Scientific Officer and continued his academic career as a visiting scholar for a number of educational institutions. In 1996 he joined National University of Science & Technology Pakistan (NUST) as an Associate Professor; NUST is one of the top few universities in Pakistan. In 1999 he joined an International Company Lineo Inc, Canada as Manager Compiler Group, where he headed the group for developing Compiler Tool Chain and Porting of Operating Systems for the BLACKfin processor. The processor development was a joint venture by Intel and Analog Devices. In 2002 Lineo Inc., was taken over by another company, so he joined Aalborg University Denmark as an Assistant Professor.\nProfessor Akbar has truly a multi-disciplined career and he continued his legacy and making progress in many areas of his interests both in teaching and research. He has contributed in stochastic estimation of control area especially, in the Multiple Target Tracking and Interactive Multiple Model (IMM) research, Ball & Beam Control Problem, Robotics, Levitation Control. He has contributed in developing Algorithms for Fingerprint Matching, Computer Vision and Face Recognition. He has been supervising Pattern Recognition, Formal Languages and Distributed Processing projects for several years. He has reviewed many books on Management, Computer Science. Currently, he is an active and permanent reviewer for many international conferences and symposia and the program committee member for many international conferences.\nIn teaching he has taught the core computer science subjects like, Digital Design, Real Time Embedded System Programming, Operating Systems, Software Engineering, Data Structures, Databases, Compiler Construction. In the Engineering side, Digital Signal Processing, Computer Architecture, Electronics Devices, Digital Filtering and Engineering Management.\nApart from his Academic Interest and activities he loves sport especially, Cricket, Football, Snooker and Squash. He plays cricket for Esbjerg city in the second division team as an opener wicket keeper batsman. He is a very good player of squash but has not played squash since his arrival in Denmark.",institutionString:null,institution:null},{id:"611",title:"Prof.",name:"T",middleName:null,surname:"Nagarajan",slug:"t-nagarajan",fullName:"T Nagarajan",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universiti Teknologi Petronas",country:{name:"Malaysia"}}}],filtersByRegion:[{group:"region",caption:"North America",value:1,count:6675},{group:"region",caption:"Middle and South America",value:2,count:5955},{group:"region",caption:"Africa",value:3,count:2459},{group:"region",caption:"Asia",value:4,count:12718},{group:"region",caption:"Australia and Oceania",value:5,count:1017},{group:"region",caption:"Europe",value:6,count:17720}],offset:12,limit:12,total:134177},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{topicId:"12"},books:[{type:"book",id:"10845",title:"Marine Ecosystems - Biodiversity, Ecosystem Services and Human Impacts",subtitle:null,isOpenForSubmission:!0,hash:"727e7eb3d4ba529ec5eb4f150e078523",slug:null,bookSignature:"Dr. Ana M.M. Marta Gonçalves",coverURL:"https://cdn.intechopen.com/books/images_new/10845.jpg",editedByType:null,editors:[{id:"320124",title:"Dr.",name:"Ana M.M.",surname:"Gonçalves",slug:"ana-m.m.-goncalves",fullName:"Ana M.M. Gonçalves"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11450",title:"Environmental Impacts of COVID-19 Pandemic on the World",subtitle:null,isOpenForSubmission:!0,hash:"a58c7b02d07903004be70f744f2e1835",slug:null,bookSignature:"Prof. Mohamed Nageeb Rashed and Prof. Wafaa M. Abd El-Rahim",coverURL:"https://cdn.intechopen.com/books/images_new/11450.jpg",editedByType:null,editors:[{id:"63465",title:"Prof.",name:"Mohamed Nageeb",surname:"Rashed",slug:"mohamed-nageeb-rashed",fullName:"Mohamed Nageeb Rashed"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11457",title:"Forest Degradation Under Global Change",subtitle:null,isOpenForSubmission:!0,hash:"8df7150b01ae754024c65d1a62f190d9",slug:null,bookSignature:"Dr. Pavel Samec",coverURL:"https://cdn.intechopen.com/books/images_new/11457.jpg",editedByType:null,editors:[{id:"317087",title:"Dr.",name:"Pavel",surname:"Samec",slug:"pavel-samec",fullName:"Pavel Samec"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11650",title:"Aquifers - New Insights",subtitle:null,isOpenForSubmission:!0,hash:"27c1a2a053cb1d83de903c5b969bc3a2",slug:null,bookSignature:"Dr. Abhay Soni and Dr. Prabhat Jain",coverURL:"https://cdn.intechopen.com/books/images_new/11650.jpg",editedByType:null,editors:[{id:"271093",title:"Dr.",name:"Abhay",surname:"Soni",slug:"abhay-soni",fullName:"Abhay Soni"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11664",title:"Recent Advances in Sensing Technologies for Environmental Control and Monitoring",subtitle:null,isOpenForSubmission:!0,hash:"cf1ee76443e393bc7597723c3ee3e26f",slug:null,bookSignature:"Dr. Toonika Rinken and Dr. Kairi Kivirand",coverURL:"https://cdn.intechopen.com/books/images_new/11664.jpg",editedByType:null,editors:[{id:"24687",title:"Dr.",name:"Toonika",surname:"Rinken",slug:"toonika-rinken",fullName:"Toonika Rinken"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11665",title:"Recent Advances in Wildlife Management",subtitle:null,isOpenForSubmission:!0,hash:"73da0df494a1a56ab9c4faf2ee811899",slug:null,bookSignature:"Dr. Farzana Khan Perveen",coverURL:"https://cdn.intechopen.com/books/images_new/11665.jpg",editedByType:null,editors:[{id:"75563",title:"Dr.",name:"Farzana Khan",surname:"Perveen",slug:"farzana-khan-perveen",fullName:"Farzana Khan Perveen"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11666",title:"Soil Contamination - Recent Advances and Future Perspectives",subtitle:null,isOpenForSubmission:!0,hash:"c8890038b86fb6e5af16ea3c22669ae9",slug:null,bookSignature:"Dr. Adnan Mustafa and Dr. Muhammad Naveed",coverURL:"https://cdn.intechopen.com/books/images_new/11666.jpg",editedByType:null,editors:[{id:"299110",title:"Dr.",name:"Adnan",surname:"Mustafa",slug:"adnan-mustafa",fullName:"Adnan Mustafa"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11668",title:"Mercury Pollution",subtitle:null,isOpenForSubmission:!0,hash:"0bd111f57835089cad4a9741326dbab7",slug:null,bookSignature:"Dr. Ahmed Abdelhafez and Dr. Mohamed Abbas",coverURL:"https://cdn.intechopen.com/books/images_new/11668.jpg",editedByType:null,editors:[{id:"196849",title:"Dr.",name:"Ahmed",surname:"Abdelhafez",slug:"ahmed-abdelhafez",fullName:"Ahmed Abdelhafez"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12130",title:"Sustainable Built Environment",subtitle:null,isOpenForSubmission:!0,hash:"ed1dbae71b967e06efb049208f0c1068",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/12130.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12131",title:"Climate Change and Fires",subtitle:null,isOpenForSubmission:!0,hash:"ea0858f07a3e87aaf9e5eaa75b4b44bd",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/12131.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12180",title:"Wetlands",subtitle:null,isOpenForSubmission:!0,hash:"8957c5c2baaed32223f911a6d4aa5a03",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/12180.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12221",title:"Air Pollution",subtitle:null,isOpenForSubmission:!0,hash:"439a018ee0c4960560cb798601f2a372",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/12221.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:38},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:12},{group:"topic",caption:"Business, Management and Economics",value:7,count:7},{group:"topic",caption:"Chemistry",value:8,count:22},{group:"topic",caption:"Computer and Information Science",value:9,count:23},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:15},{group:"topic",caption:"Engineering",value:11,count:65},{group:"topic",caption:"Environmental Sciences",value:12,count:10},{group:"topic",caption:"Immunology and Microbiology",value:13,count:15},{group:"topic",caption:"Materials Science",value:14,count:24},{group:"topic",caption:"Mathematics",value:15,count:11},{group:"topic",caption:"Medicine",value:16,count:114},{group:"topic",caption:"Nanotechnology and Nanomaterials",value:17,count:6},{group:"topic",caption:"Neuroscience",value:18,count:4},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:9},{group:"topic",caption:"Physics",value:20,count:9},{group:"topic",caption:"Psychology",value:21,count:10},{group:"topic",caption:"Robotics",value:22,count:2},{group:"topic",caption:"Social Sciences",value:23,count:9},{group:"topic",caption:"Veterinary Medicine and Science",value:25,count:4}],offset:12,limit:12,total:15},popularBooks:{featuredBooks:[{type:"book",id:"10858",title:"MOOC (Massive Open Online Courses)",subtitle:null,isOpenForSubmission:!1,hash:"d32f86793bc72dde32532f509b1ec5b0",slug:"mooc-massive-open-online-courses-",bookSignature:"Dragan Cvetković",coverURL:"https://cdn.intechopen.com/books/images_new/10858.jpg",editors:[{id:"101330",title:"Dr.",name:"Dragan",middleName:"Mladen",surname:"Cvetković",slug:"dragan-cvetkovic",fullName:"Dragan Cvetković"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10195",title:"Serotonin and the CNS",subtitle:"New Developments in Pharmacology and Therapeutics",isOpenForSubmission:!1,hash:"7ed9d96da98233a885bd2869a8056c36",slug:"serotonin-and-the-cns-new-developments-in-pharmacology-and-therapeutics",bookSignature:"Berend Olivier",coverURL:"https://cdn.intechopen.com/books/images_new/10195.jpg",editors:[{id:"71579",title:"Prof.",name:"Berend",middleName:null,surname:"Olivier",slug:"berend-olivier",fullName:"Berend Olivier"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10755",title:"Corporate Governance",subtitle:"Recent Advances and Perspectives",isOpenForSubmission:!1,hash:"ffe06d1d5c4bf0fc2e63511825fe1257",slug:"corporate-governance-recent-advances-and-perspectives",bookSignature:"Okechukwu Lawrence Emeagwali and Feyza Bhatti",coverURL:"https://cdn.intechopen.com/books/images_new/10755.jpg",editors:[{id:"196317",title:"Associate Prof.",name:"Okechukwu Lawrence",middleName:null,surname:"Emeagwali",slug:"okechukwu-lawrence-emeagwali",fullName:"Okechukwu Lawrence Emeagwali"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11120",title:"Environmental Impact and Remediation of Heavy Metals",subtitle:null,isOpenForSubmission:!1,hash:"9e77514288e7394f1e6cd13481af3509",slug:"environmental-impact-and-remediation-of-heavy-metals",bookSignature:"Hosam M. Saleh and Amal I. Hassan",coverURL:"https://cdn.intechopen.com/books/images_new/11120.jpg",editors:[{id:"144691",title:"Prof.",name:"Hosam M.",middleName:null,surname:"Saleh",slug:"hosam-m.-saleh",fullName:"Hosam M. Saleh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10901",title:"Grapes and Wine",subtitle:null,isOpenForSubmission:!1,hash:"5d7f2aa74874444bc6986e613ccebd7c",slug:"grapes-and-wine",bookSignature:"Antonio Morata, Iris Loira and Carmen González",coverURL:"https://cdn.intechopen.com/books/images_new/10901.jpg",editors:[{id:"180952",title:"Prof.",name:"Antonio",middleName:null,surname:"Morata",slug:"antonio-morata",fullName:"Antonio Morata"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11080",title:"Engineering Principles",subtitle:"Welding and Residual Stresses",isOpenForSubmission:!1,hash:"6c07a13a113bce94174b40096f30fb5e",slug:"engineering-principles-welding-and-residual-stresses",bookSignature:"Kavian Omar Cooke and Ronaldo Câmara Cozza",coverURL:"https://cdn.intechopen.com/books/images_new/11080.jpg",editors:[{id:"138778",title:"Dr.",name:"Kavian",middleName:"Omar",surname:"Cooke",slug:"kavian-cooke",fullName:"Kavian Cooke"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11332",title:"Essential Oils",subtitle:"Advances in Extractions and Biological Applications",isOpenForSubmission:!1,hash:"742e6cae3a35686f975edc8d7f9afa94",slug:"essential-oils-advances-in-extractions-and-biological-applications",bookSignature:"Mozaniel Santana de Oliveira and Eloisa Helena de Aguiar Andrade",coverURL:"https://cdn.intechopen.com/books/images_new/11332.jpg",editors:[{id:"195290",title:"Ph.D.",name:"Mozaniel",middleName:null,surname:"Santana De Oliveira",slug:"mozaniel-santana-de-oliveira",fullName:"Mozaniel Santana De Oliveira"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11029",title:"Hepatitis B",subtitle:null,isOpenForSubmission:!1,hash:"609701f502efc3538c112ff47a2c2119",slug:"hepatitis-b",bookSignature:"Luis Rodrigo",coverURL:"https://cdn.intechopen.com/books/images_new/11029.jpg",editors:[{id:"73208",title:"Prof.",name:"Luis",middleName:null,surname:"Rodrigo",slug:"luis-rodrigo",fullName:"Luis Rodrigo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9537",title:"Human Rights in the Contemporary World",subtitle:null,isOpenForSubmission:!1,hash:"54f05b93812fd434f3962956d6413a6b",slug:"human-rights-in-the-contemporary-world",bookSignature:"Trudy Corrigan",coverURL:"https://cdn.intechopen.com/books/images_new/9537.jpg",editors:[{id:"197557",title:"Dr.",name:"Trudy",middleName:null,surname:"Corrigan",slug:"trudy-corrigan",fullName:"Trudy Corrigan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11371",title:"Cerebral Circulation",subtitle:"Updates on Models, Diagnostics and Treatments of Related Diseases",isOpenForSubmission:!1,hash:"e2d3335445d2852d0b906bb9750e939f",slug:"cerebral-circulation-updates-on-models-diagnostics-and-treatments-of-related-diseases",bookSignature:"Alba Scerrati, Luca Ricciardi and Flavia Dones",coverURL:"https://cdn.intechopen.com/books/images_new/11371.jpg",editors:[{id:"182614",title:"Dr.",name:"Alba",middleName:null,surname:"Scerrati",slug:"alba-scerrati",fullName:"Alba Scerrati"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11012",title:"Radiopharmaceuticals",subtitle:"Current Research for Better Diagnosis and Therapy",isOpenForSubmission:!1,hash:"f9046d6f96148b285e776f384991120d",slug:"radiopharmaceuticals-current-research-for-better-diagnosis-and-therapy",bookSignature:"Farid A. Badria",coverURL:"https://cdn.intechopen.com/books/images_new/11012.jpg",editors:[{id:"41865",title:"Prof.",name:"Farid A.",middleName:null,surname:"Badria",slug:"farid-a.-badria",fullName:"Farid A. Badria"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9974",title:"E-Learning and Digital Education in the Twenty-First Century",subtitle:null,isOpenForSubmission:!1,hash:"88b58d66e975df20425fc1dfd22d53aa",slug:"e-learning-and-digital-education-in-the-twenty-first-century",bookSignature:"M. Mahruf C. Shohel",coverURL:"https://cdn.intechopen.com/books/images_new/9974.jpg",editors:[{id:"94099",title:"Dr.",name:"M. Mahruf C.",middleName:null,surname:"Shohel",slug:"m.-mahruf-c.-shohel",fullName:"M. Mahruf C. Shohel"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:12,limit:12,total:4431},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[{type:"book",id:"10858",title:"MOOC (Massive Open Online Courses)",subtitle:null,isOpenForSubmission:!1,hash:"d32f86793bc72dde32532f509b1ec5b0",slug:"mooc-massive-open-online-courses-",bookSignature:"Dragan Cvetković",coverURL:"https://cdn.intechopen.com/books/images_new/10858.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:1677,editors:[{id:"101330",title:"Dr.",name:"Dragan",middleName:"Mladen",surname:"Cvetković",slug:"dragan-cvetkovic",fullName:"Dragan Cvetković"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10195",title:"Serotonin and the CNS",subtitle:"New Developments in Pharmacology and Therapeutics",isOpenForSubmission:!1,hash:"7ed9d96da98233a885bd2869a8056c36",slug:"serotonin-and-the-cns-new-developments-in-pharmacology-and-therapeutics",bookSignature:"Berend Olivier",coverURL:"https://cdn.intechopen.com/books/images_new/10195.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:1337,editors:[{id:"71579",title:"Prof.",name:"Berend",middleName:null,surname:"Olivier",slug:"berend-olivier",fullName:"Berend Olivier"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10755",title:"Corporate Governance",subtitle:"Recent Advances and Perspectives",isOpenForSubmission:!1,hash:"ffe06d1d5c4bf0fc2e63511825fe1257",slug:"corporate-governance-recent-advances-and-perspectives",bookSignature:"Okechukwu Lawrence Emeagwali and Feyza Bhatti",coverURL:"https://cdn.intechopen.com/books/images_new/10755.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:1309,editors:[{id:"196317",title:"Associate Prof.",name:"Okechukwu Lawrence",middleName:null,surname:"Emeagwali",slug:"okechukwu-lawrence-emeagwali",fullName:"Okechukwu Lawrence Emeagwali"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11120",title:"Environmental Impact and Remediation of Heavy Metals",subtitle:null,isOpenForSubmission:!1,hash:"9e77514288e7394f1e6cd13481af3509",slug:"environmental-impact-and-remediation-of-heavy-metals",bookSignature:"Hosam M. Saleh and Amal I. Hassan",coverURL:"https://cdn.intechopen.com/books/images_new/11120.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:847,editors:[{id:"144691",title:"Prof.",name:"Hosam M.",middleName:null,surname:"Saleh",slug:"hosam-m.-saleh",fullName:"Hosam M. Saleh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10901",title:"Grapes and Wine",subtitle:null,isOpenForSubmission:!1,hash:"5d7f2aa74874444bc6986e613ccebd7c",slug:"grapes-and-wine",bookSignature:"Antonio Morata, Iris Loira and Carmen González",coverURL:"https://cdn.intechopen.com/books/images_new/10901.jpg",publishedDate:"June 15th 2022",numberOfDownloads:2273,editors:[{id:"180952",title:"Prof.",name:"Antonio",middleName:null,surname:"Morata",slug:"antonio-morata",fullName:"Antonio Morata"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11080",title:"Engineering Principles",subtitle:"Welding and Residual Stresses",isOpenForSubmission:!1,hash:"6c07a13a113bce94174b40096f30fb5e",slug:"engineering-principles-welding-and-residual-stresses",bookSignature:"Kavian Omar Cooke and Ronaldo Câmara Cozza",coverURL:"https://cdn.intechopen.com/books/images_new/11080.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:591,editors:[{id:"138778",title:"Dr.",name:"Kavian",middleName:"Omar",surname:"Cooke",slug:"kavian-cooke",fullName:"Kavian Cooke"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11332",title:"Essential Oils",subtitle:"Advances in Extractions and Biological Applications",isOpenForSubmission:!1,hash:"742e6cae3a35686f975edc8d7f9afa94",slug:"essential-oils-advances-in-extractions-and-biological-applications",bookSignature:"Mozaniel Santana de Oliveira and Eloisa Helena de Aguiar Andrade",coverURL:"https://cdn.intechopen.com/books/images_new/11332.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:515,editors:[{id:"195290",title:"Ph.D.",name:"Mozaniel",middleName:null,surname:"Santana De Oliveira",slug:"mozaniel-santana-de-oliveira",fullName:"Mozaniel Santana De Oliveira"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11029",title:"Hepatitis B",subtitle:null,isOpenForSubmission:!1,hash:"609701f502efc3538c112ff47a2c2119",slug:"hepatitis-b",bookSignature:"Luis Rodrigo",coverURL:"https://cdn.intechopen.com/books/images_new/11029.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:413,editors:[{id:"73208",title:"Prof.",name:"Luis",middleName:null,surname:"Rodrigo",slug:"luis-rodrigo",fullName:"Luis Rodrigo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9537",title:"Human Rights in the Contemporary World",subtitle:null,isOpenForSubmission:!1,hash:"54f05b93812fd434f3962956d6413a6b",slug:"human-rights-in-the-contemporary-world",bookSignature:"Trudy Corrigan",coverURL:"https://cdn.intechopen.com/books/images_new/9537.jpg",publishedDate:"June 8th 2022",numberOfDownloads:2194,editors:[{id:"197557",title:"Dr.",name:"Trudy",middleName:null,surname:"Corrigan",slug:"trudy-corrigan",fullName:"Trudy Corrigan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11371",title:"Cerebral Circulation",subtitle:"Updates on Models, Diagnostics and Treatments of Related Diseases",isOpenForSubmission:!1,hash:"e2d3335445d2852d0b906bb9750e939f",slug:"cerebral-circulation-updates-on-models-diagnostics-and-treatments-of-related-diseases",bookSignature:"Alba Scerrati, Luca Ricciardi and Flavia Dones",coverURL:"https://cdn.intechopen.com/books/images_new/11371.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:341,editors:[{id:"182614",title:"Dr.",name:"Alba",middleName:null,surname:"Scerrati",slug:"alba-scerrati",fullName:"Alba Scerrati"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],latestBooks:[{type:"book",id:"11043",title:"Endometriosis",subtitle:"Recent Advances, New Perspectives and Treatments",isOpenForSubmission:!1,hash:"7baf1c70b11d41400bb9302ae9411ca4",slug:"endometriosis-recent-advances-new-perspectives-and-treatments",bookSignature:"Giovana Ap. Gonçalves",coverURL:"https://cdn.intechopen.com/books/images_new/11043.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"185930",title:"Associate Prof.",name:"Giovana",middleName:null,surname:"Gonçalves",slug:"giovana-goncalves",fullName:"Giovana Gonçalves"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10536",title:"Campylobacter",subtitle:null,isOpenForSubmission:!1,hash:"c4b132b741dd0a2ed539b824ab63965f",slug:"campylobacter",bookSignature:"Guillermo Tellez-Isaias and Saeed El-Ashram",coverURL:"https://cdn.intechopen.com/books/images_new/10536.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"73465",title:"Dr.",name:"Guillermo",middleName:null,surname:"Téllez",slug:"guillermo-tellez",fullName:"Guillermo Téllez"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10798",title:"Starch",subtitle:"Evolution and Recent Advances",isOpenForSubmission:!1,hash:"f197f6062c1574a9a90e50a369271bcf",slug:"starch-evolution-and-recent-advances",bookSignature:"Martins Ochubiojo Emeje",coverURL:"https://cdn.intechopen.com/books/images_new/10798.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"94311",title:"Prof.",name:"Martins",middleName:"Ochubiojo",surname:"Ochubiojo Emeje",slug:"martins-ochubiojo-emeje",fullName:"Martins Ochubiojo Emeje"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11083",title:"Hazardous Waste Management",subtitle:null,isOpenForSubmission:!1,hash:"d553bd4f6f1c4b115ca69bd19faac7dc",slug:"hazardous-waste-management",bookSignature:"Rajesh Banu Jeyakumar, Kavitha Sankarapandian and Yukesh Kannah Ravi",coverURL:"https://cdn.intechopen.com/books/images_new/11083.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"218539",title:"Dr.",name:"Rajesh Banu",middleName:null,surname:"Jeyakumar",slug:"rajesh-banu-jeyakumar",fullName:"Rajesh Banu Jeyakumar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10848",title:"Tribology of Machine Elements",subtitle:"Fundamentals and Applications",isOpenForSubmission:!1,hash:"3c4ca4c4692ca8d4fa749b4ae81ec1fa",slug:"tribology-of-machine-elements-fundamentals-and-applications",bookSignature:"Giuseppe Pintaude, Tiago Cousseau and Anna Rudawska",coverURL:"https://cdn.intechopen.com/books/images_new/10848.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"18347",title:"Prof.",name:"Giuseppe",middleName:null,surname:"Pintaude",slug:"giuseppe-pintaude",fullName:"Giuseppe Pintaude"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10856",title:"Crude Oil",subtitle:"New Technologies and Recent Approaches",isOpenForSubmission:!1,hash:"8d0a7ca35b3de95b295dc4eab39a087e",slug:"crude-oil-new-technologies-and-recent-approaches",bookSignature:"Manar Elsayed Abdel-Raouf and Mohamed Hasan El-Keshawy",coverURL:"https://cdn.intechopen.com/books/images_new/10856.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"102626",title:"Prof.",name:"Manar",middleName:null,surname:"Elsayed Abdel-Raouf",slug:"manar-elsayed-abdel-raouf",fullName:"Manar Elsayed Abdel-Raouf"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9625",title:"Spinocerebellar Ataxia",subtitle:"Concepts, Particularities and Generalities",isOpenForSubmission:!1,hash:"365a7025fd46eb45de2549bdd9d50b98",slug:"spinocerebellar-ataxia-concepts-particularities-and-generalities",bookSignature:"Patricia Bozzetto Ambrosi",coverURL:"https://cdn.intechopen.com/books/images_new/9625.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"221787",title:"Dr.",name:"Patricia",middleName:null,surname:"Bozzetto Ambrosi",slug:"patricia-bozzetto-ambrosi",fullName:"Patricia Bozzetto Ambrosi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10905",title:"Plant Defense Mechanisms",subtitle:null,isOpenForSubmission:!1,hash:"84ad5b27dde5f01dc76087d0fd6fa834",slug:"plant-defense-mechanisms",bookSignature:"Josphert Ngui Kimatu",coverURL:"https://cdn.intechopen.com/books/images_new/10905.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"224171",title:"Prof.",name:"Josphert N.",middleName:null,surname:"Kimatu",slug:"josphert-n.-kimatu",fullName:"Josphert N. Kimatu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10686",title:"Natural Gas",subtitle:"New Perspectives and Future Developments",isOpenForSubmission:!1,hash:"581763788a6a59e653a9d1d9b5a42d79",slug:"natural-gas-new-perspectives-and-future-developments",bookSignature:"Maryam Takht Ravanchi",coverURL:"https://cdn.intechopen.com/books/images_new/10686.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"2416",title:"Dr.",name:"Maryam",middleName:null,surname:"Takht Ravanchi",slug:"maryam-takht-ravanchi",fullName:"Maryam Takht Ravanchi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10988",title:"Railway Transport Planning and Manageme",subtitle:null,isOpenForSubmission:!1,hash:"5cb54cc53caedad9ec78372563c82e2c",slug:"railway-transport-planning-and-management",bookSignature:"Stefano de Luca, Roberta Di Pace and Chiara Fiori",coverURL:"https://cdn.intechopen.com/books/images_new/10988.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"271061",title:"Prof.",name:"Stefano",middleName:null,surname:"de Luca",slug:"stefano-de-luca",fullName:"Stefano de Luca"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},subject:{topic:{id:"1203",title:"Phytopharmacology",slug:"phytopharmacology",parent:{id:"219",title:"Pharmacology",slug:"pharmacology-toxicology-and-pharmaceutical-science-pharmacology"},numberOfBooks:2,numberOfSeries:0,numberOfAuthorsAndEditors:34,numberOfWosCitations:116,numberOfCrossrefCitations:42,numberOfDimensionsCitations:129,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicId:"1203",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"6810",title:"Capsaicin and its Human Therapeutic Development",subtitle:null,isOpenForSubmission:!1,hash:"9b0d5832824ac89f96d0557555448206",slug:"capsaicin-and-its-human-therapeutic-development",bookSignature:"Gyula Mozsik",coverURL:"https://cdn.intechopen.com/books/images_new/6810.jpg",editedByType:"Edited by",editors:[{id:"58390",title:"Dr.",name:"Gyula",middleName:null,surname:"Mozsik",slug:"gyula-mozsik",fullName:"Gyula Mozsik"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1957",title:"Bioactive Compounds in Phytomedicine",subtitle:null,isOpenForSubmission:!1,hash:"96a42f100ca94ca668a45dd7d98d7d65",slug:"bioactive-compounds-in-phytomedicine",bookSignature:"Iraj Rasooli",coverURL:"https://cdn.intechopen.com/books/images_new/1957.jpg",editedByType:"Edited by",editors:[{id:"61446",title:"Prof.",name:"Iraj",middleName:null,surname:"Rasooli",slug:"iraj-rasooli",fullName:"Iraj Rasooli"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:2,seriesByTopicCollection:[],seriesByTopicTotal:0,mostCitedChapters:[{id:"25787",doi:"10.5772/26700",title:"Diosgenin, a Steroid Saponin Constituent of Yams and Fenugreek: Emerging Evidence for Applications in Medicine",slug:"diosgenin-a-steroid-saponin-constituent-of-yams-and-fenugreek-emerging-evidence-for-applications-in-",totalDownloads:16877,totalCrossrefCites:17,totalDimensionsCites:42,abstract:null,book:{id:"1957",slug:"bioactive-compounds-in-phytomedicine",title:"Bioactive Compounds in Phytomedicine",fullTitle:"Bioactive Compounds in Phytomedicine"},signatures:"Jayadev Raju and Chinthalapally V. Rao",authors:[{id:"67603",title:"Dr.",name:"Jayadev",middleName:null,surname:"Raju",slug:"jayadev-raju",fullName:"Jayadev Raju"},{id:"74726",title:"Prof.",name:"Chinthalapally",middleName:"V.",surname:"Rao",slug:"chinthalapally-rao",fullName:"Chinthalapally Rao"}]},{id:"25790",doi:"10.5772/26037",title:"Zanthoxylum Genus as Potential Source of Bioactive Compounds",slug:"zanthoxylum-genus-as-potential-source-of-bioactive-compounds",totalDownloads:6981,totalCrossrefCites:9,totalDimensionsCites:29,abstract:null,book:{id:"1957",slug:"bioactive-compounds-in-phytomedicine",title:"Bioactive Compounds in Phytomedicine",fullTitle:"Bioactive Compounds in Phytomedicine"},signatures:"L. Oscar Javier Patiño, R. Juliet Angélica Prieto and S. Luis Enrique Cuca",authors:[{id:"65330",title:"Dr.",name:"Oscar",middleName:null,surname:"Patiño",slug:"oscar-patino",fullName:"Oscar Patiño"},{id:"76143",title:"Dr.",name:"Luis Enrique",middleName:null,surname:"Cuca Suárez",slug:"luis-enrique-cuca-suarez",fullName:"Luis Enrique Cuca Suárez"},{id:"76144",title:"Dr.",name:"Juliet",middleName:"Angélica",surname:"Prieto Rodríguez",slug:"juliet-prieto-rodriguez",fullName:"Juliet Prieto Rodríguez"}]},{id:"25785",doi:"10.5772/30270",title:"The Phytochemical and In Vitro Pharmacological Testing of Maltese Medicinal Plants",slug:"the-phytochemical-and-in-vitro-pharmacological-testing-of-maltese-medicinal-plants",totalDownloads:6259,totalCrossrefCites:3,totalDimensionsCites:13,abstract:null,book:{id:"1957",slug:"bioactive-compounds-in-phytomedicine",title:"Bioactive Compounds in Phytomedicine",fullTitle:"Bioactive Compounds in Phytomedicine"},signatures:"Everaldo Attard and Pierpaolo Pacioni",authors:[{id:"81688",title:"Prof.",name:"Everaldo",middleName:"G.",surname:"Attard",slug:"everaldo-attard",fullName:"Everaldo Attard"},{id:"81699",title:"Dr.",name:"Pierpaolo",middleName:null,surname:"Pacioni",slug:"pierpaolo-pacioni",fullName:"Pierpaolo Pacioni"}]},{id:"25788",doi:"10.5772/26102",title:"Polyphenols as Adaptogens – The Real Mechanism of the Antioxidant Effect?",slug:"polyphenols-as-adaptogens-the-real-mechanism-of-the-antioxidant-effect-",totalDownloads:3750,totalCrossrefCites:1,totalDimensionsCites:9,abstract:null,book:{id:"1957",slug:"bioactive-compounds-in-phytomedicine",title:"Bioactive Compounds in Phytomedicine",fullTitle:"Bioactive Compounds in Phytomedicine"},signatures:"David E. Stevenson",authors:[{id:"65554",title:"Dr.",name:"David",middleName:null,surname:"Stevenson",slug:"david-stevenson",fullName:"David Stevenson"}]},{id:"61858",doi:"10.5772/intechopen.78243",title:"Capsaicinoids and Vitamins in Hot Pepper and Their Role in Disease Therapy",slug:"capsaicinoids-and-vitamins-in-hot-pepper-and-their-role-in-disease-therapy",totalDownloads:1773,totalCrossrefCites:7,totalDimensionsCites:9,abstract:"Members of the genus Capsicum (Family: Solanaceae), which belongs to a dicotyledonous group of flowering plants, show fluctuating degrees of spiciness that mirror the relative concentrations of capsaicin, dihydrocapsaicin, and other analogs (nordihydrocapsaicin, homocapsaicin, and homodihydrocapsaicin) collectively known as capsaicinoids present in the fruit placenta. Pungent Chili varieties are grown for their food value, health-promoting properties and as a source of capsaicinoids that have a variety of medicinal uses. Accessions of the cultivated species (Capsicum annuum, C. baccatum, C. chinense, C. frutescens, and C. pubescens) have not all been analyzed for their capsaicinoids content. Identifying Capsicum species and accessions (genotypes) within species with high levels of antioxidants and bioactive compounds (capsaicin, dihydrocapsaicin, vitamin C, vitamin E, phenols, and β-carotene) that contribute to human disease therapy is the focus of this investigation. The main objectives of this chapter are to compile an overview of most recent achievements of the pharmacological properties of hot pepper compounds and provide a rationale for their use as analgesics and to present an evidence that supports the use of capsaicinoids in the treatment of neuropathic pain and other top leading death of worldwide human diseases.",book:{id:"6810",slug:"capsaicin-and-its-human-therapeutic-development",title:"Capsaicin and its Human Therapeutic Development",fullTitle:"Capsaicin and its Human Therapeutic Development"},signatures:"George F. Antonious",authors:[{id:"174916",title:"Dr.",name:"George",middleName:"Fouad",surname:"Antonious",slug:"george-antonious",fullName:"George Antonious"}]}],mostDownloadedChaptersLast30Days:[{id:"25790",title:"Zanthoxylum Genus as Potential Source of Bioactive Compounds",slug:"zanthoxylum-genus-as-potential-source-of-bioactive-compounds",totalDownloads:6981,totalCrossrefCites:9,totalDimensionsCites:29,abstract:null,book:{id:"1957",slug:"bioactive-compounds-in-phytomedicine",title:"Bioactive Compounds in Phytomedicine",fullTitle:"Bioactive Compounds in Phytomedicine"},signatures:"L. Oscar Javier Patiño, R. Juliet Angélica Prieto and S. Luis Enrique Cuca",authors:[{id:"65330",title:"Dr.",name:"Oscar",middleName:null,surname:"Patiño",slug:"oscar-patino",fullName:"Oscar Patiño"},{id:"76143",title:"Dr.",name:"Luis Enrique",middleName:null,surname:"Cuca Suárez",slug:"luis-enrique-cuca-suarez",fullName:"Luis Enrique Cuca Suárez"},{id:"76144",title:"Dr.",name:"Juliet",middleName:"Angélica",surname:"Prieto Rodríguez",slug:"juliet-prieto-rodriguez",fullName:"Juliet Prieto Rodríguez"}]},{id:"25789",title:"Erythrina, a Potential Source of Chemicals from the Neotropics",slug:"erythrina-a-potential-source-of-chemicals-from-the-neotropics",totalDownloads:5907,totalCrossrefCites:0,totalDimensionsCites:3,abstract:null,book:{id:"1957",slug:"bioactive-compounds-in-phytomedicine",title:"Bioactive Compounds in Phytomedicine",fullTitle:"Bioactive Compounds in Phytomedicine"},signatures:"R. Marcos Soto-Hernández, Rosario García-Mateos, Rubén San Miguel-Chávez, Geoffrey Kite, Mariano Martínez-Vázquez and Ana C. Ramos-Valdivia",authors:[{id:"65790",title:"Prof.",name:"Marcos",middleName:null,surname:"Soto-Hernández",slug:"marcos-soto-hernandez",fullName:"Marcos Soto-Hernández"}]},{id:"61858",title:"Capsaicinoids and Vitamins in Hot Pepper and Their Role in Disease Therapy",slug:"capsaicinoids-and-vitamins-in-hot-pepper-and-their-role-in-disease-therapy",totalDownloads:1773,totalCrossrefCites:7,totalDimensionsCites:9,abstract:"Members of the genus Capsicum (Family: Solanaceae), which belongs to a dicotyledonous group of flowering plants, show fluctuating degrees of spiciness that mirror the relative concentrations of capsaicin, dihydrocapsaicin, and other analogs (nordihydrocapsaicin, homocapsaicin, and homodihydrocapsaicin) collectively known as capsaicinoids present in the fruit placenta. Pungent Chili varieties are grown for their food value, health-promoting properties and as a source of capsaicinoids that have a variety of medicinal uses. Accessions of the cultivated species (Capsicum annuum, C. baccatum, C. chinense, C. frutescens, and C. pubescens) have not all been analyzed for their capsaicinoids content. Identifying Capsicum species and accessions (genotypes) within species with high levels of antioxidants and bioactive compounds (capsaicin, dihydrocapsaicin, vitamin C, vitamin E, phenols, and β-carotene) that contribute to human disease therapy is the focus of this investigation. The main objectives of this chapter are to compile an overview of most recent achievements of the pharmacological properties of hot pepper compounds and provide a rationale for their use as analgesics and to present an evidence that supports the use of capsaicinoids in the treatment of neuropathic pain and other top leading death of worldwide human diseases.",book:{id:"6810",slug:"capsaicin-and-its-human-therapeutic-development",title:"Capsaicin and its Human Therapeutic Development",fullTitle:"Capsaicin and its Human Therapeutic Development"},signatures:"George F. Antonious",authors:[{id:"174916",title:"Dr.",name:"George",middleName:"Fouad",surname:"Antonious",slug:"george-antonious",fullName:"George Antonious"}]},{id:"62311",title:"CAP and Metabolic Diseases: A Mini Review on Preclinical Mechanisms and Clinical Efficacy",slug:"cap-and-metabolic-diseases-a-mini-review-on-preclinical-mechanisms-and-clinical-efficacy",totalDownloads:1336,totalCrossrefCites:1,totalDimensionsCites:2,abstract:"Capsaicin (CAP) is the chief active ingredient of natural chili peppers. It has culinary and medicinal benefits. CAP activates its receptor, transient receptor potential vanilloid subfamily 1 (TRPV1), which is expressed in the sensory and motor neurons, adipocytes, liver, vascular smooth muscle cells, neuromuscular junction, skeletal muscle, heart and brain. The specificity of CAP to activate TRPV1 is the fundamental mechanism for its medicinal benefits to treat pain, obesity, hypertension, and other diseases. Preclinical data from rodent model of high fat diet-induced obesity collectively suggest that CAP exerts its effects by activating TRPV1 signaling pathway, which stimulates thermogenic mechanisms in the white and brown adipose tissues to induce browning of white adipose tissues and brown adipose tissue thermogenesis. This leads to enhancement of metabolic activity and thermogenesis to counter obesity. Although CAP and its pungent and non-pungent analogs are used in human clinical studies, their effects on satiety and energy expenditure have been the highlights of such studies. The precise mechanism of action of CAP has not been evaluated in humans. This article summarizes these data and suggests that long-term safety and tolerance studies are important for advancing CAP to treat human obesity.",book:{id:"6810",slug:"capsaicin-and-its-human-therapeutic-development",title:"Capsaicin and its Human Therapeutic Development",fullTitle:"Capsaicin and its Human Therapeutic Development"},signatures:"Baskaran Thyagarajan, Vivek Krishnan and Padmamalini Baskaran",authors:null},{id:"61453",title:"A Matter of Taste: Capsaicinoid Diversity in Chile Peppers and the Importance to Human Food Preference",slug:"a-matter-of-taste-capsaicinoid-diversity-in-chile-peppers-and-the-importance-to-human-food-preferenc",totalDownloads:1279,totalCrossrefCites:0,totalDimensionsCites:1,abstract:"Chile peppers are valued worldwide for their distinct capsaicinoid compounds that have been used traditionally in medicine and culinary practices. With 32 known species, five of them domesticated, they provide unique chemical profiles, when consumed by humans. Capsaicinoids, the spicy compounds, are alkaloids used to deter herbivory in the wild, offering protection to the chile pepper fruit seeds. Among the 22 known capsaicinoid structures, capsaicin and dihydrocapsaicin are normally the most abundant. In humans, capsaicin binds to nociceptor TRPV1 that generates a heat sensation. Capsaicin also mitigates inflammation responses in the digestive tract and has the potential to aid in nutrient absorption. Distinct heat profiles were recently described for the five domesticated Capsicum species showing a difference in heat sensations specific to species and pod type. Due to the many capsaicinoid structures, we explore the implications and opportunities of having a diverse array of heat profiles in genetically diverse Capsicum species.",book:{id:"6810",slug:"capsaicin-and-its-human-therapeutic-development",title:"Capsaicin and its Human Therapeutic Development",fullTitle:"Capsaicin and its Human Therapeutic Development"},signatures:"Ivette Guzmán and Paul W. Bosland",authors:null}],onlineFirstChaptersFilter:{topicId:"1203",limit:6,offset:0},onlineFirstChaptersCollection:[],onlineFirstChaptersTotal:0},preDownload:{success:null,errors:{}},subscriptionForm:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[],offset:8,limit:8,total:0},allSeries:{pteSeriesList:[{id:"14",title:"Artificial Intelligence",numberOfPublishedBooks:9,numberOfPublishedChapters:89,numberOfOpenTopics:6,numberOfUpcomingTopics:0,issn:"2633-1403",doi:"10.5772/intechopen.79920",isOpenForSubmission:!0},{id:"7",title:"Biomedical Engineering",numberOfPublishedBooks:12,numberOfPublishedChapters:104,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2631-5343",doi:"10.5772/intechopen.71985",isOpenForSubmission:!0}],lsSeriesList:[{id:"11",title:"Biochemistry",numberOfPublishedBooks:32,numberOfPublishedChapters:318,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2632-0983",doi:"10.5772/intechopen.72877",isOpenForSubmission:!0},{id:"25",title:"Environmental Sciences",numberOfPublishedBooks:1,numberOfPublishedChapters:12,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2754-6713",doi:"10.5772/intechopen.100362",isOpenForSubmission:!0},{id:"10",title:"Physiology",numberOfPublishedBooks:11,numberOfPublishedChapters:141,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-8261",doi:"10.5772/intechopen.72796",isOpenForSubmission:!0}],hsSeriesList:[{id:"3",title:"Dentistry",numberOfPublishedBooks:8,numberOfPublishedChapters:129,numberOfOpenTopics:2,numberOfUpcomingTopics:0,issn:"2631-6218",doi:"10.5772/intechopen.71199",isOpenForSubmission:!0},{id:"6",title:"Infectious Diseases",numberOfPublishedBooks:13,numberOfPublishedChapters:113,numberOfOpenTopics:3,numberOfUpcomingTopics:1,issn:"2631-6188",doi:"10.5772/intechopen.71852",isOpenForSubmission:!0},{id:"13",title:"Veterinary Medicine and Science",numberOfPublishedBooks:11,numberOfPublishedChapters:106,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2632-0517",doi:"10.5772/intechopen.73681",isOpenForSubmission:!0}],sshSeriesList:[{id:"22",title:"Business, Management and Economics",numberOfPublishedBooks:1,numberOfPublishedChapters:19,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2753-894X",doi:"10.5772/intechopen.100359",isOpenForSubmission:!0},{id:"23",title:"Education and Human Development",numberOfPublishedBooks:0,numberOfPublishedChapters:5,numberOfOpenTopics:1,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100360",isOpenForSubmission:!0},{id:"24",title:"Sustainable Development",numberOfPublishedBooks:0,numberOfPublishedChapters:15,numberOfOpenTopics:5,numberOfUpcomingTopics:0,issn:null,doi:"10.5772/intechopen.100361",isOpenForSubmission:!0}],testimonialsList:[{id:"6",text:"It is great to work with the IntechOpen to produce a worthwhile collection of research that also becomes a great educational resource and guide for future research endeavors.",author:{id:"259298",name:"Edward",surname:"Narayan",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/259298/images/system/259298.jpeg",slug:"edward-narayan",institution:{id:"3",name:"University of Queensland",country:{id:null,name:"Australia"}}}},{id:"13",text:"The collaboration with and support of the technical staff of IntechOpen is fantastic. The whole process of submitting an article and editing of the submitted article goes extremely smooth and fast, the number of reads and downloads of chapters is high, and the contributions are also frequently cited.",author:{id:"55578",name:"Antonio",surname:"Jurado-Navas",institutionString:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRisIQAS/Profile_Picture_1626166543950",slug:"antonio-jurado-navas",institution:{id:"720",name:"University of Malaga",country:{id:null,name:"Spain"}}}}]},series:{item:{id:"11",title:"Biochemistry",doi:"10.5772/intechopen.72877",issn:"2632-0983",scope:"Biochemistry, the study of chemical transformations occurring within living organisms, impacts all areas of life sciences, from molecular crystallography and genetics to ecology, medicine, and population biology. Biochemistry examines macromolecules - proteins, nucleic acids, carbohydrates, and lipids – and their building blocks, structures, functions, and interactions. Much of biochemistry is devoted to enzymes, proteins that catalyze chemical reactions, enzyme structures, mechanisms of action and their roles within cells. Biochemistry also studies small signaling molecules, coenzymes, inhibitors, vitamins, and hormones, which play roles in life processes. Biochemical experimentation, besides coopting classical chemistry methods, e.g., chromatography, adopted new techniques, e.g., X-ray diffraction, electron microscopy, NMR, radioisotopes, and developed sophisticated microbial genetic tools, e.g., auxotroph mutants and their revertants, fermentation, etc. More recently, biochemistry embraced the ‘big data’ omics systems. Initial biochemical studies have been exclusively analytic: dissecting, purifying, and examining individual components of a biological system; in the apt words of Efraim Racker (1913 –1991), “Don’t waste clean thinking on dirty enzymes.” Today, however, biochemistry is becoming more agglomerative and comprehensive, setting out to integrate and describe entirely particular biological systems. The ‘big data’ metabolomics can define the complement of small molecules, e.g., in a soil or biofilm sample; proteomics can distinguish all the comprising proteins, e.g., serum; metagenomics can identify all the genes in a complex environment, e.g., the bovine rumen. This Biochemistry Series will address the current research on biomolecules and the emerging trends with great promise.",coverUrl:"https://cdn.intechopen.com/series/covers/11.jpg",latestPublicationDate:"June 29th, 2022",hasOnlineFirst:!0,numberOfPublishedBooks:32,editor:{id:"31610",title:"Dr.",name:"Miroslav",middleName:null,surname:"Blumenberg",slug:"miroslav-blumenberg",fullName:"Miroslav Blumenberg",profilePictureURL:"https://mts.intechopen.com/storage/users/31610/images/system/31610.jpg",biography:"Miroslav Blumenberg, Ph.D., was born in Subotica and received his BSc in Belgrade, Yugoslavia. He completed his Ph.D. at MIT in Organic Chemistry; he followed up his Ph.D. with two postdoctoral study periods at Stanford University. Since 1983, he has been a faculty member of the RO Perelman Department of Dermatology, NYU School of Medicine, where he is codirector of a training grant in cutaneous biology. Dr. Blumenberg’s research is focused on the epidermis, expression of keratin genes, transcription profiling, keratinocyte differentiation, inflammatory diseases and cancers, and most recently the effects of the microbiome on the skin. He has published more than 100 peer-reviewed research articles and graduated numerous Ph.D. and postdoctoral students.",institutionString:null,institution:{name:"New York University Langone Medical Center",institutionURL:null,country:{name:"United States of America"}}},editorTwo:null,editorThree:null},subseries:{paginationCount:4,paginationItems:[{id:"14",title:"Cell and Molecular Biology",coverUrl:"https://cdn.intechopen.com/series_topics/covers/14.jpg",isOpenForSubmission:!0,editor:{id:"165627",title:"Dr.",name:"Rosa María",middleName:null,surname:"Martínez-Espinosa",slug:"rosa-maria-martinez-espinosa",fullName:"Rosa María Martínez-Espinosa",profilePictureURL:"https://mts.intechopen.com/storage/users/165627/images/system/165627.jpeg",biography:"Dr. Rosa María Martínez-Espinosa has been a Spanish Full Professor since 2020 (Biochemistry and Molecular Biology) and is currently Vice-President of International Relations and Cooperation development and leader of the research group 'Applied Biochemistry” (University of Alicante, Spain). Other positions she has held at the university include Vice-Dean of Master Programs, Vice-Dean of the Degree in Biology and Vice-Dean for Mobility and Enterprise and Engagement at the Faculty of Science (University of Alicante). She received her Bachelor in Biology in 1998 (University of Alicante) and her PhD in 2003 (Biochemistry, University of Alicante). She undertook post-doctoral research at the University of East Anglia (Norwich, U.K. 2004-2005; 2007-2008).\nHer multidisciplinary research focuses on investigating archaea and their potential applications in biotechnology. She has an H-index of 21. She has authored one patent and has published more than 70 indexed papers and around 60 book chapters.\nShe has contributed to more than 150 national and international meetings during the last 15 years. Her research interests include archaea metabolism, enzymes purification and characterization, gene regulation, carotenoids and bioplastics production, antioxidant\ncompounds, waste water treatments, and brines bioremediation.\nRosa María’s other roles include editorial board member for several journals related\nto biochemistry, reviewer for more than 60 journals (biochemistry, molecular biology, biotechnology, chemistry and microbiology) and president of several organizing committees in international meetings related to the N-cycle or respiratory processes.",institutionString:null,institution:{name:"University of Alicante",institutionURL:null,country:{name:"Spain"}}},editorTwo:null,editorThree:null},{id:"15",title:"Chemical Biology",coverUrl:"https://cdn.intechopen.com/series_topics/covers/15.jpg",isOpenForSubmission:!0,editor:{id:"441442",title:"Dr.",name:"Şükrü",middleName:null,surname:"Beydemir",slug:"sukru-beydemir",fullName:"Şükrü Beydemir",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y00003GsUoIQAV/Profile_Picture_1634557147521",biography:"Dr. Şükrü Beydemir obtained a BSc in Chemistry in 1995 from Yüzüncü Yıl University, MSc in Biochemistry in 1998, and PhD in Biochemistry in 2002 from Atatürk University, Turkey. He performed post-doctoral studies at Max-Planck Institute, Germany, and University of Florence, Italy in addition to making several scientific visits abroad. He currently works as a Full Professor of Biochemistry in the Faculty of Pharmacy, Anadolu University, Turkey. Dr. Beydemir has published over a hundred scientific papers spanning protein biochemistry, enzymology and medicinal chemistry, reviews, book chapters and presented several conferences to scientists worldwide. He has received numerous publication awards from various international scientific councils. He serves in the Editorial Board of several international journals. Dr. Beydemir is also Rector of Bilecik Şeyh Edebali University, Turkey.",institutionString:null,institution:{name:"Anadolu University",institutionURL:null,country:{name:"Turkey"}}},editorTwo:{id:"13652",title:"Prof.",name:"Deniz",middleName:null,surname:"Ekinci",slug:"deniz-ekinci",fullName:"Deniz Ekinci",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYLT1QAO/Profile_Picture_1634557223079",biography:"Dr. Deniz Ekinci obtained a BSc in Chemistry in 2004, MSc in Biochemistry in 2006, and PhD in Biochemistry in 2009 from Atatürk University, Turkey. He studied at Stetson University, USA, in 2007-2008 and at the Max Planck Institute of Molecular Cell Biology and Genetics, Germany, in 2009-2010. Dr. Ekinci currently works as a Full Professor of Biochemistry in the Faculty of Agriculture and is the Head of the Enzyme and Microbial Biotechnology Division, Ondokuz Mayıs University, Turkey. He is a member of the Turkish Biochemical Society, American Chemical Society, and German Genetics society. Dr. Ekinci published around ninety scientific papers, reviews and book chapters, and presented several conferences to scientists. He has received numerous publication awards from several scientific councils. Dr. Ekinci serves as the Editor in Chief of four international books and is involved in the Editorial Board of several international journals.",institutionString:null,institution:{name:"Ondokuz Mayıs University",institutionURL:null,country:{name:"Turkey"}}},editorThree:null},{id:"17",title:"Metabolism",coverUrl:"https://cdn.intechopen.com/series_topics/covers/17.jpg",isOpenForSubmission:!0,editor:{id:"138626",title:"Dr.",name:"Yannis",middleName:null,surname:"Karamanos",slug:"yannis-karamanos",fullName:"Yannis Karamanos",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002g6Jv2QAE/Profile_Picture_1629356660984",biography:"Yannis Karamanos, born in Greece in 1953, completed his pre-graduate studies at the Université Pierre et Marie Curie, Paris, then his Masters and Doctoral degree at the Université de Lille (1983). He was associate professor at the University of Limoges (1987) before becoming full professor of biochemistry at the Université d’Artois (1996). He worked on the structure-function relationships of glycoconjugates and his main project was the investigations on the biological roles of the de-N-glycosylation enzymes (Endo-N-acetyl-β-D-glucosaminidase and peptide-N4-(N-acetyl-β-glucosaminyl) asparagine amidase). From 2002 he contributes to the understanding of the Blood-brain barrier functioning using proteomics approaches. He has published more than 70 papers. His teaching areas are energy metabolism and regulation, integration and organ specialization and metabolic adaptation.",institutionString:null,institution:{name:"Artois University",institutionURL:null,country:{name:"France"}}},editorTwo:null,editorThree:null},{id:"18",title:"Proteomics",coverUrl:"https://cdn.intechopen.com/series_topics/covers/18.jpg",isOpenForSubmission:!0,editor:{id:"200689",title:"Prof.",name:"Paolo",middleName:null,surname:"Iadarola",slug:"paolo-iadarola",fullName:"Paolo Iadarola",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSCl8QAG/Profile_Picture_1623568118342",biography:"Paolo Iadarola graduated with a degree in Chemistry from the University of Pavia (Italy) in July 1972. He then worked as an Assistant Professor at the Faculty of Science of the same University until 1984. In 1985, Prof. Iadarola became Associate Professor at the Department of Biology and Biotechnologies of the University of Pavia and retired in October 2017. Since then, he has been working as an Adjunct Professor in the same Department at the University of Pavia. His research activity during the first years was primarily focused on the purification and structural characterization of enzymes from animal and plant sources. During this period, Prof. Iadarola familiarized himself with the conventional techniques used in column chromatography, spectrophotometry, manual Edman degradation, and electrophoresis). Since 1995, he has been working on: i) the determination in biological fluids (serum, urine, bronchoalveolar lavage, sputum) of proteolytic activities involved in the degradation processes of connective tissue matrix, and ii) on the identification of biological markers of lung diseases. In this context, he has developed and validated new methodologies (e.g., Capillary Electrophoresis coupled to Laser-Induced Fluorescence, CE-LIF) whose application enabled him to determine both the amounts of biochemical markers (Desmosines) in urine/serum of patients affected by Chronic Obstructive Pulmonary Disease (COPD) and the activity of proteolytic enzymes (Human Neutrophil Elastase, Cathepsin G, Pseudomonas aeruginosa elastase) in sputa of these patients. More recently, Prof. Iadarola was involved in developing techniques such as two-dimensional electrophoresis coupled to liquid chromatography/mass spectrometry (2DE-LC/MS) for the proteomic analysis of biological fluids aimed at the identification of potential biomarkers of different lung diseases. He is the author of about 150 publications (According to Scopus: H-Index: 23; Total citations: 1568- According to WOS: H-Index: 20; Total Citations: 1296) of peer-reviewed international journals. He is a Consultant Reviewer for several journals, including the Journal of Chromatography A, Journal of Chromatography B, Plos ONE, Proteomes, International Journal of Molecular Science, Biotech, Electrophoresis, and others. He is also Associate Editor of Biotech.",institutionString:null,institution:{name:"University of Pavia",institutionURL:null,country:{name:"Italy"}}},editorTwo:{id:"201414",title:"Dr.",name:"Simona",middleName:null,surname:"Viglio",slug:"simona-viglio",fullName:"Simona Viglio",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRKDHQA4/Profile_Picture_1630402531487",biography:"Simona Viglio is an Associate Professor of Biochemistry at the Department of Molecular Medicine at the University of Pavia. She has been working since 1995 on the determination of proteolytic enzymes involved in the degradation process of connective tissue matrix and on the identification of biological markers of lung diseases. She gained considerable experience in developing and validating new methodologies whose applications allowed her to determine both the amount of biomarkers (Desmosine and Isodesmosine) in the urine of patients affected by COPD, and the activity of proteolytic enzymes (HNE, Cathepsin G, Pseudomonas aeruginosa elastase) in the sputa of these patients. Simona Viglio was also involved in research dealing with the supplementation of amino acids in patients with brain injury and chronic heart failure. She is presently engaged in the development of 2-DE and LC-MS techniques for the study of proteomics in biological fluids. The aim of this research is the identification of potential biomarkers of lung diseases. She is an author of about 90 publications (According to Scopus: H-Index: 23; According to WOS: H-Index: 20) on peer-reviewed journals, a member of the “Società Italiana di Biochimica e Biologia Molecolare,“ and a Consultant Reviewer for International Journal of Molecular Science, Journal of Chromatography A, COPD, Plos ONE and Nutritional Neuroscience.",institutionString:null,institution:{name:"University of Pavia",institutionURL:null,country:{name:"Italy"}}},editorThree:null}]},overviewPageOFChapters:{paginationCount:36,paginationItems:[{id:"82195",title:"Endoplasmic Reticulum: A Hub in Lipid Homeostasis",doi:"10.5772/intechopen.105450",signatures:"Raúl Ventura and María Isabel Hernández-Alvarez",slug:"endoplasmic-reticulum-a-hub-in-lipid-homeostasis",totalDownloads:4,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Updates on Endoplasmic Reticulum",coverURL:"https://cdn.intechopen.com/books/images_new/11674.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"82409",title:"Purinergic Signaling in Covid-19 Disease",doi:"10.5772/intechopen.105008",signatures:"Hailian Shen",slug:"purinergic-signaling-in-covid-19-disease",totalDownloads:5,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Purinergic System",coverURL:"https://cdn.intechopen.com/books/images_new/10801.jpg",subseries:{id:"17",title:"Metabolism"}}},{id:"82374",title:"The Potential of the Purinergic System as a Therapeutic Target of Natural Compounds in Cutaneous Melanoma",doi:"10.5772/intechopen.105457",signatures:"Gilnei Bruno da Silva, Daiane Manica, Marcelo Moreno and Margarete Dulce Bagatini",slug:"the-potential-of-the-purinergic-system-as-a-therapeutic-target-of-natural-compounds-in-cutaneous-mel",totalDownloads:10,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Purinergic System",coverURL:"https://cdn.intechopen.com/books/images_new/10801.jpg",subseries:{id:"17",title:"Metabolism"}}},{id:"82103",title:"The Role of Endoplasmic Reticulum Stress and Its Regulation in the Progression of Neurological and Infectious Diseases",doi:"10.5772/intechopen.105543",signatures:"Mary Dover, Michael Kishek, Miranda Eddins, Naneeta Desar, Ketema Paul and Milan Fiala",slug:"the-role-of-endoplasmic-reticulum-stress-and-its-regulation-in-the-progression-of-neurological-and-i",totalDownloads:6,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Updates on Endoplasmic Reticulum",coverURL:"https://cdn.intechopen.com/books/images_new/11674.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}}]},overviewPagePublishedBooks:{paginationCount:32,paginationItems:[{type:"book",id:"7006",title:"Biochemistry and Health Benefits of Fatty Acids",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7006.jpg",slug:"biochemistry-and-health-benefits-of-fatty-acids",publishedDate:"December 19th 2018",editedByType:"Edited by",bookSignature:"Viduranga Waisundara",hash:"c93a00abd68b5eba67e5e719f67fd20b",volumeInSeries:1,fullTitle:"Biochemistry and Health Benefits of Fatty Acids",editors:[{id:"194281",title:"Dr.",name:"Viduranga Y.",middleName:null,surname:"Waisundara",slug:"viduranga-y.-waisundara",fullName:"Viduranga Y. Waisundara",profilePictureURL:"https://mts.intechopen.com/storage/users/194281/images/system/194281.jpg",biography:"Dr. Viduranga Waisundara obtained her Ph.D. in Food Science\nand Technology from the Department of Chemistry, National\nUniversity of Singapore, in 2010. She was a lecturer at Temasek Polytechnic, Singapore from July 2009 to March 2013.\nShe relocated to her motherland of Sri Lanka and spearheaded the Functional Food Product Development Project at the\nNational Institute of Fundamental Studies from April 2013 to\nOctober 2016. She was a senior lecturer on a temporary basis at the Department of\nFood Technology, Faculty of Technology, Rajarata University of Sri Lanka. She is\ncurrently Deputy Principal of the Australian College of Business and Technology –\nKandy Campus, Sri Lanka. She is also the Global Harmonization Initiative (GHI)",institutionString:"Australian College of Business & Technology",institution:null}]},{type:"book",id:"6820",title:"Keratin",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/6820.jpg",slug:"keratin",publishedDate:"December 19th 2018",editedByType:"Edited by",bookSignature:"Miroslav Blumenberg",hash:"6def75cd4b6b5324a02b6dc0359896d0",volumeInSeries:2,fullTitle:"Keratin",editors:[{id:"31610",title:"Dr.",name:"Miroslav",middleName:null,surname:"Blumenberg",slug:"miroslav-blumenberg",fullName:"Miroslav Blumenberg",profilePictureURL:"https://mts.intechopen.com/storage/users/31610/images/system/31610.jpg",biography:"Miroslav Blumenberg, Ph.D., was born in Subotica and received his BSc in Belgrade, Yugoslavia. He completed his Ph.D. at MIT in Organic Chemistry; he followed up his Ph.D. with two postdoctoral study periods at Stanford University. Since 1983, he has been a faculty member of the RO Perelman Department of Dermatology, NYU School of Medicine, where he is codirector of a training grant in cutaneous biology. Dr. Blumenberg’s research is focused on the epidermis, expression of keratin genes, transcription profiling, keratinocyte differentiation, inflammatory diseases and cancers, and most recently the effects of the microbiome on the skin. He has published more than 100 peer-reviewed research articles and graduated numerous Ph.D. and postdoctoral students.",institutionString:null,institution:{name:"New York University Langone Medical Center",institutionURL:null,country:{name:"United States of America"}}}]},{type:"book",id:"7978",title:"Vitamin A",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7978.jpg",slug:"vitamin-a",publishedDate:"May 15th 2019",editedByType:"Edited by",bookSignature:"Leila Queiroz Zepka, Veridiana Vera de Rosso and Eduardo Jacob-Lopes",hash:"dad04a658ab9e3d851d23705980a688b",volumeInSeries:3,fullTitle:"Vitamin A",editors:[{id:"261969",title:"Dr.",name:"Leila",middleName:null,surname:"Queiroz Zepka",slug:"leila-queiroz-zepka",fullName:"Leila Queiroz Zepka",profilePictureURL:"https://mts.intechopen.com/storage/users/261969/images/system/261969.png",biography:"Prof. Dr. Leila Queiroz Zepka is currently an associate professor in the Department of Food Technology and Science, Federal University of Santa Maria, Brazil. She has more than fifteen years of teaching and research experience. She has published more than 550 scientific publications/communications, including 15 books, 50 book chapters, 100 original research papers, 380 research communications in national and international conferences, and 12 patents. She is a member of the editorial board of five journals and acts as a reviewer for several national and international journals. Her research interests include microalgal biotechnology with an emphasis on microalgae-based products.",institutionString:"Universidade Federal de Santa Maria",institution:{name:"Universidade Federal de Santa Maria",institutionURL:null,country:{name:"Brazil"}}}]},{type:"book",id:"7953",title:"Bioluminescence",subtitle:"Analytical Applications and Basic Biology",coverURL:"https://cdn.intechopen.com/books/images_new/7953.jpg",slug:"bioluminescence-analytical-applications-and-basic-biology",publishedDate:"September 25th 2019",editedByType:"Edited by",bookSignature:"Hirobumi Suzuki",hash:"3a8efa00b71abea11bf01973dc589979",volumeInSeries:4,fullTitle:"Bioluminescence - Analytical Applications and Basic Biology",editors:[{id:"185746",title:"Dr.",name:"Hirobumi",middleName:null,surname:"Suzuki",slug:"hirobumi-suzuki",fullName:"Hirobumi Suzuki",profilePictureURL:"https://mts.intechopen.com/storage/users/185746/images/system/185746.png",biography:"Dr. Hirobumi Suzuki received his Ph.D. in 1997 from Tokyo Metropolitan University, Japan, where he studied firefly phylogeny and the evolution of mating systems. He is especially interested in the genetic differentiation pattern and speciation process that correlate to the flashing pattern and mating behavior of some fireflies in Japan. He then worked for Olympus Corporation, a Japanese manufacturer of optics and imaging products, where he was involved in the development of luminescence technology and produced a bioluminescence microscope that is currently being used for gene expression analysis in chronobiology, neurobiology, and developmental biology. Dr. Suzuki currently serves as a visiting researcher at Kogakuin University, Japan, and also a vice president of the Japan Firefly Society.",institutionString:"Kogakuin University",institution:null}]}]},openForSubmissionBooks:{paginationCount:1,paginationItems:[{id:"11478",title:"Recent Advances in the Study of Dyslexia",coverURL:"https://cdn.intechopen.com/books/images_new/11478.jpg",hash:"26764a18c6b776698823e0e1c3022d2f",secondStepPassed:!0,currentStepOfPublishingProcess:3,submissionDeadline:"June 30th 2022",isOpenForSubmission:!0,editors:[{id:"294281",title:"Prof.",name:"Jonathan",surname:"Glazzard",slug:"jonathan-glazzard",fullName:"Jonathan Glazzard"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},onlineFirstChapters:{paginationCount:36,paginationItems:[{id:"82195",title:"Endoplasmic Reticulum: A Hub in Lipid Homeostasis",doi:"10.5772/intechopen.105450",signatures:"Raúl Ventura and María Isabel Hernández-Alvarez",slug:"endoplasmic-reticulum-a-hub-in-lipid-homeostasis",totalDownloads:4,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Updates on Endoplasmic Reticulum",coverURL:"https://cdn.intechopen.com/books/images_new/11674.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"82409",title:"Purinergic Signaling in Covid-19 Disease",doi:"10.5772/intechopen.105008",signatures:"Hailian Shen",slug:"purinergic-signaling-in-covid-19-disease",totalDownloads:5,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Purinergic System",coverURL:"https://cdn.intechopen.com/books/images_new/10801.jpg",subseries:{id:"17",title:"Metabolism"}}},{id:"82374",title:"The Potential of the Purinergic System as a Therapeutic Target of Natural Compounds in Cutaneous Melanoma",doi:"10.5772/intechopen.105457",signatures:"Gilnei Bruno da Silva, Daiane Manica, Marcelo Moreno and Margarete Dulce Bagatini",slug:"the-potential-of-the-purinergic-system-as-a-therapeutic-target-of-natural-compounds-in-cutaneous-mel",totalDownloads:10,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Purinergic System",coverURL:"https://cdn.intechopen.com/books/images_new/10801.jpg",subseries:{id:"17",title:"Metabolism"}}},{id:"82103",title:"The Role of Endoplasmic Reticulum Stress and Its Regulation in the Progression of Neurological and Infectious Diseases",doi:"10.5772/intechopen.105543",signatures:"Mary Dover, Michael Kishek, Miranda Eddins, Naneeta Desar, Ketema Paul and Milan Fiala",slug:"the-role-of-endoplasmic-reticulum-stress-and-its-regulation-in-the-progression-of-neurological-and-i",totalDownloads:6,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Updates on Endoplasmic Reticulum",coverURL:"https://cdn.intechopen.com/books/images_new/11674.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"82212",title:"Protein Prenylation and Their Applications",doi:"10.5772/intechopen.104700",signatures:"Khemchand R. Surana, Ritesh B. Pawar, Ritesh A. Khairnar and Sunil K. Mahajan",slug:"protein-prenylation-and-their-applications",totalDownloads:9,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Modifications of Biomolecules",coverURL:"https://cdn.intechopen.com/books/images_new/11098.jpg",subseries:null}},{id:"80954",title:"Ion Channels and Neurodegenerative Disease Aging Related",doi:"10.5772/intechopen.103074",signatures:"Marika Cordaro, Salvatore Cuzzocrea and Rosanna Di Paola",slug:"ion-channels-and-neurodegenerative-disease-aging-related",totalDownloads:7,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Ion Channels - From Basic Properties to Medical Treatment",coverURL:"https://cdn.intechopen.com/books/images_new/10838.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"82096",title:"An Important Component of Tumor Progression: Fatty Acids",doi:"10.5772/intechopen.105087",signatures:"Jin Wang, Qifei Wang and Guangzhen Wu",slug:"an-important-component-of-tumor-progression-fatty-acids",totalDownloads:9,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Fatty Acids - Recent Advances",coverURL:"https://cdn.intechopen.com/books/images_new/11669.jpg",subseries:{id:"17",title:"Metabolism"}}},{id:"82029",title:"Synthesis, Characterization and Antimicrobial Properties of Novel Benzimidazole Amide Derivatives Bearing Thiophene Moiety",doi:"10.5772/intechopen.104908",signatures:"Vinayak Adimule, Pravin Kendrekar and Sheetal Batakurki",slug:"synthesis-characterization-and-antimicrobial-properties-of-novel-benzimidazole-amide-derivatives-bea",totalDownloads:4,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Benzimidazole",coverURL:"https://cdn.intechopen.com/books/images_new/10840.jpg",subseries:{id:"15",title:"Chemical Biology"}}},{id:"81927",title:"Purinergic System in Immune Response",doi:"10.5772/intechopen.104485",signatures:"Yerly Magnolia Useche Salvador",slug:"purinergic-system-in-immune-response",totalDownloads:15,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Purinergic System",coverURL:"https://cdn.intechopen.com/books/images_new/10801.jpg",subseries:{id:"17",title:"Metabolism"}}},{id:"80495",title:"Iron in Cell Metabolism and Disease",doi:"10.5772/intechopen.101908",signatures:"Eeka Prabhakar",slug:"iron-in-cell-metabolism-and-disease",totalDownloads:16,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Iron Metabolism - Iron a Double‐Edged Sword",coverURL:"https://cdn.intechopen.com/books/images_new/10842.jpg",subseries:{id:"17",title:"Metabolism"}}}]},subseriesFiltersForOFChapters:[{caption:"Proteomics",value:18,count:1,group:"subseries"},{caption:"Chemical Biology",value:15,count:5,group:"subseries"},{caption:"Metabolism",value:17,count:13,group:"subseries"},{caption:"Cell and Molecular Biology",value:14,count:15,group:"subseries"}],publishedBooks:{paginationCount:32,paginationItems:[{type:"book",id:"10798",title:"Starch",subtitle:"Evolution and Recent Advances",coverURL:"https://cdn.intechopen.com/books/images_new/10798.jpg",slug:"starch-evolution-and-recent-advances",publishedDate:"June 28th 2022",editedByType:"Edited by",bookSignature:"Martins Ochubiojo Emeje",hash:"f197f6062c1574a9a90e50a369271bcf",volumeInSeries:33,fullTitle:"Starch - Evolution and Recent Advances",editors:[{id:"94311",title:"Prof.",name:"Martins",middleName:"Ochubiojo",surname:"Ochubiojo Emeje",slug:"martins-ochubiojo-emeje",fullName:"Martins Ochubiojo Emeje",profilePictureURL:"https://mts.intechopen.com/storage/users/94311/images/system/94311.jpeg",institutionString:"National Institute for Pharmaceutical Research and Development",institution:{name:"National Institute for Pharmaceutical Research and Development",institutionURL:null,country:{name:"Nigeria"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"11332",title:"Essential Oils",subtitle:"Advances in Extractions and Biological Applications",coverURL:"https://cdn.intechopen.com/books/images_new/11332.jpg",slug:"essential-oils-advances-in-extractions-and-biological-applications",publishedDate:"June 23rd 2022",editedByType:"Edited by",bookSignature:"Mozaniel Santana de Oliveira and Eloisa Helena de Aguiar Andrade",hash:"742e6cae3a35686f975edc8d7f9afa94",volumeInSeries:32,fullTitle:"Essential Oils - Advances in Extractions and Biological Applications",editors:[{id:"195290",title:"Ph.D.",name:"Mozaniel",middleName:null,surname:"Santana De Oliveira",slug:"mozaniel-santana-de-oliveira",fullName:"Mozaniel Santana De Oliveira",profilePictureURL:"https://mts.intechopen.com/storage/users/195290/images/system/195290.png",institutionString:"Museu Paraense Emílio Goeldi",institution:{name:"Museu Paraense Emílio Goeldi",institutionURL:null,country:{name:"Brazil"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10839",title:"Protein Detection",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/10839.jpg",slug:"protein-detection",publishedDate:"June 23rd 2022",editedByType:"Edited by",bookSignature:"Yusuf Tutar and Lütfi Tutar",hash:"2f1c0e4e0207fc45c936e7d22a5369c4",volumeInSeries:31,fullTitle:"Protein Detection",editors:[{id:"158492",title:"Prof.",name:"Yusuf",middleName:null,surname:"Tutar",slug:"yusuf-tutar",fullName:"Yusuf Tutar",profilePictureURL:"https://mts.intechopen.com/storage/users/158492/images/system/158492.jpeg",institutionString:"University of Health Sciences",institution:null}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10797",title:"Cell Culture",subtitle:"Advanced Technology and Applications in Medical and Life Sciences",coverURL:"https://cdn.intechopen.com/books/images_new/10797.jpg",slug:"cell-culture-advanced-technology-and-applications-in-medical-and-life-sciences",publishedDate:"June 15th 2022",editedByType:"Edited by",bookSignature:"Xianquan Zhan",hash:"2c628f4757f9639a4450728d839a7842",volumeInSeries:30,fullTitle:"Cell Culture - Advanced Technology and Applications in Medical and Life Sciences",editors:[{id:"223233",title:"Prof.",name:"Xianquan",middleName:null,surname:"Zhan",slug:"xianquan-zhan",fullName:"Xianquan Zhan",profilePictureURL:"https://mts.intechopen.com/storage/users/223233/images/system/223233.png",institutionString:"Shandong First Medical University",institution:{name:"Affiliated Hospital of Shandong Academy of Medical Sciences",institutionURL:null,country:{name:"China"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10841",title:"Hydrolases",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/10841.jpg",slug:"hydrolases",publishedDate:"June 15th 2022",editedByType:"Edited by",bookSignature:"Sajjad Haider, Adnan Haider and Angel Catalá",hash:"4e868cde273d65a7ff54b1817d640629",volumeInSeries:29,fullTitle:"Hydrolases",editors:[{id:"110708",title:"Dr.",name:"Sajjad",middleName:null,surname:"Haider",slug:"sajjad-haider",fullName:"Sajjad Haider",profilePictureURL:"https://mts.intechopen.com/storage/users/110708/images/system/110708.png",institutionString:"King Saud University",institution:{name:"King Saud University",institutionURL:null,country:{name:"Saudi Arabia"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10803",title:"Reactive Oxygen Species",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/10803.jpg",slug:"reactive-oxygen-species",publishedDate:"April 28th 2022",editedByType:"Edited by",bookSignature:"Rizwan Ahmad",hash:"176adcf090fdd1f93cb8ce3146e79ca1",volumeInSeries:28,fullTitle:"Reactive Oxygen Species",editors:[{id:"40482",title:null,name:"Rizwan",middleName:null,surname:"Ahmad",slug:"rizwan-ahmad",fullName:"Rizwan Ahmad",profilePictureURL:"https://mts.intechopen.com/storage/users/40482/images/system/40482.jpeg",institutionString:"Imam Abdulrahman Bin Faisal University",institution:{name:"Imam Abdulrahman Bin Faisal University",institutionURL:null,country:{name:"Saudi Arabia"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9008",title:"Vitamin K",subtitle:"Recent Topics on the Biology and Chemistry",coverURL:"https://cdn.intechopen.com/books/images_new/9008.jpg",slug:"vitamin-k-recent-topics-on-the-biology-and-chemistry",publishedDate:"March 23rd 2022",editedByType:"Edited by",bookSignature:"Hiroyuki Kagechika and Hitoshi Shirakawa",hash:"8b43add5389ba85743e0a9491e4b9943",volumeInSeries:27,fullTitle:"Vitamin K - Recent Topics on the Biology and Chemistry",editors:[{id:"180528",title:"Dr.",name:"Hiroyuki",middleName:null,surname:"Kagechika",slug:"hiroyuki-kagechika",fullName:"Hiroyuki Kagechika",profilePictureURL:"https://mts.intechopen.com/storage/users/180528/images/system/180528.jpg",institutionString:"Tokyo Medical and Dental University",institution:{name:"Tokyo Medical and Dental University",institutionURL:null,country:{name:"Japan"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10799",title:"Phenolic Compounds",subtitle:"Chemistry, Synthesis, Diversity, Non-Conventional Industrial, Pharmaceutical and Therapeutic Applications",coverURL:"https://cdn.intechopen.com/books/images_new/10799.jpg",slug:"phenolic-compounds-chemistry-synthesis-diversity-non-conventional-industrial-pharmaceutical-and-therapeutic-applications",publishedDate:"February 23rd 2022",editedByType:"Edited by",bookSignature:"Farid A. Badria",hash:"339199f254d2987ef3167eef74fb8a38",volumeInSeries:26,fullTitle:"Phenolic Compounds - Chemistry, Synthesis, Diversity, Non-Conventional Industrial, Pharmaceutical and Therapeutic Applications",editors:[{id:"41865",title:"Prof.",name:"Farid A.",middleName:null,surname:"Badria",slug:"farid-a.-badria",fullName:"Farid A. Badria",profilePictureURL:"https://mts.intechopen.com/storage/users/41865/images/system/41865.jpg",institutionString:"Mansoura University",institution:{name:"Mansoura University",institutionURL:null,country:{name:"Egypt"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9659",title:"Fibroblasts",subtitle:"Advances in Inflammation, Autoimmunity and Cancer",coverURL:"https://cdn.intechopen.com/books/images_new/9659.jpg",slug:"fibroblasts-advances-in-inflammation-autoimmunity-and-cancer",publishedDate:"December 22nd 2021",editedByType:"Edited by",bookSignature:"Mojca Frank Bertoncelj and Katja Lakota",hash:"926fa6446f6befbd363fc74971a56de2",volumeInSeries:25,fullTitle:"Fibroblasts - Advances in Inflammation, Autoimmunity and Cancer",editors:[{id:"328755",title:"Ph.D.",name:"Mojca",middleName:null,surname:"Frank Bertoncelj",slug:"mojca-frank-bertoncelj",fullName:"Mojca Frank Bertoncelj",profilePictureURL:"https://mts.intechopen.com/storage/users/328755/images/system/328755.jpg",institutionString:"BioMed X Institute",institution:{name:"University Hospital of Zurich",institutionURL:null,country:{name:"Switzerland"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8977",title:"Protein Kinases",subtitle:"Promising Targets for Anticancer Drug Research",coverURL:"https://cdn.intechopen.com/books/images_new/8977.jpg",slug:"protein-kinases-promising-targets-for-anticancer-drug-research",publishedDate:"December 8th 2021",editedByType:"Edited by",bookSignature:"Rajesh Kumar Singh",hash:"6d200cc031706a565b554fdb1c478901",volumeInSeries:24,fullTitle:"Protein Kinases - Promising Targets for Anticancer Drug Research",editors:[{id:"329385",title:"Dr.",name:"Rajesh K.",middleName:"Kumar",surname:"Singh",slug:"rajesh-k.-singh",fullName:"Rajesh K. Singh",profilePictureURL:"https://mts.intechopen.com/storage/users/329385/images/system/329385.png",institutionString:"Punjab Technical University",institution:{name:"Punjab Technical University",institutionURL:null,country:{name:"India"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8018",title:"Extracellular Matrix",subtitle:"Developments and Therapeutics",coverURL:"https://cdn.intechopen.com/books/images_new/8018.jpg",slug:"extracellular-matrix-developments-and-therapeutics",publishedDate:"October 27th 2021",editedByType:"Edited by",bookSignature:"Rama Sashank Madhurapantula, Joseph Orgel P.R.O. and Zvi Loewy",hash:"c85e82851e80b40282ff9be99ddf2046",volumeInSeries:23,fullTitle:"Extracellular Matrix - Developments and Therapeutics",editors:[{id:"212416",title:"Dr.",name:"Rama Sashank",middleName:null,surname:"Madhurapantula",slug:"rama-sashank-madhurapantula",fullName:"Rama Sashank Madhurapantula",profilePictureURL:"https://mts.intechopen.com/storage/users/212416/images/system/212416.jpg",institutionString:"Illinois Institute of Technology",institution:{name:"Illinois Institute of Technology",institutionURL:null,country:{name:"United States of America"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9759",title:"Vitamin E in Health and Disease",subtitle:"Interactions, Diseases and Health Aspects",coverURL:"https://cdn.intechopen.com/books/images_new/9759.jpg",slug:"vitamin-e-in-health-and-disease-interactions-diseases-and-health-aspects",publishedDate:"October 6th 2021",editedByType:"Edited by",bookSignature:"Pınar Erkekoglu and Júlia Scherer Santos",hash:"6c3ddcc13626110de289b57f2516ac8f",volumeInSeries:22,fullTitle:"Vitamin E in Health and Disease - Interactions, Diseases and Health Aspects",editors:[{id:"109978",title:"Prof.",name:"Pınar",middleName:null,surname:"Erkekoğlu",slug:"pinar-erkekoglu",fullName:"Pınar Erkekoğlu",profilePictureURL:"https://mts.intechopen.com/storage/users/109978/images/system/109978.jpg",institutionString:"Hacettepe University",institution:{name:"Hacettepe University",institutionURL:null,country:{name:"Turkey"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},subseriesFiltersForPublishedBooks:[{group:"subseries",caption:"Proteomics",value:18,count:4},{group:"subseries",caption:"Metabolism",value:17,count:6},{group:"subseries",caption:"Cell and Molecular Biology",value:14,count:9},{group:"subseries",caption:"Chemical Biology",value:15,count:13}],publicationYearFilters:[{group:"publicationYear",caption:"2022",value:2022,count:8},{group:"publicationYear",caption:"2021",value:2021,count:7},{group:"publicationYear",caption:"2020",value:2020,count:12},{group:"publicationYear",caption:"2019",value:2019,count:3},{group:"publicationYear",caption:"2018",value:2018,count:2}],authors:{paginationCount:301,paginationItems:[{id:"116250",title:"Dr.",name:"Nima",middleName:null,surname:"Rezaei",slug:"nima-rezaei",fullName:"Nima Rezaei",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/116250/images/system/116250.jpg",biography:"Professor Nima Rezaei obtained an MD from Tehran University of Medical Sciences, Iran. He also obtained an MSc in Molecular and Genetic Medicine, and a Ph.D. in Clinical Immunology and Human Genetics from the University of Sheffield, UK. He also completed a short-term fellowship in Pediatric Clinical Immunology and Bone Marrow Transplantation at Newcastle General Hospital, England. Dr. Rezaei is a Full Professor of Immunology and Vice Dean of International Affairs and Research, at the School of Medicine, Tehran University of Medical Sciences, and the co-founder and head of the Research Center for Immunodeficiencies. He is also the founding president of the Universal Scientific Education and Research Network (USERN). Dr. Rezaei has directed more than 100 research projects and has designed and participated in several international collaborative projects. He is an editor, editorial assistant, or editorial board member of more than forty international journals. He has edited more than 50 international books, presented more than 500 lectures/posters in congresses/meetings, and published more than 1,100 scientific papers in international journals.",institutionString:"Tehran University of Medical Sciences",institution:{name:"Tehran University of Medical Sciences",country:{name:"Iran"}}},{id:"180733",title:"Dr.",name:"Jean",middleName:null,surname:"Engohang-Ndong",slug:"jean-engohang-ndong",fullName:"Jean Engohang-Ndong",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/180733/images/system/180733.png",biography:"Dr. Jean Engohang-Ndong was born and raised in Gabon. After obtaining his Associate Degree of Science at the University of Science and Technology of Masuku, Gabon, he continued his education in France where he obtained his BS, MS, and Ph.D. in Medical Microbiology. He worked as a post-doctoral fellow at the Public Health Research Institute (PHRI), Newark, NJ for four years before accepting a three-year faculty position at Brigham Young University-Hawaii. Dr. Engohang-Ndong is a tenured faculty member with the academic rank of Full Professor at Kent State University, Ohio, where he teaches a wide range of biological science courses and pursues his research in medical and environmental microbiology. Recently, he expanded his research interest to epidemiology and biostatistics of chronic diseases in Gabon.",institutionString:"Kent State University",institution:{name:"Kent State University",country:{name:"United States of America"}}},{id:"188773",title:"Prof.",name:"Emmanuel",middleName:null,surname:"Drouet",slug:"emmanuel-drouet",fullName:"Emmanuel Drouet",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/188773/images/system/188773.png",biography:"Emmanuel Drouet, PharmD, is a Professor of Virology at the Faculty of Pharmacy, the University Grenoble-Alpes, France. As a head scientist at the Institute of Structural Biology in Grenoble, Dr. Drouet’s research investigates persisting viruses in humans (RNA and DNA viruses) and the balance with our host immune system. He focuses on these viruses’ effects on humans (both their impact on pathology and their symbiotic relationships in humans). He has an excellent track record in the herpesvirus field, and his group is engaged in clinical research in the field of Epstein-Barr virus diseases. He is the editor of the online Encyclopedia of Environment and he coordinates the Universal Health Coverage education program for the BioHealth Computing Schools of the European Institute of Science.",institutionString:null,institution:{name:"Grenoble Alpes University",country:{name:"France"}}},{id:"131400",title:"Prof.",name:"Alfonso J.",middleName:null,surname:"Rodriguez-Morales",slug:"alfonso-j.-rodriguez-morales",fullName:"Alfonso J. Rodriguez-Morales",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/131400/images/system/131400.png",biography:"Dr. Rodriguez-Morales is an expert in tropical and emerging diseases, particularly zoonotic and vector-borne diseases (especially arboviral diseases). He is the president of the Travel Medicine Committee of the Pan-American Infectious Diseases Association (API), as well as the president of the Colombian Association of Infectious Diseases (ACIN). He is a member of the Committee on Tropical Medicine, Zoonoses, and Travel Medicine of ACIN. He is a vice-president of the Latin American Society for Travel Medicine (SLAMVI) and a Member of the Council of the International Society for Infectious Diseases (ISID). Since 2014, he has been recognized as a Senior Researcher, at the Ministry of Science of Colombia. He is a professor at the Faculty of Medicine of the Fundacion Universitaria Autonoma de las Americas, in Pereira, Risaralda, Colombia. He is an External Professor, Master in Research on Tropical Medicine and International Health, Universitat de Barcelona, Spain. He is also a professor at the Master in Clinical Epidemiology and Biostatistics, Universidad Científica del Sur, Lima, Peru. In 2021 he has been awarded the “Raul Isturiz Award” Medal of the API. Also, in 2021, he was awarded with the “Jose Felix Patiño” Asclepius Staff Medal of the Colombian Medical College, due to his scientific contributions to COVID-19 during the pandemic. He is currently the Editor in Chief of the journal Travel Medicine and Infectious Diseases. His Scopus H index is 47 (Google Scholar H index, 68).",institutionString:"Institución Universitaria Visión de las Américas, Colombia",institution:null},{id:"332819",title:"Dr.",name:"Chukwudi Michael",middleName:"Michael",surname:"Egbuche",slug:"chukwudi-michael-egbuche",fullName:"Chukwudi Michael Egbuche",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/332819/images/14624_n.jpg",biography:"I an Dr. Chukwudi Michael Egbuche. I am a Senior Lecturer in the Department of Parasitology and Entomology, Nnamdi Azikiwe University, Awka.",institutionString:null,institution:{name:"Nnamdi Azikiwe University",country:{name:"Nigeria"}}},{id:"284232",title:"Mr.",name:"Nikunj",middleName:"U",surname:"Tandel",slug:"nikunj-tandel",fullName:"Nikunj Tandel",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/284232/images/8275_n.jpg",biography:'Mr. Nikunj Tandel has completed his Master\'s degree in Biotechnology from VIT University, India in the year of 2012. He is having 8 years of research experience especially in the field of malaria epidemiology, immunology, and nanoparticle-based drug delivery system against the infectious diseases, autoimmune disorders and cancer. He has worked for the NIH funded-International Center of Excellence in Malaria Research project "Center for the study of complex malaria in India (CSCMi)" in collaboration with New York University. The preliminary objectives of the study are to understand and develop the evidence-based tools and interventions for the control and prevention of malaria in different sites of the INDIA. Alongside, with the help of next-generation genomics study, the team has studied the antimalarial drug resistance in India. Further, he has extended his research in the development of Humanized mice for the study of liver-stage malaria and identification of molecular marker(s) for the Artemisinin resistance. At present, his research focuses on understanding the role of B cells in the activation of CD8+ T cells in malaria. Received the CSIR-SRF (Senior Research Fellow) award-2018, FIMSA (Federation of Immunological Societies of Asia-Oceania) Travel Bursary award to attend the IUIS-IIS-FIMSA Immunology course-2019',institutionString:"Nirma University",institution:{name:"Nirma University",country:{name:"India"}}},{id:"334383",title:"Ph.D.",name:"Simone",middleName:"Ulrich",surname:"Ulrich Picoli",slug:"simone-ulrich-picoli",fullName:"Simone Ulrich Picoli",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/334383/images/15919_n.jpg",biography:"Graduated in Pharmacy from Universidade Luterana do Brasil (1999), Master in Agricultural and Environmental Microbiology from Federal University of Rio Grande do Sul (2002), Specialization in Clinical Microbiology from Universidade de São Paulo, USP (2007) and PhD in Sciences in Gastroenterology and Hepatology (2012). She is currently an Adjunct Professor at Feevale University in Medicine and Biomedicine courses and a permanent professor of the Academic Master\\'s Degree in Virology. She has experience in the field of Microbiology, with an emphasis on Bacteriology, working mainly on the following topics: bacteriophages, bacterial resistance, clinical microbiology and food microbiology.",institutionString:null,institution:{name:"Universidade Feevale",country:{name:"Brazil"}}},{id:"229220",title:"Dr.",name:"Amjad",middleName:"Islam",surname:"Aqib",slug:"amjad-aqib",fullName:"Amjad Aqib",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/229220/images/system/229220.png",biography:"Dr. Amjad Islam Aqib obtained a DVM and MSc (Hons) from University of Agriculture Faisalabad (UAF), Pakistan, and a PhD from the University of Veterinary and Animal Sciences Lahore, Pakistan. Dr. Aqib joined the Department of Clinical Medicine and Surgery at UAF for one year as an assistant professor where he developed a research laboratory designated for pathogenic bacteria. Since 2018, he has been Assistant Professor/Officer in-charge, Department of Medicine, Manager Research Operations and Development-ORIC, and President One Health Club at Cholistan University of Veterinary and Animal Sciences, Bahawalpur, Pakistan. He has nearly 100 publications to his credit. His research interests include epidemiological patterns and molecular analysis of antimicrobial resistance and modulation and vaccine development against animal pathogens of public health concern.",institutionString:"Cholistan University of Veterinary and Animal Sciences",institution:null},{id:"62900",title:"Prof.",name:"Fethi",middleName:null,surname:"Derbel",slug:"fethi-derbel",fullName:"Fethi Derbel",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/62900/images/system/62900.jpeg",biography:"Professor Fethi Derbel was born in 1960 in Tunisia. He received his medical degree from the Sousse Faculty of Medicine at Sousse, University of Sousse, Tunisia. He completed his surgical residency in General Surgery at the University Hospital Farhat Hached of Sousse and was a member of the Unit of Liver Transplantation in the University of Rennes, France. He then worked in the Department of Surgery at the Sahloul University Hospital in Sousse. Professor Derbel is presently working at the Clinique les Oliviers, Sousse, Tunisia. His hospital activities are mostly concerned with laparoscopic, colorectal, pancreatic, hepatobiliary, and gastric surgery. He is also very interested in hernia surgery and performs ventral hernia repairs and inguinal hernia repairs. He has been a member of the GREPA and Tunisian Hernia Society (THS). During his residency, he managed patients suffering from diabetic foot, and he was very interested in this pathology. For this reason, he decided to coordinate a book project dealing with the diabetic foot. Professor Derbel has published many articles in journals and collaborates intensively with IntechOpen Access Publisher as an editor.",institutionString:"Clinique les Oliviers",institution:null},{id:"300144",title:"Dr.",name:"Meriem",middleName:null,surname:"Braiki",slug:"meriem-braiki",fullName:"Meriem Braiki",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/300144/images/system/300144.jpg",biography:"Dr. Meriem Braiki is a specialist in pediatric surgeon from Tunisia. She was born in 1985. She received her medical degree from the University of Medicine at Sousse, Tunisia. She achieved her surgical residency training periods in Pediatric Surgery departments at University Hospitals in Monastir, Tunis and France.\r\nShe is currently working at the Pediatric surgery department, Sidi Bouzid Hospital, Tunisia. Her hospital activities are mostly concerned with laparoscopic, parietal, urological and digestive surgery. She has published several articles in diffrent journals.",institutionString:"Sidi Bouzid Regional Hospital",institution:null},{id:"229481",title:"Dr.",name:"Erika M.",middleName:"Martins",surname:"de Carvalho",slug:"erika-m.-de-carvalho",fullName:"Erika M. de Carvalho",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/229481/images/6397_n.jpg",biography:null,institutionString:null,institution:{name:"Oswaldo Cruz Foundation",country:{name:"Brazil"}}},{id:"186537",title:"Prof.",name:"Tonay",middleName:null,surname:"Inceboz",slug:"tonay-inceboz",fullName:"Tonay Inceboz",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/186537/images/system/186537.jfif",biography:"I was graduated from Ege University of Medical Faculty (Turkey) in 1988 and completed his Med. PhD degree in Medical Parasitology at the same university. I became an Associate Professor in 2008 and Professor in 2014. I am currently working as a Professor at the Department of Medical Parasitology at Dokuz Eylul University, Izmir, Turkey.\n\nI have given many lectures, presentations in different academic meetings. I have more than 60 articles in peer-reviewed journals, 18 book chapters, 1 book editorship.\n\nMy research interests are Echinococcus granulosus, Echinococcus multilocularis (diagnosis, life cycle, in vitro and in vivo cultivation), and Trichomonas vaginalis (diagnosis, PCR, and in vitro cultivation).",institutionString:"Dokuz Eylül University",institution:{name:"Dokuz Eylül University",country:{name:"Turkey"}}},{id:"71812",title:"Prof.",name:"Hanem Fathy",middleName:"Fathy",surname:"Khater",slug:"hanem-fathy-khater",fullName:"Hanem Fathy Khater",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/71812/images/1167_n.jpg",biography:"Prof. Khater is a Professor of Parasitology at Benha University, Egypt. She studied for her doctoral degree, at the Department of Entomology, College of Agriculture, Food and Natural Resources, University of Missouri, Columbia, USA. She has completed her Ph.D. degrees in Parasitology in Egypt, from where she got the award for “the best scientific Ph.D. dissertation”. She worked at the School of Biological Sciences, Bristol, England, the UK in controlling insects of medical and veterinary importance as a grant from Newton Mosharafa, the British Council. Her research is focused on searching of pesticides against mosquitoes, house flies, lice, green bottle fly, camel nasal botfly, soft and hard ticks, mites, and the diamondback moth as well as control of several parasites using safe and natural materials to avoid drug resistances and environmental contamination.",institutionString:null,institution:{name:"Banha University",country:{name:"Egypt"}}},{id:"99780",title:"Prof.",name:"Omolade",middleName:"Olayinka",surname:"Okwa",slug:"omolade-okwa",fullName:"Omolade Okwa",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/99780/images/system/99780.jpg",biography:"Omolade Olayinka Okwa is presently a Professor of Parasitology at Lagos State University, Nigeria. She has a PhD in Parasitology (1997), an MSc in Cellular Parasitology (1992), and a BSc (Hons) Zoology (1990) all from the University of Ibadan, Nigeria. She teaches parasitology at the undergraduate and postgraduate levels. She was a recipient of a Commonwealth fellowship supported by British Council tenable at the Centre for Entomology and Parasitology (CAEP), Keele University, United Kingdom between 2004 and 2005. She was awarded an Honorary Visiting Research Fellow at the same university from 2005 to 2007. \nShe has been an external examiner to the Department of Veterinary Microbiology and Parasitology, University of Ibadan, MSc programme between 2010 and 2012. She is a member of the Nigerian Society of Experimental Biology (NISEB), Parasitology and Public Health Society of Nigeria (PPSN), Science Association of Nigeria (SAN), Zoological Society of Nigeria (ZSN), and is Vice Chairperson of the Organisation of Women in Science (OWSG), LASU chapter. She served as Head of Department of Zoology and Environmental Biology, Lagos State University from 2007 to 2010 and 2014 to 2016. She is a reviewer for several local and international journals such as Unilag Journal of Science, Libyan Journal of Medicine, Journal of Medicine and Medical Sciences, and Annual Research and Review in Science. \nShe has authored 45 scientific research publications in local and international journals, 8 scientific reviews, 4 books, and 3 book chapters, which includes the books “Malaria Parasites” and “Malaria” which are IntechOpen access publications.",institutionString:"Lagos State University",institution:{name:"Lagos State University",country:{name:"Nigeria"}}},{id:"273100",title:"Dr.",name:"Vijay",middleName:null,surname:"Gayam",slug:"vijay-gayam",fullName:"Vijay Gayam",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/273100/images/system/273100.jpeg",biography:"Dr. Vijay Bhaskar Reddy Gayam is currently practicing as an internist at Interfaith Medical Center in Brooklyn, New York, USA. He is also a Clinical Assistant Professor at the SUNY Downstate University Hospital and Adjunct Professor of Medicine at the American University of Antigua. He is a holder of an M.B.B.S. degree bestowed to him by Osmania Medical College and received his M.D. at Interfaith Medical Center. His career goals thus far have heavily focused on direct patient care, medical education, and clinical research. He currently serves in two leadership capacities; Assistant Program Director of Medicine at Interfaith Medical Center and as a Councilor for the American\r\nFederation for Medical Research. As a true academician and researcher, he has more than 50 papers indexed in international peer-reviewed journals. He has also presented numerous papers in multiple national and international scientific conferences. His areas of research interest include general internal medicine, gastroenterology and hepatology. He serves as an editor, editorial board member and reviewer for multiple international journals. His research on Hepatitis C has been very successful and has led to multiple research awards, including the 'Equity in Prevention and Treatment Award” from the New York Department of Health Viral Hepatitis Symposium (2018) and the 'Presidential Poster Award” awarded to him by the American College of Gastroenterology (2018). He was also awarded 'Outstanding Clinician in General Medicine” by Venus International Foundation for his extensive research expertise and services, perform over and above the standard expected in the advancement of healthcare, patient safety and quality of care.",institutionString:"Interfaith Medical Center",institution:{name:"Interfaith Medical Center",country:{name:"United States of America"}}},{id:"93517",title:"Dr.",name:"Clement",middleName:"Adebajo",surname:"Meseko",slug:"clement-meseko",fullName:"Clement Meseko",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/93517/images/system/93517.jpg",biography:"Dr. Clement Meseko obtained DVM and PhD degree in Veterinary Medicine and Virology respectively. He has worked for over 20 years in both private and public sectors including the academia, contributing to knowledge and control of infectious disease. Through the application of epidemiological skill, classical and molecular virological skills, he investigates viruses of economic and public health importance for the mitigation of the negative impact on people, animal and the environment in the context of Onehealth. \r\nDr. Meseko’s field experience on animal and zoonotic diseases and pathogen dynamics at the human-animal interface over the years shaped his carrier in research and scientific inquiries. He has been part of the investigation of Highly Pathogenic Avian Influenza incursions in sub Saharan Africa and monitors swine Influenza (Pandemic influenza Virus) agro-ecology and potential for interspecies transmission. He has authored and reviewed a number of journal articles and book chapters.",institutionString:"National Veterinary Research Institute",institution:{name:"National Veterinary Research Institute",country:{name:"Nigeria"}}},{id:"158026",title:"Prof.",name:"Shailendra K.",middleName:null,surname:"Saxena",slug:"shailendra-k.-saxena",fullName:"Shailendra K. Saxena",position:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRET3QAO/Profile_Picture_2022-05-10T10:10:26.jpeg",biography:"Professor Dr. Shailendra K. Saxena is a vice dean and professor at King George's Medical University, Lucknow, India. His research interests involve understanding the molecular mechanisms of host defense during human viral infections and developing new predictive, preventive, and therapeutic strategies for them using Japanese encephalitis virus (JEV), HIV, and emerging viruses as a model via stem cell and cell culture technologies. His research work has been published in various high-impact factor journals (Science, PNAS, Nature Medicine) with a high number of citations. He has received many awards and honors in India and abroad including various Young Scientist Awards, BBSRC India Partnering Award, and Dr. JC Bose National Award of Department of Biotechnology, Min. of Science and Technology, Govt. of India. Dr. Saxena is a fellow of various international societies/academies including the Royal College of Pathologists, United Kingdom; Royal Society of Medicine, London; Royal Society of Biology, United Kingdom; Royal Society of Chemistry, London; and Academy of Translational Medicine Professionals, Austria. He was named a Global Leader in Science by The Scientist. He is also an international opinion leader/expert in vaccination for Japanese encephalitis by IPIC (UK).",institutionString:"King George's Medical University",institution:{name:"King George's Medical University",country:{name:"India"}}},{id:"94928",title:"Dr.",name:"Takuo",middleName:null,surname:"Mizukami",slug:"takuo-mizukami",fullName:"Takuo Mizukami",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/94928/images/6402_n.jpg",biography:null,institutionString:null,institution:{name:"National Institute of Infectious Diseases",country:{name:"Japan"}}},{id:"233433",title:"Dr.",name:"Yulia",middleName:null,surname:"Desheva",slug:"yulia-desheva",fullName:"Yulia Desheva",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/233433/images/system/233433.png",biography:"Dr. Yulia Desheva is a leading researcher at the Institute of Experimental Medicine, St. Petersburg, Russia. She is a professor in the Stomatology Faculty, St. Petersburg State University. She has expertise in the development and evaluation of a wide range of live mucosal vaccines against influenza and bacterial complications. Her research interests include immunity against influenza and COVID-19 and the development of immunization schemes for high-risk individuals.",institutionString:'Federal State Budgetary Scientific Institution "Institute of Experimental Medicine"',institution:null},{id:"238958",title:"Mr.",name:"Atamjit",middleName:null,surname:"Singh",slug:"atamjit-singh",fullName:"Atamjit Singh",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/238958/images/6575_n.jpg",biography:null,institutionString:null,institution:null},{id:"333753",title:"Dr.",name:"Rais",middleName:null,surname:"Ahmed",slug:"rais-ahmed",fullName:"Rais Ahmed",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/333753/images/20168_n.jpg",biography:null,institutionString:null,institution:null},{id:"252058",title:"M.Sc.",name:"Juan",middleName:null,surname:"Sulca",slug:"juan-sulca",fullName:"Juan Sulca",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/252058/images/12834_n.jpg",biography:null,institutionString:null,institution:null},{id:"191392",title:"Dr.",name:"Marimuthu",middleName:null,surname:"Govindarajan",slug:"marimuthu-govindarajan",fullName:"Marimuthu Govindarajan",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/191392/images/5828_n.jpg",biography:"Dr. M. Govindarajan completed his BSc degree in Zoology at Government Arts College (Autonomous), Kumbakonam, and MSc, MPhil, and PhD degrees at Annamalai University, Annamalai Nagar, Tamil Nadu, India. He is serving as an assistant professor at the Department of Zoology, Annamalai University. His research interests include isolation, identification, and characterization of biologically active molecules from plants and microbes. He has identified more than 20 pure compounds with high mosquitocidal activity and also conducted high-quality research on photochemistry and nanosynthesis. He has published more than 150 studies in journals with impact factor and 2 books in Lambert Academic Publishing, Germany. He serves as an editorial board member in various national and international scientific journals.",institutionString:null,institution:null},{id:"274660",title:"Dr.",name:"Damodar",middleName:null,surname:"Paudel",slug:"damodar-paudel",fullName:"Damodar Paudel",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/274660/images/8176_n.jpg",biography:"I am DrDamodar Paudel,currently working as consultant Physician in Nepal police Hospital.",institutionString:null,institution:null},{id:"241562",title:"Dr.",name:"Melvin",middleName:null,surname:"Sanicas",slug:"melvin-sanicas",fullName:"Melvin Sanicas",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/241562/images/6699_n.jpg",biography:null,institutionString:null,institution:null},{id:"337446",title:"Dr.",name:"Maria",middleName:null,surname:"Zavala-Colon",slug:"maria-zavala-colon",fullName:"Maria Zavala-Colon",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Puerto Rico, Medical Sciences Campus",country:{name:"United States of America"}}},{id:"338856",title:"Mrs.",name:"Nur Alvira",middleName:null,surname:"Pascawati",slug:"nur-alvira-pascawati",fullName:"Nur Alvira Pascawati",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universitas Respati Yogyakarta",country:{name:"Indonesia"}}},{id:"441116",title:"Dr.",name:"Jovanka M.",middleName:null,surname:"Voyich",slug:"jovanka-m.-voyich",fullName:"Jovanka M. Voyich",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Montana State University",country:{name:"United States of America"}}},{id:"330412",title:"Dr.",name:"Muhammad",middleName:null,surname:"Farhab",slug:"muhammad-farhab",fullName:"Muhammad Farhab",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Agriculture Faisalabad",country:{name:"Pakistan"}}},{id:"349495",title:"Dr.",name:"Muhammad",middleName:null,surname:"Ijaz",slug:"muhammad-ijaz",fullName:"Muhammad Ijaz",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Veterinary and Animal Sciences",country:{name:"Pakistan"}}}]}},subseries:{item:{id:"12",type:"subseries",title:"Human Physiology",keywords:"Anatomy, Cells, Organs, Systems, Homeostasis, Functions",scope:"Human physiology is the scientific exploration of the various functions (physical, biochemical, and mechanical properties) of humans, their organs, and their constituent cells. The endocrine and nervous systems play important roles in maintaining homeostasis in the human body. Integration, which is the biological basis of physiology, is achieved through communication between the many overlapping functions of the human body's systems, which takes place through electrical and chemical means. Much of the basis of our knowledge of human physiology has been provided by animal experiments. Because of the close relationship between structure and function, studies in human physiology and anatomy seek to understand the mechanisms that help the human body function. The series on human physiology deals with the various mechanisms of interaction between the various organs, nerves, and cells in the human body.",coverUrl:"https://cdn.intechopen.com/series_topics/covers/12.jpg",hasOnlineFirst:!0,hasPublishedBooks:!0,annualVolume:11408,editor:{id:"195829",title:"Prof.",name:"Kunihiro",middleName:null,surname:"Sakuma",slug:"kunihiro-sakuma",fullName:"Kunihiro Sakuma",profilePictureURL:"https://mts.intechopen.com/storage/users/195829/images/system/195829.jpg",biography:"Professor Kunihiro Sakuma, Ph.D., currently works in the Institute for Liberal Arts at the Tokyo Institute of Technology. He is a physiologist working in the field of skeletal muscle. He was awarded his sports science diploma in 1995 by the University of Tsukuba and began his scientific work at the Department of Physiology, Aichi Human Service Center, focusing on the molecular mechanism of congenital muscular dystrophy and normal muscle regeneration. His interest later turned to the molecular mechanism and attenuating strategy of sarcopenia (age-related muscle atrophy). His opinion is to attenuate sarcopenia by improving autophagic defects using nutrient- and pharmaceutical-based treatments.",institutionString:null,institution:{name:"Tokyo Institute of Technology",institutionURL:null,country:{name:"Japan"}}},editorTwo:{id:"331519",title:"Dr.",name:"Kotomi",middleName:null,surname:"Sakai",slug:"kotomi-sakai",fullName:"Kotomi Sakai",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000031QtFXQA0/Profile_Picture_1637053227318",biography:"Senior researcher Kotomi Sakai, Ph.D., MPH, works at the Research Organization of Science and Technology in Ritsumeikan University. She is a researcher in the geriatric rehabilitation and public health field. She received Ph.D. from Nihon University and MPH from St.Luke’s International University. Her main research interest is sarcopenia in older adults, especially its association with nutritional status. Additionally, to understand how to maintain and improve physical function in older adults, to conduct studies about the mechanism of sarcopenia and determine when possible interventions are needed.",institutionString:null,institution:{name:"Ritsumeikan University",institutionURL:null,country:{name:"Japan"}}},editorThree:null,series:{id:"10",title:"Physiology",doi:"10.5772/intechopen.72796",issn:"2631-8261"},editorialBoard:[{id:"213786",title:"Dr.",name:"Henrique P.",middleName:null,surname:"Neiva",slug:"henrique-p.-neiva",fullName:"Henrique P. Neiva",profilePictureURL:"https://mts.intechopen.com/storage/users/213786/images/system/213786.png",institutionString:null,institution:{name:"University of Beira Interior",institutionURL:null,country:{name:"Portugal"}}},{id:"39275",title:"Prof.",name:"Herbert Ryan",middleName:null,surname:"Marini",slug:"herbert-ryan-marini",fullName:"Herbert Ryan Marini",profilePictureURL:"https://mts.intechopen.com/storage/users/39275/images/9459_n.jpg",institutionString:null,institution:{name:"University of Messina",institutionURL:null,country:{name:"Italy"}}},{id:"319576",title:"Prof.",name:"Nikolay",middleName:null,surname:"Boyadjiev",slug:"nikolay-boyadjiev",fullName:"Nikolay Boyadjiev",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y00002v4b3cQAA/Profile_Picture_2022-06-07T08:30:58.jpeg",institutionString:null,institution:{name:"Medical University Plovdiv",institutionURL:null,country:{name:"Bulgaria"}}},{id:"196218",title:"Dr.",name:"Pasquale",middleName:null,surname:"Cianci",slug:"pasquale-cianci",fullName:"Pasquale Cianci",profilePictureURL:"https://mts.intechopen.com/storage/users/196218/images/system/196218.png",institutionString:null,institution:{name:"University of Foggia",institutionURL:null,country:{name:"Italy"}}}]},onlineFirstChapters:{paginationCount:13,paginationItems:[{id:"81566",title:"New and Emerging Technologies for Integrative Ambulatory Autonomic Assessment and Intervention as a Catalyst in the Synergy of Remote Geocoded Biosensing, Algorithmic Networked Cloud Computing, Deep Learning, and Regenerative/Biomic Medicine: Further Real",doi:"10.5772/intechopen.104092",signatures:"Robert L. Drury",slug:"new-and-emerging-technologies-for-integrative-ambulatory-autonomic-assessment-and-intervention-as-a-",totalDownloads:18,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Autonomic Nervous System - Special Interest Topics",coverURL:"https://cdn.intechopen.com/books/images_new/10835.jpg",subseries:{id:"12",title:"Human Physiology"}}},{id:"81286",title:"Potassium Derangements: A Pathophysiological Review, Diagnostic Approach, and Clinical Management",doi:"10.5772/intechopen.103016",signatures:"Sairah Sharif and Jie Tang",slug:"potassium-derangements-a-pathophysiological-review-diagnostic-approach-and-clinical-management",totalDownloads:41,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Potassium in Human Health",coverURL:"https://cdn.intechopen.com/books/images_new/10794.jpg",subseries:{id:"12",title:"Human Physiology"}}},{id:"80895",title:"Heart Rate Variability as a Marker of Homeostatic Level",doi:"10.5772/intechopen.102500",signatures:"Moacir Fernandes de Godoy and Michele Lima Gregório",slug:"heart-rate-variability-as-a-marker-of-homeostatic-level",totalDownloads:36,totalCrossrefCites:0,totalDimensionsCites:0,authors:[{name:"Moacir",surname:"Godoy"},{name:"Michele",surname:"Gregório"}],book:{title:"Autonomic Nervous System - Special Interest Topics",coverURL:"https://cdn.intechopen.com/books/images_new/10835.jpg",subseries:{id:"12",title:"Human Physiology"}}},{id:"80433",title:"Heart Autonomic Nervous System: Basic Science and Clinical Implications",doi:"10.5772/intechopen.101718",signatures:"Elvan Wiyarta and Nayla Karima",slug:"heart-autonomic-nervous-system-basic-science-and-clinical-implications",totalDownloads:71,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Autonomic Nervous System - Special Interest Topics",coverURL:"https://cdn.intechopen.com/books/images_new/10835.jpg",subseries:{id:"12",title:"Human Physiology"}}},{id:"80316",title:"Central Control of the Larynx in Mammals",doi:"10.5772/intechopen.102009",signatures:"Manuel Víctor López-González, Marta González-García, Laura Carrillo-Franco, Amelia Díaz-Casares and Marc Stefan Dawid-Milner",slug:"central-control-of-the-larynx-in-mammals",totalDownloads:46,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Autonomic Nervous System - Special Interest Topics",coverURL:"https://cdn.intechopen.com/books/images_new/10835.jpg",subseries:{id:"12",title:"Human Physiology"}}},{id:"80402",title:"General Anesthesia and Autonomic Nervous System: Control and Management in Neurosurgery",doi:"10.5772/intechopen.101829",signatures:"Irina Alexandrovna Savvina, Anna Olegovna Petrova and Yulia Mikhailovna Zabrodskaya",slug:"general-anesthesia-and-autonomic-nervous-system-control-and-management-in-neurosurgery",totalDownloads:71,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Autonomic Nervous System - Special Interest Topics",coverURL:"https://cdn.intechopen.com/books/images_new/10835.jpg",subseries:{id:"12",title:"Human Physiology"}}},{id:"80035",title:"Healthy Lifestyle, Autonomic Nervous System Activity, and Sleep Status for Healthy Aging",doi:"10.5772/intechopen.101837",signatures:"Miki Sato, Feni Betriana, Ryuichi Tanioka, Kyoko Osaka, Tetsuya Tanioka and Savina Schoenhofer",slug:"healthy-lifestyle-autonomic-nervous-system-activity-and-sleep-status-for-healthy-aging",totalDownloads:74,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Autonomic Nervous System - Special Interest Topics",coverURL:"https://cdn.intechopen.com/books/images_new/10835.jpg",subseries:{id:"12",title:"Human Physiology"}}},{id:"80175",title:"Signaling Pathways Regulating Axogenesis and Dendritogenesis in Sympathetic Neurons",doi:"10.5772/intechopen.102442",signatures:"Vidya Chandrasekaran",slug:"signaling-pathways-regulating-axogenesis-and-dendritogenesis-in-sympathetic-neurons",totalDownloads:75,totalCrossrefCites:0,totalDimensionsCites:0,authors:[{name:"Vidya",surname:"Chandrasekaran"}],book:{title:"Autonomic Nervous System - Special Interest Topics",coverURL:"https://cdn.intechopen.com/books/images_new/10835.jpg",subseries:{id:"12",title:"Human Physiology"}}},{id:"80176",title:"Impacts of Environmental Stressors on Autonomic Nervous System",doi:"10.5772/intechopen.101842",signatures:"Mayowa Adeniyi",slug:"impacts-of-environmental-stressors-on-autonomic-nervous-system",totalDownloads:77,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Autonomic Nervous System - Special Interest Topics",coverURL:"https://cdn.intechopen.com/books/images_new/10835.jpg",subseries:{id:"12",title:"Human Physiology"}}},{id:"79655",title:"The Autonomic Nervous System, Sex Differences, and Chronobiology under General Anesthesia in In Vivo Experiments Involving Rats",doi:"10.5772/intechopen.101075",signatures:"Pavol Svorc Jr and Pavol Svorc",slug:"the-autonomic-nervous-system-sex-differences-and-chronobiology-under-general-anesthesia-in-in-vivo-e",totalDownloads:99,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Autonomic Nervous System - Special Interest Topics",coverURL:"https://cdn.intechopen.com/books/images_new/10835.jpg",subseries:{id:"12",title:"Human Physiology"}}},{id:"79194",title:"Potassium in Solid Cancers",doi:"10.5772/intechopen.101108",signatures:"Jessica Iorio, Lisa Lastraioli and Elena Lastraioli",slug:"potassium-in-solid-cancers",totalDownloads:155,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Potassium in Human Health",coverURL:"https://cdn.intechopen.com/books/images_new/10794.jpg",subseries:{id:"12",title:"Human Physiology"}}},{id:"78820",title:"Potassium Homeostasis",doi:"10.5772/intechopen.100368",signatures:"Shakuntala S. Patil and Sachin M. Patil",slug:"potassium-homeostasis",totalDownloads:120,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Potassium in Human Health",coverURL:"https://cdn.intechopen.com/books/images_new/10794.jpg",subseries:{id:"12",title:"Human Physiology"}}},{id:"78193",title:"Potassium and Cardiac Surgery",doi:"10.5772/intechopen.99735",signatures:"Shawn Kant, Frank W. Sellke and Jun Feng",slug:"potassium-and-cardiac-surgery",totalDownloads:203,totalCrossrefCites:1,totalDimensionsCites:1,authors:null,book:{title:"Potassium in Human Health",coverURL:"https://cdn.intechopen.com/books/images_new/10794.jpg",subseries:{id:"12",title:"Human Physiology"}}}]},publishedBooks:{paginationCount:7,paginationItems:[{type:"book",id:"7102",title:"Pneumonia",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7102.jpg",slug:"pneumonia",publishedDate:"May 11th 2022",editedByType:"Edited by",bookSignature:"Nima Rezaei",hash:"9fd70142814192dcec58a176749f1b60",volumeInSeries:13,fullTitle:"Pneumonia",editors:[{id:"116250",title:"Dr.",name:"Nima",middleName:null,surname:"Rezaei",slug:"nima-rezaei",fullName:"Nima Rezaei",profilePictureURL:"https://mts.intechopen.com/storage/users/116250/images/system/116250.jpg",institutionString:"Tehran University of Medical Sciences",institution:{name:"Tehran University of Medical Sciences",institutionURL:null,country:{name:"Iran"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9615",title:"Chikungunya Virus",subtitle:"A Growing Global Public Health Threat",coverURL:"https://cdn.intechopen.com/books/images_new/9615.jpg",slug:"chikungunya-virus-a-growing-global-public-health-threat",publishedDate:"February 9th 2022",editedByType:"Edited by",bookSignature:"Jean Engohang-Ndong",hash:"c960d94a63867dd12a8ab15176a3ff06",volumeInSeries:12,fullTitle:"Chikungunya Virus - A Growing Global Public Health Threat",editors:[{id:"180733",title:"Dr.",name:"Jean",middleName:null,surname:"Engohang-Ndong",slug:"jean-engohang-ndong",fullName:"Jean Engohang-Ndong",profilePictureURL:"https://mts.intechopen.com/storage/users/180733/images/system/180733.png",institutionString:"Kent State University",institution:{name:"Kent State University",institutionURL:null,country:{name:"United States of America"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9619",title:"Epstein-Barr Virus",subtitle:"New Trends",coverURL:"https://cdn.intechopen.com/books/images_new/9619.jpg",slug:"epstein-barr-virus-new-trends",publishedDate:"December 22nd 2021",editedByType:"Edited by",bookSignature:"Emmanuel Drouet",hash:"a2128c53becb6064589570cbe8d976f8",volumeInSeries:11,fullTitle:"Epstein-Barr Virus - New Trends",editors:[{id:"188773",title:"Prof.",name:"Emmanuel",middleName:null,surname:"Drouet",slug:"emmanuel-drouet",fullName:"Emmanuel Drouet",profilePictureURL:"https://mts.intechopen.com/storage/users/188773/images/system/188773.png",institutionString:null,institution:{name:"Grenoble Alpes University",institutionURL:null,country:{name:"France"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9613",title:"Dengue Fever in a One Health Perspective",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/9613.jpg",slug:"dengue-fever-in-a-one-health-perspective",publishedDate:"October 28th 2020",editedByType:"Edited by",bookSignature:"Márcia Aparecida Sperança",hash:"77ecce8195c11092230b4156df6d83ff",volumeInSeries:7,fullTitle:"Dengue Fever in a One Health Perspective",editors:[{id:"176579",title:"Dr.",name:"Márcia Aparecida",middleName:null,surname:"Sperança",slug:"marcia-aparecida-speranca",fullName:"Márcia Aparecida Sperança",profilePictureURL:"https://mts.intechopen.com/storage/users/176579/images/system/176579.jpg",institutionString:null,institution:{name:"Universidade Federal do ABC",institutionURL:null,country:{name:"Brazil"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"7887",title:"Hepatitis B and C",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7887.jpg",slug:"hepatitis-b-and-c",publishedDate:"April 8th 2020",editedByType:"Edited by",bookSignature:"Luis Rodrigo",hash:"8dd6dab483cf505d83caddaeaf497f2c",volumeInSeries:5,fullTitle:"Hepatitis B and C",editors:[{id:"73208",title:"Prof.",name:"Luis",middleName:null,surname:"Rodrigo",slug:"luis-rodrigo",fullName:"Luis Rodrigo",profilePictureURL:"https://mts.intechopen.com/storage/users/73208/images/system/73208.jpg",institutionString:"University of Oviedo",institution:{name:"University of Oviedo",institutionURL:null,country:{name:"Spain"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"7064",title:"Current Perspectives in Human Papillomavirus",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7064.jpg",slug:"current-perspectives-in-human-papillomavirus",publishedDate:"May 2nd 2019",editedByType:"Edited by",bookSignature:"Shailendra K. Saxena",hash:"d92a4085627bab25ddc7942fbf44cf05",volumeInSeries:2,fullTitle:"Current Perspectives in Human Papillomavirus",editors:[{id:"158026",title:"Prof.",name:"Shailendra K.",middleName:null,surname:"Saxena",slug:"shailendra-k.-saxena",fullName:"Shailendra K. Saxena",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRET3QAO/Profile_Picture_2022-05-10T10:10:26.jpeg",institutionString:"King George's Medical University",institution:{name:"King George's Medical University",institutionURL:null,country:{name:"India"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"6667",title:"Influenza",subtitle:"Therapeutics and Challenges",coverURL:"https://cdn.intechopen.com/books/images_new/6667.jpg",slug:"influenza-therapeutics-and-challenges",publishedDate:"September 19th 2018",editedByType:"Edited by",bookSignature:"Shailendra K. Saxena",hash:"105e347b2d5dbbe6b593aceffa051efa",volumeInSeries:1,fullTitle:"Influenza - Therapeutics and Challenges",editors:[{id:"158026",title:"Prof.",name:"Shailendra K.",middleName:null,surname:"Saxena",slug:"shailendra-k.-saxena",fullName:"Shailendra K. Saxena",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRET3QAO/Profile_Picture_2022-05-10T10:10:26.jpeg",institutionString:"King George's Medical University",institution:{name:"King George's Medical University",institutionURL:null,country:{name:"India"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},testimonialsList:[{id:"8",text:"I work with IntechOpen for a number of reasons: their professionalism, their mission in support of Open Access publishing, and the quality of their peer-reviewed publications, but also because they believe in equality.",author:{id:"202192",name:"Catrin",surname:"Rutland",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/202192/images/system/202192.png",slug:"catrin-rutland",institution:{id:"134",name:"University of Nottingham",country:{id:null,name:"United Kingdom"}}}},{id:"27",text:"The opportunity to work with a prestigious publisher allows for the possibility to collaborate with more research groups interested in animal nutrition, leading to the development of new feeding strategies and food valuation while being more sustainable with the environment, allowing more readers to learn about the subject.",author:{id:"175967",name:"Manuel",surname:"Gonzalez Ronquillo",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/175967/images/system/175967.png",slug:"manuel-gonzalez-ronquillo",institution:{id:"6221",name:"Universidad Autónoma del Estado de México",country:{id:null,name:"Mexico"}}}},{id:"18",text:"It was great publishing with IntechOpen, the process was straightforward and I had support all along.",author:{id:"71579",name:"Berend",surname:"Olivier",institutionString:"Utrecht University",profilePictureURL:"https://mts.intechopen.com/storage/users/71579/images/system/71579.png",slug:"berend-olivier",institution:{id:"253",name:"Utrecht University",country:{id:null,name:"Netherlands"}}}}]},submityourwork:{pteSeriesList:[{id:"14",title:"Artificial Intelligence",numberOfPublishedBooks:9,numberOfPublishedChapters:89,numberOfOpenTopics:6,numberOfUpcomingTopics:0,issn:"2633-1403",doi:"10.5772/intechopen.79920",isOpenForSubmission:!0},{id:"7",title:"Biomedical Engineering",numberOfPublishedBooks:12,numberOfPublishedChapters:104,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2631-5343",doi:"10.5772/intechopen.71985",isOpenForSubmission:!0}],lsSeriesList:[{id:"11",title:"Biochemistry",numberOfPublishedBooks:32,numberOfPublishedChapters:318,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2632-0983",doi:"10.5772/intechopen.72877",isOpenForSubmission:!0},{id:"25",title:"Environmental Sciences",numberOfPublishedBooks:1,numberOfPublishedChapters:12,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2754-6713",doi:"10.5772/intechopen.100362",isOpenForSubmission:!0},{id:"10",title:"Physiology",numberOfPublishedBooks:11,numberOfPublishedChapters:141,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-8261",doi:"10.5772/intechopen.72796",isOpenForSubmission:!0}],hsSeriesList:[{id:"3",title:"Dentistry",numberOfPublishedBooks:8,numberOfPublishedChapters:129,numberOfOpenTopics:2,numberOfUpcomingTopics:0,issn:"2631-6218",doi:"10.5772/intechopen.71199",isOpenForSubmission:!0},{id:"6",title:"Infectious Diseases",numberOfPublishedBooks:13,numberOfPublishedChapters:113,numberOfOpenTopics:3,numberOfUpcomingTopics:1,issn:"2631-6188",doi:"10.5772/intechopen.71852",isOpenForSubmission:!0},{id:"13",title:"Veterinary Medicine and Science",numberOfPublishedBooks:11,numberOfPublishedChapters:106,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2632-0517",doi:"10.5772/intechopen.73681",isOpenForSubmission:!0}],sshSeriesList:[{id:"22",title:"Business, Management and Economics",numberOfPublishedBooks:1,numberOfPublishedChapters:19,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2753-894X",doi:"10.5772/intechopen.100359",isOpenForSubmission:!0},{id:"23",title:"Education and Human Development",numberOfPublishedBooks:0,numberOfPublishedChapters:5,numberOfOpenTopics:1,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100360",isOpenForSubmission:!0},{id:"24",title:"Sustainable Development",numberOfPublishedBooks:0,numberOfPublishedChapters:15,numberOfOpenTopics:5,numberOfUpcomingTopics:0,issn:null,doi:"10.5772/intechopen.100361",isOpenForSubmission:!0}],subseriesList:[{id:"14",title:"Cell and Molecular Biology",scope:"The Cell and Molecular Biology topic within the IntechOpen Biochemistry Series aims to rapidly publish contributions on all aspects of cell and molecular biology, including aspects related to biochemical and genetic research (not only in humans but all living beings). We encourage the submission of manuscripts that provide novel and mechanistic insights that report significant advances in the fields. Topics include, but are not limited to: Advanced techniques of cellular and molecular biology (Molecular methodologies, imaging techniques, and bioinformatics); Biological activities at the molecular level; Biological processes of cell functions, cell division, senescence, maintenance, and cell death; Biomolecules interactions; Cancer; Cell biology; Chemical biology; Computational biology; Cytochemistry; Developmental biology; Disease mechanisms and therapeutics; DNA, and RNA metabolism; Gene functions, genetics, and genomics; Genetics; Immunology; Medical microbiology; Molecular biology; Molecular genetics; Molecular processes of cell and organelle dynamics; Neuroscience; Protein biosynthesis, degradation, and functions; Regulation of molecular interactions in a cell; Signalling networks and system biology; Structural biology; Virology and microbiology.",coverUrl:"https://cdn.intechopen.com/series_topics/covers/14.jpg",keywords:"Omics (Transcriptomics; Proteomics; Metabolomics), Molecular Biology, Cell Biology, Signal Transduction and Regulation, Cell Growth and Differentiation, Apoptosis, Necroptosis, Ferroptosis, Autophagy, Cell Cycle, Macromolecules and Complexes, Gene Expression"},{id:"15",title:"Chemical Biology",scope:"Chemical biology spans the fields of chemistry and biology involving the application of biological and chemical molecules and techniques. In recent years, the application of chemistry to biological molecules has gained significant interest in medicinal and pharmacological studies. This topic will be devoted to understanding the interplay between biomolecules and chemical compounds, their structure and function, and their potential applications in related fields. Being a part of the biochemistry discipline, the ideas and concepts that have emerged from Chemical Biology have affected other related areas. This topic will closely deal with all emerging trends in this discipline.",coverUrl:"https://cdn.intechopen.com/series_topics/covers/15.jpg",keywords:"Phenolic Compounds, Essential Oils, Modification of Biomolecules, Glycobiology, Combinatorial Chemistry, Therapeutic peptides, Enzyme Inhibitors"},{id:"17",title:"Metabolism",scope:"Metabolism is frequently defined in biochemistry textbooks as the overall process that allows living systems to acquire and use the free energy they need for their vital functions or the chemical processes that occur within a living organism to maintain life. Behind these definitions are hidden all the aspects of normal and pathological functioning of all processes that the topic ‘Metabolism’ will cover within the Biochemistry Series. Thus all studies on metabolism will be considered for publication.",coverUrl:"https://cdn.intechopen.com/series_topics/covers/17.jpg",keywords:"Biomolecules Metabolism, Energy Metabolism, Metabolic Pathways, Key Metabolic Enzymes, Metabolic Adaptation"},{id:"18",title:"Proteomics",scope:"With the recognition that the human genome cannot provide answers to the etiology of a disorder, changes in the proteins expressed by a genome became a focus in research. Thus proteomics, an area of research that detects all protein forms expressed in an organism, including splice isoforms and post-translational modifications, is more suitable than genomics for a comprehensive understanding of the biochemical processes that govern life. The most common proteomics applications are currently in the clinical field for the identification, in a variety of biological matrices, of biomarkers for diagnosis and therapeutic intervention of disorders. From the comparison of proteomic profiles of control and disease or different physiological states, which may emerge, changes in protein expression can provide new insights into the roles played by some proteins in human pathologies. Understanding how proteins function and interact with each other is another goal of proteomics that makes this approach even more intriguing. Specialized technology and expertise are required to assess the proteome of any biological sample. Currently, proteomics relies mainly on mass spectrometry (MS) combined with electrophoretic (1 or 2-DE-MS) and/or chromatographic techniques (LC-MS/MS). MS is an excellent tool that has gained popularity in proteomics because of its ability to gather a complex body of information such as cataloging protein expression, identifying protein modification sites, and defining protein interactions. The Proteomics topic aims to attract contributions on all aspects of MS-based proteomics that, by pushing the boundaries of MS capabilities, may address biological problems that have not been resolved yet.",coverUrl:"https://cdn.intechopen.com/series_topics/covers/18.jpg",keywords:"Mono- and Two-Dimensional Gel Electrophoresis (1-and 2-DE), Liquid Chromatography (LC), Mass Spectrometry/Tandem Mass Spectrometry (MS; MS/MS), Proteins"}],annualVolumeBook:{},thematicCollection:[],selectedSeries:null,selectedSubseries:null},seriesLanding:{item:null},libraryRecommendation:{success:null,errors:{},institutions:[]},route:{name:"chapter.detail",path:"/chapters/45187",hash:"",query:{},params:{id:"45187"},fullPath:"/chapters/45187",meta:{},from:{name:null,path:"/",hash:"",query:{},params:{},fullPath:"/",meta:{}}}},function(){var e;(e=document.currentScript||document.scripts[document.scripts.length-1]).parentNode.removeChild(e)}()